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Polymers constituted the basis for the plastics, rubber, adhesives, fiber, 
and coating industries. It is usually classified according to their use, such as 
thickening agents, film formers, resinous powders, and humectants. Polymer 
science tends to be quite interdisciplinary as it combines chemistry, chemical 
engineering, and other fields as well. Chemically, macromolecules are long 
chain molecules of high molecular weight. 
Polymers in different forms are used in pharmaceuticals in various 
ways, such as gelling and viscosity increasing agents, filling materials, 
suspending agents, tablet binders, film fonners, and extended release materials 
[1]. The amalgamation of polymer and pharmaceutical sciences led to the 
introduction of polymer in the design and development of drug delivery 
systems. Polymeric delivery systems are mainly intended to achieve controlled 
or sustained drug delivery. 
Polymer conjugation is a well known and widely exploited technique 
useful to improve therapeutic properties of various drugs, they are important in 
a variety of pharmaceutical applications. Prolonged half-life, higher stability, 
water solubility, lower immunogenicity and antigenicity can be expected from 
polymer conjugated drugs [2]. They are useful for the specific targeting to 
tissues or cells. Moreover, polymer-amphiphile interaction is also very much 
important in various industries including pharmaceuticals and medical. 
The synthetic polyiners represent variations in both the nature and 
degree of substitution and will be used to obtain a broad and unifying picture of 
the interaction in such systems [3]. Fairly detailed pictures of the interaction 
between drug-polymer have been obtained. Amphiphile involves adsorption of 
micelle-like aggregates (clusters) onto the polymer molecule as the 
fundamental step. The adsorption of amphiphile molecules onto the polymer 
has been found to be a cooperative process. 
Amphiphilic molecules which contain both a hydrophobic and 
hydrophilic part, in aqueous solution frequently assemble at interfaces and 
self-associate in an attempt to sequester their apolar regions from contact with 
the aqueous phase. This self-association gives rise to a rich variety of phase 
structures. 
Several drug molecules such as phenothiazine [4] and benzodiazapin [5] 
tranquilizers, analgesics [6] tricyclic antidepressants [7] and non-steroidal 
anti-inflammatory drugs [8] display amphiphilic behavior. They aggregate in a 
typical surfactant-like manner and self-associate above a critical concentration 
value and can interact with biological membranes. They have rather bulky and 
rigid nonpolar parts and do not form simple spherical micelles (like typical 
surfactant molecules do) but rather non-spherical aggregates are formed with a 
low aggregation number. Although the micelle formation in these drugs 
generally occurs at concentrations well above their therapeutic levels, it is a 
possibility that accumulation of these drugs cause a localized high 
concentration at a particular site in human body which may affect the 
biological activity of these drugs. 
Aggregation is not, however, just limited to aqueous solution; it is 
sometimes observed in non-aqueous polar solvents such as ethylene glycol etc. 
The self-aggregational behavior of these drugs plays an important role in 
controlling their pharmacological efficiency. The interaction of drugs with 
macromolecules had been interesting topic, because of their biological 
importance. The system becomes more interesting when the drug is 
amphiphilic [9]. Thus, a biowledge of the aggregation behavior of amphiphilic 
drugs in aqueous medium (especially, in the presence of other foreign 
materials) is vital for understanding how these molecules participate as 
components in practical applications. There is both a technological interest in 
optimizing the manipulation and control of these mixtures and a scientific 
interest in understanding the physico-chemical reasons that determine high 
performance of some polymer-amphiphilic drug combinations. The 
physico-chemical aspect of this problem can be addressed through the study of 
interaction mechanism in aqueous medium. Further, in order to achieve the 
goal of reducing the side effects of drugs, supplementary components are used, 
which improve the solubility of drugs or restrict the area of contact between 
drug and mucous membrane. Various polymers are among these supplementary 
components. 
Drug delivery has matured in the last few decades and is now 
recognized as an integral part of drug discovery and development, with current 
emphasis in designing/selecting favorable physicochemical properties of new 
carriers. The key aspect of any successful solution formulations are solubility 
and stability. Several problems arise with respect to their formulation, 
solubilization in body fluids, and interaction with barrier membranes in the 
organism, to reach their final targets. The effects of micellar solubilization on 
the solubility and absorption of non-polar solutes are quite well documented. It 
is well documented that polymer-amphiphile interactions depend on both the 
concentration and molecular structure of the two components. Successful drug 
delivery necessitates concern of various factors and simultaneously the 
effectiveness and safety of therapy are of foremost important [10]. 
In view of the above, we report herein the interaction of amphiphilic 
drugs with polymers (synthetic polymers). To achieve a deep understanding of 
the drug-polymer interaction, a multidisciplinary approach has been used and 
several physical, chemical, and biomedical techniques have been combined to 
obtain a broader, and more integrated range of information. The work has been 
divided into following chapters. 
Chapter-I describes the general introduction of polymers, classification 
of polymers, critical micelle concentration (CMC), micelle formation, types of 
micelles, thermodynamics of micelle formation, drugs and their classification, 
clouding phenomenon, drug-polymer (synthetic polymers) interactions etc. 
Chapter-II deals with experimental details which have been followed 
in study. Materials used, their purities, make, etc., are given in tabular form. 
Chapter-Ill The physicochemical understanding of dmg-polymer 
mixtures is important in order to help in rationalizing materials for 
pharmaceutical development and formulations. Therefore, studies performed 
on aqueous mixtures of two cationic and one anionic amphiphilic drugs 
(imipramine hydrochloride, IMP; promethazine hydrochloride, PMT, and 
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sodium salt of ibuprofen IBF, respectively with nonionic, cationic and anionic 
polymers. Part (A) the interaction between cationic amphiphilic drug 
imipramine hydrochloride (IMP) with a denatured protein, gelatin, was studied. 
From the conductivity and surface tension data it was found 'that critical 
aggregation concentration (CAC) decreases while polymer saturation point 
(PSP) increases on increasing the gelatin concentration. AGagg and AGj decrease 
while AGpsp increases on increasing the gelatin concentration. From the surface 
tension data it was found that the gelatin-IMP complex is highly surface active. 
CD measurements have enabled us to conclude that IMP affects the secondary 
structure of gelatin by increasing its random coil conformation. Part (B) the 
interaction between cationic and anionic amphiphilic drugs IMP, PMT, IBF, 
respectively with nonionic, cationic and anionic polymers was studied. The 
similar trend was obtained as in Part A regarding CAC and PSP. In the case of 
IBF the decrease in CAC on increasing the polymer concentration was much 
sharp in case of cationic and nonionic polymers as compared to the anionic 
polymers due to the possible repulsion between the anionic-anionic pair (of the 
drug and the polymer). It was also observed that the CMC was maximum in 
case of cationic polymers and minimum for the anionic polymers, while in the 
case of cationic drugs the results reveal that the anionic polymer NaCMC 
interacts strongly with the cationic drugs as compared to nonionic and cationic 
polymers due to the possible electrostatic attraction between the anion-cation 
pair of the drugs and the polymer. Similarly as in Part A, it was observed that 
the free energy of aggregation AGagg and free energy of transfer AGt decrease 
while free energy of micellization AGmjc increases on increasing the polymer 
concentration. The decrease in values of AG^ gg and AG, indicates stronger 
interaction between the IBF/IMP/PMT + Polymer systems. From surface 
tension data it was observed that the variation in the values F,^^, A,,^ ,^  and n^^^^ 
shows that the strength of interactions between the drugs IBF/IMP/PMT and 
the polymers depends on the nature and concentration of the latter. From the 
observed data it was found that the hydrophobicity plays important role in the 
polymer-amphiphile interactions and is capable to dominate the repulsion 
between the same charges. Part (C) the interaction of various polymers (four 
nonionic and two anionic) with amphiphihc drug IBF was studied by 
fluorimetric and 'H N M R shidies. Following results can be concluded from the 
study. It can be seen that the inclusion of polymers tends to lower the 
aggregation number of the micelles in comparison with that in pure water. This 
reduction becomes more evident with increasing the polymer content, i.e., 
aggregation number depends strongly on polymers percentage. The ' H NMR 
spectroscopy was used in the present investigation to probe the molecular 
investigation between ibuprofen and the cellulose ether polymers. Changes in 
the chemical shifts of H^ NMR spectrum due to alteration in the chemical 
environment of amphiphile molecule provide direct and strong evidence of 
aggregation and micellar growth [11]. Upon addition of polymer, 5 values of 
pure ibuprofen increase or shift down field. This depicts that, on addition of 
polymer to amphiphilic solution, micellar aggregate gets deshielded, this shows 
strong interaction between drug-polymer. 
Chapter-IV describes water-soluble polymers play an important role 
in the pharmaceutical and petrochemical industries. These polymers exhibit 
clouding upon heating their solution. The clouding process can be influenced 
by additives, and both delay and enhancement by them. We have perfonned 
cloud point (CP) measurements to study (i) the influence of three drags (IMP, 
PMZ and IBF) on the CP of the nonionic polymer HPMC, and (ii) the effect of 
additives (salts) on the CP of HPMC in the presence and absence of drugs 
(IMP/PMZ/IBF). The effectiveness of the drugs to raise the CP values was 
found to be in the order PMZ > IMP > IBF, which shows the stronger 
interaction of cationic drugs with the polymer as compared to anionic drug 
IBF. The CP values of HPMC decreases with the augmentation of salt 
concentration in the presence of IMP, PMZ and IBF, whereas in their absence 
the effect is negligible. It was found that, in the presence of fixed concentration 
(100 niM) of NaF, NaCl, NaBr and NaNOj, the CP of HPMC shows a 
minimum with respect to the concentrations of drugs IMP, PMZ and IBF. 
Multivalent anions show better efficiencies than monovalent anions at much 
lower molar concentrations. As the drug's concentration increases, AG°c 
becomes less negative and TAS°c becomes more negative indicating that 
clouding is energetically less favorable. In the absence of IMP, PMZ and IBF 
salts decrease the CP of HPMC, Na2S04 and Na3P04 was found to be much 
effective in decreasing the CP. The effect of MP, PMZ and IBF in presence of 
fixed concentrations of NaCl, NaF, NaBr, KCl, KBr, KNO3, NaNOa, Na2S04 
and Na3P04 is dependent on the nature and concentration of the salts. The 
clouding of HPMC becomes energetically less favorable whenever the 
concentration of IMP, PMZ and IBF increases in the system and the crowding 
of dmg monomers decrease the clouding tendency of polymers as indicated by 
the AG c values. 
In the absence of salts, the AH c and TAS c values are negative in 
all the cases and the system becomes slightly more ordered on increasing the 
concentration of IMP/PMZ/IBF as indicated by a decrease in the entropy. 
However, in the presence of salts, AH°o and TAS'^ c values are negative or 
positive, depending upon the type, nature and concentration of the salts. The 
TAS^ c^ values are found to be negative in most of the systems, except at lower 
concentrations of the IMP/PMZ/IBF in the presence of some salts. This 
behavior may not be expected, as the increase in concentration of drugs can 
cause for the micelle foraiation and thereby disrupting the water structure. 
However, energetic parameters reveal that the disruption of water structure 
becomes significantly prominent at lower concentrations of the drugs in the 
presence of fixed concentration of the salts. A decrease in the TAS'^ c with the 
increase in the concentration of drugs suggests that the ordering of drug 
molecules in the presence of HPMC is either not disturbing the water structure 
much or the total entropy of the system is decreased (compared to the 
disordered structure, which is expected at lower concentrations of the 
amphiphilic drags). 
The present results can be exploited in petrochemical, pharmaceutical, 
and other formulations as HPMC is an important ingredient in all these 
industries. 
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Chapter I Introduction 
Polymer science entered our academic life much after polymers 
constituted the basis for the plastics, rubber, adhesives, fiber, and coating 
industries. Perhaps due to its origins, polymer science tends to be quite 
interdisciplinary as it combines chemistry, chemical engineering, and other 
fields as well. Chemically, macromolecules are long chain molecules of high 
molecular weight. Polymers are referred as resins, this term was used even 
before the chemical structure of the long chains was understood. In the 
beginning, the polymers were used as natural products like cotton, starch, 
proteins, and wool. Synthetic polymers were found in early twentieth century. 
Important polymers, like Bakelite and nylon, showed tremendous possibilities 
of the new materials. However, the scientists in those days did not understand 
the relationship between chemical structures and physical properties that 
resulted. The size, shape, and organization of polymer depend of the manner in 
which the polymer was crystallized. Effects like annealing are very important, 
as they have a profound influence on the final state of molecular organization. 
Other polymers are amorphous, because their chains are too irregular to permit 
regular packing. The onset of chain molecular motion heralds the glass 
transition and softens the polymer from the glassy (plastic) state to the rubbery 
state. 
Modulus, stress relaxation, and elongation to break are some of 
molecular behavior. Each of these are related to the polymer's basic molecular 
structure and its history. Although physical polymer science does not include 
polymer synthesis, some knowledge of how polymers are made is helpful in 
understanding configurational aspects, such as tacticity, which are concerned 
with how the atoms are organized along the chain. Similarly, polymer 
molecular weights and distributions are controlled by the synthetic detail [1]. 
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Figure 1.1: Schematic representation of polymer. 
Smaller molecules in large number unite to form much longer chain of 
molecules called as polymers (Figure 1.1). The word polymer is derived from 
the Greek word "poly", meaning many, and "meros" meaning parts. A 
chemical reaction called polymerization joins many monomeric units. The 
degree of polymerization is the number of monomer units present in the chain. 
The length of the chain provides unique properties to a polymer. The molecular 
weight of a polymer is the degree of polymerization multiplied by the 
molecular weight of the monomer unit. Organic polymers (or polyelectrolytes) 
are water soluble linear polymers with molecular weight as low as a few 
hundred thousand and as high as ten million or greater. 
A polymer with equal interactions with water displays a random 
conformation in solution. This conformation is called random coil and can be 
described by the random walk model [2]. If the monomer-solvent interaction is 
favorable than the polymer-polymer ones, the polymer chain extends more 
than the random coil, whereas, if the polymer-solvent interaction is 
2 
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unfavorable the polymer chain is contracted. The latter, however, is to some 
extent balanced by excluded volume effects, and equal balance rendered at so-
called 0-conditions, where the polymer once behaves as a random coil. As per 
the Mark-Houwink equation 
[ri] = K.M" (I.l) 
if a is 0.5, the polymer behaves like a random coil and if it is larger or smaller 
it is extended or contracted, respectively, a of the polyethylene glycols was 
determined to be equal to 0.59 indicating on a slightly extended chain 
formation in water [3]. 
A polymer is analogous to a necklace made from many small beads 
(monomers). Its properties and interaction depend on a large degree on the 
chemical properties of the monomers, due to their charges that are more soluble 
in water than a corresponding nonionic polymer. Polyethylene glycol (PEG) is 
more water soluble compared to polymers such as polyethylene, owing to the 
hydrophilic heteroatoms enabling hydrogen bonds with water. However, 
monomer-solvent (water) interactions do not exclusively determine polymer 
solubility. For example, entropy gain is one of the most important parameter 
for miscibility of a polymer in solvent. Their effects are also different in a 
polymer solution compared to a solution of monomers as the monomers are 
attached to each other and their solubility decreases with increasing molecular 
weight. Figure 1.2 shows three architectures of a polymer molecule. 
KM iSV '^&^ 
(a) (b) (c) 
Figure 1.2: Architecture of polymer chain: (a) linear chain, (b) branched chain, 
(c) cross-linked. 
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Copolymers are polymers containing two types of monomers. A 
copolymer A-B has two constituent monomers, A and B. When the monomer 
sequence is random, i.e., the probability of a given monomer to be A does not 
depend on B, then the copolymer is called a random copolymer. There is a 
different class of copolymer called as linear copolymers (Figure 1.3). 
In an A-B diblock copolymer, a whole chain consists of an A block, a B block, 
and a joint between them. In a triblock copolymer, the chain has three blocks, 
A, B, and C. The C block can be another A block. A polymer consisting of a 
single type of monomers is distinguished from the copolymers and is called a 
homopolymer. 
Homopolymer A-A—A-A 
Diblockcopolymer A—A-B—-B 
Triblockcopolymer A-—A-B-—B-C-—C 
Figure 1.3: Homopolymer and block copolymers. 
Polymer Size and Shape 
The general problem of the size and shape of polymer molecules stand 
at the very heart of polymer science and engineering. If the molecular weight 
and molecular weight distribution (MDW) are known, many mechanical and 
rheological properties can be predicted. Wliile the question of molecular weight 
pervades the entire area of the chemical arts, polymers have classically 
presented several special problems such as-
The molecular weights of polymers are very high, ranging from about 25,000 
to 1,000,000g/mol or higher. At lower molecular weights, the term oligomer is 
used for a polymer with only a few repeat units, having degrees of 
polymerization of not more than 10 to 100 [4]. A range of molecular weights 
up to 500 to 5000g/mol result if we assume a molecular weight of 50g/mol for 
each monomer. Although the term telomer is sometimes used for higher 
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molecular weight materials, it is used primarily for polymers whose molecular 
weights are in the oligomer range. These are formed by chain transfer 
reactions. The term telechelic polymers are used for oligomers and telomers 
with functional groups on both ends [5]. Telechelic polymers are usually 
intended for further chemical reaction, particularly polymer network formation. 
Polymers having a reactive group at only one end are called macromers [6] 
(an abbreviation for macro-monomers). Super high molecular weight polymers 
with molecular weights greater than 1x10 g/mol have been called pleistomers 
[6]. 
Conformations are spatial arrangements of polymer chain that can be 
determined in dilute solutions by light-scattering and in the bulk state by 
small-angle neutron-scattering (SANS). Conformations can also be estimated 
theoretically from the structure and molecular weight of the polymer. 
Polymer chain conformations are functions of temperature, solvent, structure, 
crystallization, extension, and the presence of other polymers. 
Classification of Polymer 
Polymers are usually classified according to their use, such as 
thickening agents, film formers, resinous powders, and humectants. The 
viscosity of products is adjusted by thickening agents to make them easy to use 
and to maintain the product stability. For example, to ensure the stability of 
milky lotions and liquid foundations by preventing the separation of emulsified 
particles and powders. Natural polymers, gums and resins, have been used in 
the industry since the early 1940s as water-soluble binders, thickeners, and 
film forming agents. In today's products they are added in many cosmetic 
formulations to fulfill various functions, they are often used simply because of 
the growing consumer demand for "natural products". There are drawbacks, 
however, to the use of polymers isolated from natural sources, they vary in 
purity and physical appearance, and they are relatively expensive, compared to 
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common synthetic polymers. Problems securing stable supplies coupled with 
variations in viscosity and microbial contamination led to a change of synthetic 
or semi-synthetic substitutes. Synthetic or semi-synthetic polymers, which are 
chemically modified, have been developed to match the properties of gums and 
resins. Today, the industry is driven by a need of improved formulations, 
attainable through the use of current synthetic methodology and the molecular 
interactions between the polymers and the other components of a care product 
[7]. 
(A) On the basis of natural occurrence: 
(1) Natural Polymers 
(2) Synthetic Polymers 
(3) Semi-synthetic Polymers 
(1) Natural Polymers 
The polymers obtained from nature (plants and animals) are called 
natural polymers. These polymers are very essential for life. They are as under-
(i) Starch 
It is polymer of glucose and food reserve of plants. 
(ii) Cellulose 
Cellulose is a chief structural material of the plant. Both starch and 
cellulose are made by plants from glucose (hexose sugar) produced during 
photosynthesis. Both are linked together at the 1,4 position but are different as 
cellulose has a P linkage and starch has the a linkage. The P linkage has the 
effect of alternating the structure of the glucosides in an up-down-up-down 
configuration, while the a linkage makes them all up-up-up-up. Cellulose 
(Figure 1.4) is highly crystalline and indigestible by humans. Starch is much 
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less crystalline but highly digestible, as too many overweight people know. The 
difference in digestibility is caused by the lack of an enzyme (a protein) to 
attack the p linkage. It must be pointed out that there are many structurally 
different polysaccharides in nature. 
CUtulcf* 
Figure 1.4: The structure of cellulose. 
(ill) Blopolymers 
Biopolymers are further classified as polypeptides, polysaccharides and 
polynucleotides. In living cells, they may be synthesized by enzyme-mediated 
processes, such as the formation of DNA catalyzed by DNA polymerase. 
(2) Synthetic Polymers 
Polymers prepared in the laboratories are called synthetic polymers. 
These are also called man made polymers. For example, polyethene, poly vinyl 
chloride, Nylon, Teflon, Bakelite, synthetic rubber, etc. 
(3) Semi-synthetic Polymers 
These polymers are mostly derived from naturally occurring polymers 
by chemical modifications. For example, cellulose is a naturally occurring 
polymer; it forms cellulose diacetate polymers on acetylation with acetic 
anhydride in the presence of sulphuric acid. Cellulose is used in making thread 
7 
Chapter 11 Introduction 
and film glasses, etc. Vulcanized rubber is also an example of semi-synthetic 
polymers used in making tyres, etc., and gun cotton. 
(B) On the basis of thermal behavior: 
(1) Thermoplastics 
(2) Thermo sets 
(3) Elastomers 
(1) Thermoplastics 
Molecules in a thermoplastic are held together by relatively weak 
intermolecular forces so that the material softens when exposed to heat and 
then returns to its original condition when cooled. 
Thermoplastics have a wide range of applications because they can be 
formed and reformed in so many shapes. Some examples are food packaging, 
insulation, automobile bumpers, and credit cards. 
(2) Thermosets 
A thermoset solidifies or "sets" ierreversibly when heated. Thermosets 
are strong and durable. They primarily are used in automobiles and 
construction. They are also used to make toys, varnishes, boat hulls, and glues. 
(3) Elastomers 
Elastomers are rubbery polymers that can be stretched easily to several 
times their unstretched length and which rapidly return to their original 
dimensions when the applied stress is released. 
Elastomers are cross-linked, but have a low cross-link density. The 
polymer chains still have some freedom to move, but are prevented from 
permanently moving relative to each other by the cross-links. An elastomer 
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must be above its glass transition temperature, Tg, and have a low degree of 
crystallinity. 
Crystalline Polymers 
Highly crystalline polymers are rigid, have high melting point, and less 
affected by solvent penetration. Crystallinity makes polymers strong, but also 
lowers their resistance. As an example, samples of polyethylene prepared under 
high pressure (5000 atm) have high crystallinities (95-99 %) but are extremely 
brittle. 
Amorphous Polymers 
Polymer chains with branches, cannot be packed together regularly 
enough to form crystals. These polymers are said to be amorphous. 
(C) On the basis of polymer charge: 
(l)Nonionic 
(2)Anionic 
(3)Cationic 
(4)Amphoteric 
(l)Nonionic Polymer 
A polymer that has no net electrical charge is called nonionic polymer. 
Nonionic organic polymers are often used as antibody precipitating agents, e.g., 
polyethylene glycol. 
(2)Anionic Polymer 
Those polymers which are formed through anionic polymerization are 
called anionic polymer, e.g., sodium carboxymethyl cellulose. 
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(3)Cationic Polymer 
Those polymers which are formed through cationic polymerization are 
called cationic polymer, e.g., polyvinyl ether. 
(4)Amphoteric 
Macromolecules which bear both cationic and anionic repeat groups are 
called amphoteric. The competition between the acid-base equilibria of these 
groups leads to additional complications in their physical behavior. These 
polymers usually only dissolve when there is sufficient added salt, which 
screens the interactions between oppositely charged segments. All proteins are 
polyampholytes, as some amino acids tend to be acidic while others are basic. 
Polymeric Properties 
Polymeric properties are divided into several classes based on the scale 
at which the property is defined as well as upon its physical basis [8]. The most 
basic property of a polymer is the identity of its constituent monomers. A 
second set of properties, biown as microstructure, describes the arrangement of 
monomers within the polymer at the scale of a single chain. Structural 
properties play a major role in determining physical properties of the polymer, 
which describes how the polymer behaves as a continuous macroscopic 
material. Chemical properties, at the nano-scale, described how the chains 
interact through various physical forces. At the macro-scale, they are describes 
as how the bulk polymer interacts with other chemicals and solvents. 
Chain Length 
The physical properties of polymers [9] are strongly dependent on the 
size or length of the polymer chain [10]. For example, as chain length is 
increased, melting and boiling temperatures increase. The length of a chain is 
expressed as the degree of polymerization, which quantifies the number of 
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monomers incorporated into the chain [11]. As with other molecules, a 
polymer's size may also be expressed in terms of molecular weight. Since 
synthetic polymerization techniques typically yields a polymer product 
including a range of molecular weights, the weight is often expressed 
statistically to describe the distribution of chain lengths present in the same. 
The ratio of the number average molecular weight and weight average 
molecular weight, i.e., polydispersity index, is commonly used to express the 
width of the molecular weight distribution [12]. A final measurement is contour 
length, which can be understood as the length of the chain backbone in its fully 
extended state. 
The flexibility of an unbranched chain polymer is characterized by its 
persistence length. 
Mixing Behavior 
Polymeric mixtures are less miscible than mixtures of small 
molecule materials. This effect results from the fact that the driving force for 
mixing is usually entropy, not interaction energy. In other words, miscible 
materials usually form a solution. Since polymeric molecules are much larger 
and hence generally have much higher specific volumes than small molecules, 
the number of molecules involved in a polymeric mixture is far smaller than 
the number in a small molecule mixture of equal volume. The energetics of 
mixing, on the other hand, is comparable on a per volume basis for polymeric 
and small molecule mixtures. These increases the free energy of mixing for 
polymer solutions and thus make solvation less favorable. Thus, concentrated 
solutions of polymers are far rarer than those of small molecules. 
Furthermore, the phase behavior of polymer solutions and mixtures is 
more complex than that of small molecules mixtures. Wliereas most small 
molecule solutions exhibit only an upper critical solution temperature 
(UCST) phase transition, at which phase separation occurs. Polymer mixtures 
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commonly exhibit a lower critical solution temperature (LCST) phase 
transition, at which phase separation occurs with heating. 
How Cellulose based Polymers Interact with Amphiphiles 
The interaction between nonionic cellulose ethers and amphiphiles in 
dilute solutions has been extensively studied [13-20]. The cellulose-based 
polymers represent variations in both the nature and degree of substitution and 
are used to obtain a broad and unifying picture of the interaction in such 
systems. It involves adsorption of micelle-like aggregates (clusters) onto the 
polymer molecule as the fimdamental step. The size of the clusters increases 
with both amphiphiles and polymer concentration, hi very dilute solutions 
(well below c*, the critical overlap concentration of polymer), the clustering 
process is assumed to be an intramolecular phenomenon with involvement of 
(distant) hydrophobic parts of one polymer molecule in the same cluster, 
leading to a shrinkage of the coil hydrodynamic volume. At elevated polymer 
concentrations (c* or higher) the clusters are shared between polymer 
molecules, thus acting as tie-points creating a three-dimensional network and 
resulting in high viscosities and gel formation. The adsorption of amphiphiles 
molecules onto the polymer has been found to be a cooperative process, being 
more cooperative for the less hydrophobic polymer. An increased strength is a 
result of temperature elevation of the polymer-amphiphiles interaction as 
evidenced by a decrease in the level of cooperativity and lower values of 
aggregation numbers of the clusters. An important aspect of these interactions 
is still the question of some debate, what is the dominant driving force behind 
the interaction [21]. Studies with polymers of varying hydrophobicity, and by 
varying amphiphile alkyl chain length [22], have indicated the importance of 
hydrophobic interactions in these systems. In the physical chemistry literature 
to study polymer-amphiphile interaction [23] and the conclusions drawn are 
primarily qualitative. A reason for this is the lack of good binding models due 
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to the relatively nonspecific and nonsaturable nature of polymer- amphiphile 
binding as compared to protein-ligand binding. Among the early reports are 
those of Skerjanc et al. [24] on a polyanion-cationic amphiphiles system where 
binding isotherms were combined with calorimetry data to recover true binding 
enthalpies. Brackman et al. [25] used microcalorimetry signals as definitive 
evidence for interaction between polypropylene oxide and n-octyl 
thioglucoside. Microcalorimetry data was also used to interpret qualitatively 
the mechanism of interaction between the polymer and the micelles. Bloor et 
al. [26, 27] have examined the interaction of PVP (polyvinyl pyrrolidone), 
PPO (poly phenylene oxide), and EHEC (ethyl hydroxyl ethyl cellulose) with 
SDS (sodium dodecyl sulfate). Microcalorimetry data has been used to recover 
the critical amphiphile concentrations for the onset of binding to and saturation 
of the polymer. A detailed study has been performed by Kevelam et al. [22]. 
Wang and Olofsson [28] have published a detailed study of the mechanism of 
interaction between EHEC and SDS and some cationic amphiphiles, and the 
effect of temperature and polymer hydrophobicity. Microcalorimetry data was 
used to understand the probable mechanism of interaction, and critical 
concentrations were recovered. Apart from the above analyses, some progress 
has now been made toward the recovery of thermodynamic binding parameters, 
Wang et al. [29] where Gibbs energy, enthalpy, and entropy at critical 
aggregation concentration (CAC) have been calculated using CAC in relation 
to critical micelle concentration (CMC). More recently Blandamer et al. [30] 
have analyzed the interaction between SDS and polyvinyl pyrrolidone using a 
treatment based on Langmuir or Frumkin adsorption isotherms. Singh and 
Caram-Lelham [31] have performed a detailed analysis of a polyelectrolyte-
amphiphilic drug system where the binding isotherm data have been consider. 
Additional information can be obtained by combining microcalorimetry and 
equilibrium dialysis data for the cellulose ethers- amphiphile system. The 
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cellulose-ethers used here represent variations in both the nature and degree of 
substitution, allowing a broad and unifying picture of these interactions. 
The interaction between certain nonionic cellulose ethers (hydroxyethyl 
cellulose and hydroxypropyl methyl cellulose) and amphiphiles has been 
investigated using various methods between 25-50 °C. The data have been 
related to changes occurring in the system at the macro- and microscopic levels 
with the addition of amphiphiles and with temperature. The process consists 
polymer-amphiphiles interactions initially and amphiphile-amphiphile 
interactions at the later stages. Interaction between nonionic polymers and ionic 
amphiphiles is a consequence of weak interactions which allows for a wide 
variety and range of behaviors in these systems. The directed action of a 
number of weak interactions leads to the cooperative nature and the precise 
interactions seen in molecular recognition phenomenon involving host-guest 
combinations ranging from simple cation-ionophore pairs to sophisticated 
antibody-antigen or protein-carbohydrate systems [32, 33]. 
Similarly several dioig molecules display amphiphilic behavior. They 
aggregate in a typical amphiphiles-like manner and self-associate above a 
critical concentration value and can interact with biological membranes. They 
have rather bulky and rigid non-polar parts and do not form simple spherical 
micelles (like typical amphiphilic molecules do) but rather non-spherical 
aggregates are formed with a low aggregation number. Although the micelle 
formation in these drugs generally occurs at concentrations well above their 
therapeutic levels, it is a possibility that accumulation of these drugs cause a 
localized high concentration at a particular site in human body which may 
affect the biological activity of these drugs. 
Moreover, polymer-drug interaction is also very much important in 
various industries including pharmaceuticals and medical. 
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Amphiphiles 
Amphiphilic compounds bear an ionic (cationic, anionic or zwitterionic) 
or nonionic polar head group and a nonpolar hydrophobic portion. The word 
amphiphile was given by Paul Winsor, "amphi" meaning "double", "from both 
sides", "around", as in amphitheater or amphibian. The polar portion exhibits a 
strong affinity for polar solvents, particularly water, and it is often called 
hydrophilic part or hydrophile while nonpolar is called hydrophobe or 
lipophile. They are widely used in the industry, medicine, pharmacology, etc 
[34,35]. 
Amphiphiles exhibit other properties than tension lowering and this is 
why they are often labeled according to their main use such as: soap, detergent, 
wetting agent, disperssant, emulsifier, foaming agent, bactericide, corrosion 
inhibitor, antistatic agent, etc. In some cases they are known from the name of 
the structure they are able to build, i.e., membrane, micro-emulsion, liquid 
crystal, liposome, vesicle or gel. 
Amphiphilic Drugs 
Typical colloidal behavior is exhibited by a large number of amphiphlic 
drugs from many pharmacological groups of compounds, their properties being 
mainly determined by the nature of the aromatic ring systems of their 
hydrophobic moieties [1]. 
It is important to study the physico-chemical properties of amphiphilic 
drugs from chemical, physical, biological and pharmacological point of view 
[36]. Most of the surfactants have hydrocarbon based hydrophobic groups 
which join each other during micellization giving rise to spheroidal aggregates. 
A large number of drugs with diphenyl methane structure also have flexible 
hydrophobic groups similar to that of surfactants and lead to closer or micellar 
association. Amphiphilic drugs may resemble to typical surfactants in their 
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association behavior because they have aromatic ring with high degree of 
flexibility. 
The structural features of amphiphilic drug molecules which influence 
their association pattern in aqueous solution are identified from a survey of 
published work. Flexibility of the hydrophobic, as in the large number of drugs 
with a diphenyl methane structure, leads to a closed or micellar association. 
Drug possessing a rigid planar aromatic or heteroaromatic ring system to which 
an ester group or charge-bearing N atom is directly attached or which include a 
pyridine-like N atom, have an open or continuous association pattern. Several 
association models used to describe the association of these drugs are reviewed. 
The association pattern in water/polymer is complex with discontinuities in 
solution properties at several critical concentrations. Evidence from a variety of 
experimental techniques indicates limited association in dilute solution leading 
to the formation of a stable aggregate at the first critical concentration also 
known as critical aggregation concentration. Mukerjee [37, 38] identified 
several aspects of molecular structure which are thought to be influential in 
determining the association pattern of hydrophobic solutes. Features which are 
seen to be requirements for a micellar mode of association are high degree of 
molecular flexibility and a clear separation of charge, creating distinct polar 
and non-polar ends. Rigid aromatic or heteroaromatic ring or fused ring 
structures with no identifiable polar or non-polar regions, associate by a 
face-to-face stacking in a continuous association pattern. Amphiphilic drugs 
represent an interesting intermediate group of compounds between these two 
extremes. Although the hydrophobic groups of most drugs are aromatic they 
may in some case have a high degree of flexibility and as a consequence these 
drugs may resemble typical surfactants in their association behavior. 
An earlier review summarized the association characteristic of a large 
number of drugs with a wide variety of structures and discussed the biological 
relevance of drug surface activity and aggregation. An examination of this and 
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more recent work reveals several structural features which are of importance in 
determining association behavior. 
On the other hand, these drugs have interesting physicochemical 
properties associated both with their capacity to self-aggregate forming 
"micelle-like" structures as well as to change the properties of natural and 
model biomembranes [39-41]. Their unusual association characteristics derive 
from their hydrophobic group. The flexibility of the hydrophobic group as in, 
for example, the drugs with diphenylmethane structure, is conductive to closed 
or micellar association. The rigidity and planarity of the aromatic group, 
although an important requirement for association is clearly not the only 
structural feature influencing the mode of association, playing also the 
alkyl-side chain normally attached to it a key role. The phenothiazine dinjgs, 
although possessing tricyclic planar ring systems aggregate following a 
micellar association pattern [39]. 
Although some workers [42] have referred to this inflection point as the 
critical micelle concentration (CMC). One of the key questions of drug 
immobilization on a receptor is an achievement of sufficient therapeutic 
concentration of dmg. In spite of the phamiacological activity of these 
compounds that appears at low concentrations where aggregation is negligible 
[42], it is possible that accumulation of drugs can occur at certain sites of the 
living organism after the medium is exposed to long periods of administration, 
giving rise to the formation of aggregates unable to pass through membranes or 
decreasing transport rates, consequently leading to adverse effects in health. 
Therefore, their surface and self-association properties may have a strong 
influence on its biological activity that makes interesting the study of these 
compounds. 
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Critical Micelle Concentration (CMC) 
Micelles start to form as a critical micelle concentration, CMC, is 
reached. There is an abrupt change in the physicochemical properties of a 
surfactant solution when the CMC is exceeded, for example in surface tension, 
electrical conductivity, turbidity, osmotic pressure, etc. Micellization is an 
alternating mechanism to adsorption at the interfaces for removing 
hydrophobic groups from contact with the water, thereby reducing the free 
energy of the system. When there is little distortion of the structure of the 
solvent by the lyophobic group (e.g., in water, when the hydrophobic of the 
surfactant is short), then there is little tendency for micellization to occur. This 
is often the case in nonaqueous solvents, and therefore micelles of size 
comparable to those formed in aqueous media are seldom found in other 
solvents. 
The physico-chemical properties of amphiphiles vary markedly above 
and below the CMC value [43-46]. Below the CMC value, the 
physico-chemical properties of ionic surfactants (e.g., conductivities, 
electromotive force) resemble those of strong electrolytes. Above the CMC 
value, these properties change drastically, indicating a highly cooperative 
association process is taking place. This is illustrated by Preston's classic 
graphs (Figure 1.5). The CMC value of a surfactant micelle can be obtained by 
plotting an appropriate physico-chemical property versus the surfactant 
concentration and observe the break point in the plot. The aggregation of 
surfactants/amphiphilic compounds can be demonstrated by measuring solution 
properties such as surface tension [47, 48], dye solubilization [49], H-NMR 
[50-52], light scattering [53], fluorimetry [54, 55], osmotic pressure [56], 
electrical conductivity [57], and ultrasound velocity [58], against the 
amphiphile concentration. 
Chapter I Introduction 
Osmotic pressure 
Solubilization 
Magnetic resonance 
Surface tension 
Equivalent 
^'^-.-^ coriductivity 
Self-diffusion " '"^ 
CMC Concentration 
Figure 1.5; Changes in the concentration dependence of wide range of 
physico-chemical changes around the critical micelle concentration. 
Aggregation Number 
Micelle aggregation number is a fundamental parameter concerning the 
micelle. It gives an idea about the size of the micelle and is vital in determining 
the stabihty and practical applications of the investigated systems. In a micellar 
solution, all micelles may not have the same aggregation and polydispersity 
exists. However, for the sake of simplicity such polydispersity is generally 
ignored for calculation purposes and only monodispersed micelles with single 
aggregation number are taken into account. 
The mean aggregation number is the number of amphiphile monomers 
that assemble to fonn a supermolecular structure, i.e., a micelle. The most 
common shape of micellar aggregates in solution is spherical, and hence these 
are the most extensively studied. The main driving force for the self-assembly 
of amphiphile monomers into micelles is to minimize the hydrocarbon-water 
19 
Chapter I Introduction 
contacts in solution. For this reason, the lower limit of the number of 
amphiphile monomers that forms a micelle is dictated by the minimum number 
that must come together to effectively shield one another from contact with 
water [59]. In solution discrete aggregates, containing on the order of 100 
monomers or less implies that there must exist a force which opposes aggregate 
growth, or otherwise phase separation would be the eventual result. In ionic 
amphiphiles, electrostatic repulsion between the ionic head groups at the 
micellar surface provides the major contribution to this opposing force. In the 
case of non—ionic amphiphile, steric effects as well as a preference for the 
hydration of the head group oppose micelle formation [60]. Micelle formation 
therefore represents a cooperative process. Wliere by a number of amphiphile 
monomers come together through a compromise of opposing forces. It is 
important to note that micelles are not "monodisperse" in nature, i.e., they do 
not have a uniform size of a fixed number of monomers. Rather there exists a 
distribution of aggregate sizes from which the average number of monomers 
contained in a micelle is taken as the mean aggregation number, Nggg. The 
effect that internal (such as the stracture of the hydrophilic and hydrophobic 
moieties) and external (temperature, pressure, and additives) influences have 
on the size and dispersity of micelles in solution often makes it difficult to 
place any significance on reported values of the mean aggregation number. The 
aggregation number depends on different factors such as the nature of the 
amphiphile, temperature [57, 58], type and concentration of the added 
electrolyte [60-65], and organic additives [66-69], etc. 
Thermodynamics of Adsorption 
The concept of adsorption of thermodynamic is quite broad because 
amphiphiles are adsorbed at a surface and that includes any of the liquid/solid, 
liquid/liquid, or liquid/gas systems. The molecule is adsorbed if the surfactant 
molecule goes to the interface and locates itself with orientation. The 
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adsorption is a spontaneous phenomenon which is driven by a reduction of the 
energy when the surfactant lyophobic (which "hates" the solvent) group is 
removed from the solvent, and when one or both affinities are satisfied 
respectively at a surface or at an interface. At a liquid-solid interface, the 
relative polarity of the solid with respect to the liquid would decide whether the 
surfactant adsorbs by the head or by the tail When a solid is involved, other 
driving forces such as electrostatic attraction can play a role, and it can occur 
with substances different from surfactants. 
Adsorption efficiencies and surface activities depend on the molecular 
structure of the amphiphile, as well as the prevailing environmental conditions 
[70, 71]. The maximum decrease in interfacial tension achievable vv'hen an 
interface is completely saturated; it is a measure of the ability of a molecule to 
accumulate at an interface [70, 72] is measured by surface activity. The affinity 
of an amphiphile molecule for an interface can be described by its adsorption 
efficiency and its surface activity. The adsorption efficiency is a measure of the 
minimum amount of amphiphile required to saturate an interface 
r = - ^ (1.2) 
max 1 ^ -' 
where Ami,, is the surface area and C- is the excess amphiphile concentration at 
the surface. The accumulation of amphiphile molecules at an interface is 
characterized by the surface excess concentration. The surface excess 
concentration is often identified with an experimentally measurable parameter 
called the surface load, which is the amount of amphiphile adsorbed to the 
surface of emulsion droplets per unit area of interface. A quantitative prediction 
of the surface or interfacial tension produced by a given concentration of 
surfactant can most conveniently be made using an equation of state of the 
monolayer [72]. In such equations surface tension lowering is expressed in 
terms of the surface pressure, n, defined as 
5X = Y o - Y ^^-^^ 
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Yo is the interfacial tension of the pure air/water interface and y is the 
interfacial tension in the presence of the amphiphile [70, 73]. Langmuir 
adsorption isotherm and the Gibbs adsorption isotherm [74, 75] are two 
different thermodynamic approaches developed to describe this relationship. 
These are based on a thermodynamic analysis of the adsorption process, 
assuming that the adsorption-desorption of solutes at the surface is reversible, 
and that solute-solute interactions do not occur in the bulk solution or at the 
surface. The Langmuir adsorption isotherm is useful for relating the amount of 
solute present at a surface to the concentration and surface activity of the solute 
in the bulk solution 
C 
r 1/ 
3 = — ^ ^ (1.4) 
where s is the fraction of adsorption sites that are occupied, C is the surface 
excess concentration when the surface is completely saturated with solute, and 
C^is the solute concentration in the bulk solution where 3 = 1/2. The surface 
activity of a molecule is related to the free energy of adsorption by the 
following Equation 
K= — = oxp^^^^ (1.5) 
C,/ RT 
n 
where AG^ j^ corresponds to the free energy change associated with exchanging 
a solvent molecule with a solute molecule at the surface. There is equilibrium 
between amphiphile molecules at the interface and those in the bulk liquid. As 
the concentration in the bulk liquid is increased, so does their concentration at 
the interface. The equilibrium constant for adsoi-ption (K = 1/C,/) provides a 
n 
good measure for the surface activity or binding affinity of an amphiphile: 
greater is 1/Ci/, higher is the binding affinity. The presence of the amphiphile 
n 
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molecules at the interface shields the unfavorable contact within oil and water 
molecules and therefore reduces the tension. The relationship between the 
decrease in interfacial tension with amphiphile concentration and the amount of 
amphiphile present at the surface is known as the Gibbs isotherm Equation. 
For a dilute solution 
RTLd]nC_ 
r = 
1 
nRT 
dy 
dlnC 
(for nonionic amphiphiles) 
(for ionic amphiphiles) 
(1.6) 
(1.7) 
n is the number of species whose interfacial concentration changes with the 
change in bulk phase concentration of amphiphile. The Gibbs adsorption 
isotherm can also be presented in the form 
y = nRTfr_(c )d lnC (1.8) 
Insertion of the Langmuir adsorption isotherm into the above Eq. (1.8) and 
expressing the surface excess concentration in units of mass per unit area, 
rather than moles per unit area, gives 
nRT 
M r.in 1 + 
c 
c 
(1.9) 
/2 J 
Drugs and Their Classification 
The term drug is derived from French word 'Drogue' which means a dry 
herb. 'All chemicals other than food that affect living processes' is called as 
drug. If the affect helps the body, the drug is a medicine. However, if a drug 
causes a harmful effect on the body, the drug is a poison. The same chemical 
can be a medicine and a poison depending on conditions of use and the person 
using it. 
Another definition would be "medicinal agents used for diagnosis, 
prevention, treatment of symptoms, and cure of diseases". Contraceptives 
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would be outside of this definition unless pregnancy was considered a disease. 
It is to be noted that drugs are to be used for the benefit of recipient and 
it is presumed that this refers to total benefit-physical, mental as well as 
economical. 
Drugs are regarded as biologically active chemical compounds with a 
therapeutic purpose which can be broadly classified according to various 
criteria including chemical structure or pharmacological action into: 
(A) Biological classifiication 
(B) Chemical classification 
(C) Classification of drags according to commercial consideradon 
(D) Classification by the lay public (classification depending on the action of 
the drug, like antiseptic, tonics, laxative, etc.). 
A wide variety of drugs are, in fact, known to be surface active in nature 
[76-83]. This activity does not appear to be a fortuitous coincidence. In a 
number of cases excellent correlations between surface activity and biological 
effects have been demonstrated [84-91]. Many pharmacologically active 
compounds are amphiphilic or hydrophobic molecules, which may undergo 
different kinds of associations and whose site of action in the organism is the 
plasma meinbrane. If their target is intracellular, the interaction with first 
barrier plays a fundamental role [92]. Formation of cell membranes and 
location of receptor proteins in lipid bilayers is a consequence of surface 
activity. It is, logical to expect that the drugs acting by altering the permeability 
cell membranes after interacting with them are likely to be surface active in 
nature. The lipid bilayers, with receptors in them, represent the interface and 
thg drugs interacting with them will not reach the interface unless they are 
surface active in nature. 
Surface activity is of ubiquitous presence in living systems. Take any 
body fluid or cell soup, its surface tension is always less than that of water. 
Most of the biomolecules, proteins, lipids, etc., are surface active in nature. 
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Molecules of surface active nature are crucial to living matter and its 
organization. A consequence of surface activity is formation of biological cell. 
Surface activity in living systems is a matter of evolution, i.e., it is need based 
and therefore should have a crucial role to play in biological action. 
(A) Biological Classification 
Pharmacotherapeutic and chemotherapeutic agent, i.e., this is as disease 
oriented classification of medicinal agents used in various diseases and hence 
this classification is based on medicinal agents which are overall descriptive 
but not very accurate on scientific grounds. The broad classification based on 
gross overall biological effects is as follows: 
(a) Drugs Acting on Central Nervous System and Peripheral Nervous 
Systems 
The central nervous system (CNS) controls and regularizes the special 
functions like circulation, digestion and respiration and it also modifies the 
psychic reactions such as feeling, attitude, thoughts, and memory. It directs the 
functions of all tissues of the body. Chemical influences produce a myriad of 
effects on the activity and function of the central nervous system. Stimulants 
are drugs that exert their action through excitation of the central nervous 
system. Psychic stimulants include caffeine, cocaine, and various 
amphetamines. These drugs are used to enhance mental alertness and reduce 
drowsiness and fatigue. However, increasing the dosage of caffeine above 200 
mg (about 2 cups of coffee) does not increase mental performance but may 
increase nervousness, irritability, tremors, and headache. 
(b) Chemotherapeutic Drugs 
Chemotherapy is the treatment of disease by chemicals especially by 
killing micro-organisms or cancerous cells. Various drugs used in 
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chemotherapy are known as chemotherapeutic drugs, which have important 
therapeutic use in the treatment of parasitic infections due to insects, worms, 
protozoa, viruses, bacteria, etc. These drugs destroy offending parasites without 
damaging the host tissues. First modem chemotherapeutic agent was Paul 
EhrHch's arsphenamine, an arsenic compound discovered in 1909 and used to 
treat syphilis. This was later followed by sulfonamides discovered by Domagk 
and penicillin discovered by Alexander Fleming. Most commonly, 
chemotherapy acts by killing cells that divide rapidly, one of the main 
properties of most cancer cells. This means that it also harms cells that divide 
rapidly under normal circumstances: cells in the bone marrow, digestive tract 
and hair follicles. 
(c) Pharmacodynamic Agents 
These drugs affect the normal processes of the body like blood 
circulation, hemodynamic process, i.e., blood pressure, cardiac outputs, etc. 
Pharmacodynamic agents include the drugs which affect the heart and blood 
circulation. It also includes a wide variety of the drugs used in allergic and 
gastrointestinal diseases. 
(d) Metabolic Diseases and Endocrine Function 
It includes variety of drugs which are not conveniently classified in the 
other groups, like: 
(i) Antirheumatic and Autoimmuno Disease Drugs 
Diseases modifying antirheumatic drugs are the focus of treatment that 
addresses constant pain and inflammations of the lung, heart and eye and 
autoimmune diseases arise from an overactive immune response of the body 
against substances and tissues normally present in the body. In other words, the 
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body attacks its own cells. The treatment of autoimmune diseases is typically 
with immunosuppression-medication which decreases the immune response. 
(ii) Dermatologicals 
Dermatology is the branch of medicine dealing with the skin and its 
diseases, its unique with both medical and surgical aspects. A dermatologist 
takes care of diseases and some cosmetic problems of the skin, scalp, hair, and 
nails. 
(iii) Anti-Inflammatory Drugs 
Drugs with analgesic and antipyretic (fever-reducing) effects and which 
have, in higher doses, anti-inflammatory effects (reducing inflammation). The 
most prominent members of this group of drugs are aspirin, ibuprofen, and 
naproxen. 
(B) Chemical Classification 
Chemical classification is based on their chemical structure. According 
to this classification drugs may come under one or more of these categories 
such as quinines, semicarbazides, phenols, lactones, azo compounds, amides, 
alcohols, acetals, ketones, hydrocarbons, halogenated compounds, guanides, 
enols, esters, etc. Structurally close analogous compounds are grouped together 
with some overall activity but sometimes this classification is not very accurate 
as a few compounds with similar structure lack the activity test. Chemical 
structural classification of drugs is of advantage for study of methodology and 
structure-activity relationship. 
(C) Classification of Drugs According to Commercial Consideration 
Drugs are classified by manufacturers and distributors of therapeutic 
agents according to their operational expenses, research investment and profit 
27 
Chapter I Introduction 
margins. Medicines for rare diseases are called orphan drugs and such drugs 
lack patient protection as production costs are high and demand is less. 
Another classification of commercial consideration depends on the way 
of administration of drug, i.e., drugs are given orally, parenterally (meaning 
introduced subcutaneously, intravenously or by any route other than by way of 
the digestive tract) by inhalation, sublingually, rectally, etc. On the whole, 
orally active drugs are preferred by physicians and patients. 
(D) Classification by the Lay Public 
The few broad public classification depends upon the action of the drug, 
for example, antiseptic and disinfectant, anthelmintics, expectorants, cough 
mixtures, laxative and purgative, analgesics, tonics, ointments for skin diseases, 
etc., but this classification is scientifically inadequate and public should be well 
informed about all aspects of chemistry, biological action and fate of medicinal 
agent by experimental biologists and medicinal chemists. 
Many pharmacologically active compounds are amphiphilic molecules, 
which may undergo different kinds of association, and whose site of action in 
the organism frequently is the plasma membrane. Even if their target is 
intracellular, the interaction with this first barrier plays a fiindamental role. 
Classes of amphiphilic drugs include phenothiazine [93-99] and 
benzodiazepine [100] tranquillizers [101-103], analgesics [103], peptide [104] 
and nonpeptide [105, 86], anfibiotics [106, 107], tricychc antidepressants 
[108-111], antihistamines [112], anticholinergics [113], (3-blockers [114], 
local anesthetics (LA) [115-118], non-steroidal anti-inflammatory drugs 
[119], anticancer drugs [120], etc. Many of these drags contain one ore more 
(condensed or not) aromatic nuclei, while others are of peptide nature. A great 
deal of data on the surface active properties of the amphiphilic drugs can be 
found in the book by Attwood and Florence [121] and other reviews [82, 122, 
123]. 
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Different chemical structure surface active drugs are reported to 
self-associate and bind to membranes, causing disruption and solubilization, in 
a surfactant-like manner. The self-association is classified into two modes 
depending on the kind of drugs: micellar and nonmicellar aggregations. Here 
the micellar aggregation means a single multimer (micelle) forms above the 
CMC, and nonmicellar (stepwise) aggregation means that i-mer is successively 
formed by aggregation of (i-l)-mer and monomer [121]. 
Theories of Drug Action 
There are three theories relevant to drug action namely, occupancy 
theory, rate theory, and inactivation theory. 
(i) Occupancy Theory 
Biological responses can be measured on a continuous scale and, there is 
a systematic relationship between the dose of a drug and the magnitude of the 
response. Application of the law of mass-action to the dose-response 
relationship was largely done by Clark [124, 125]. A reflection of the 
combination of dnig molecules with receptors biological effect as an 
assumption to observed. The magnitude of a response was postulated to be 
directly proportional to the occupancy of receptors by drug molecules. The 
maximal response is assumed to be obtained when all the receptors are 
occupied. 
(ii) Rate Theory 
The actual idea in this theory is different from that in the occupancy 
theory. Instead of attributing excitation to the occupation of receptors by drug 
molecules, it is attributed to the process of occupation-each association 
between a drug molecule and a receptor providing one quantum of excitation. 
The magnitude of biological response is proportional to the rate at which drug 
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molecules associate with receptor sites. This rate depends on the concentration 
of free drug, the concentration of free receptor sites and the rate constants for 
association of drug molecules with receptor [126-128]. 
(iii) Inactivation Theory 
Receptor inactivation theory is based on the two state model originally 
proposed by Katz and Thesleff for ion channels [129]. Kenakinn on his work 
on the Torpedo nicotinic receptor reported that the multimeric receptor exists in 
active and inactive states with ligand binding altering the equilibrium between 
these two states. Synthesis of both occupancy theory and rate theory providing 
an alternative consideration for the study of the receptor ligand interaction. 
Inactivation theory assumes that RL complex is an intermediate "active state" 
that gives rise to an inactive form of the receptor, R, which is part of an RL 
complex termed RL [130] 
ki 
[R] + [L] z ^ [RL] 
[RL] 
where R stands for receptor and L for ligand, ki, kj, k^ are corresponding rate 
constants. 
Sites of Drug Action 
(i) Enzyme Inhibition 
Action of drugs within the cell modifies normal biochemical reactions. 
Enzyme inhibition may be reversible or non-reversible; competitive or 
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non-competitive. Antimetabolites may be used which mimic natural 
metabolites. Gene functions may be suppressed. 
(ii) Drug-Receptor Interaction 
Cell membrane is affected by physical and/or chemical interactions of 
drug. This is usually through specific drug receptor sites known to be located 
on the membrane. Specific chemical constituent of the cell is a receptor with 
which a drug interacts to produce its pharmacological effects. Some receptor 
sites have been identified with specific parts of proteins and nucleic acids. In 
most cases, the chemical nature of the receptor site remains obscure. 
(iij) Non-Specific Interactions 
Drugs act exclusively by physical means outside of cells. These sites 
include external surfaces of skin and gastrointestinal tract. Drags also act 
outside of cell membranes by chemical interactions. Neutralization of stomach 
acid by antacids is a good example. 
Clouding Phenomenon in Aqueous Solutions 
The temperature at which dissolved solids are no longer completely 
soluble, precipitating as a second phase giving the fluid a cloudy appearance 
[131]. Phase separation results from the competition between entropy, which 
favors miscibility of micelles in water, and enthalpy, which favors separation 
of micelles from water [132, 133]. Depending on the variation of these two 
contributions with temperature, either a lower or an upper consolute point can 
result [132, 133]. 
The partial miscibility exhibiting critical solution temperatures (GST) or 
consolute temperatures is displayed by binary liquid. GST's are of two kinds: 
upper critical solution temperature (UGST), above which the liquid pair is 
completely miscible and below which phase separation occurs, and lower 
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critical solution temperature (LCST), below which the two components are 
completely miscible while above it the two components become partially 
miscible and form two separate phases. The appearance of LCST is a rare 
phenomenon for solutions of small molecules but is more frequent when at 
least one of the molecules is large. The importance of the entropy of mixing, 
becomes relatively less important when the molecules get larger and the mixing 
process becomes more dominated by the enthalpy term, which may favor or 
disfavor mixing. 
Solution having temperature below which the amphiphile is not really 
very soluble (Figure 1.6) is known as the Krafft temperature [134-137]. If, on 
the other hand, the temperature is raised, especially for non-ionic amphiphiles 
or those with some non-ionic polar groups, a two-phase region is encountered, 
above what is known as the CP [138-140] where two liquid (micellar) phases 
are in equilibrium. Finally, increase in concentrations at ambient temperature, 
we find, at amphiphile concentrations above 40% by weight, a series of 
mesomorphic phases sometimes called liquid crystalline phases. 
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Figure 1.6: Schematic temperature (T)-concentration phase diagram 
illustrating the types of amphiphilic aggregates encountered by moving away 
from the micellar region. 
Cellulose derivative and other water-soluble polymers play an important 
role in the pharmaceutical and petroleum industries [141, 142]. These polymers 
exhibit clouding upon heating their solution. The clouding process can be 
influenced by additives, and both delay and enhancement by them has been 
reported in the literature [143-153]. An understanding of the cloud-point 
phenomena is of both practical and theoretical interest under varied thermal 
conditions [154]. The current explanation of the cloud point is that, when the 
cloud point approaches, an increased intennicellar interaction is the result of 
strong entropy dominance. As the temperature rises, the hydrogen bonding gets 
diminished and the polymer solubility becomes less and thus phase separation 
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may occur. At the CP, the polymer precipitates out of solution as a 
consequence of equal chemical potentials between the two phases, one richer in 
polymer, of solute and solvent, respectively. Thus, CP provides a simple and 
powerful tool for qualitative characterization of the polymer thermodynamics 
in systems with LCST (lower critical solubility temperature) behavior and their 
interactions with low molecular weight amphiphiles. The phase behavior of 
cellulose ethers can easily be tuned with the help of suitable additives. The 
understanding of phase behavior of HPMC including the effects of salts on CP 
has become quite important. At the cloud point, the increase in entropy is much 
more negative than that arising from the repulsive forces. Hence, the total free 
energy is negative and the CP appears. The influence of an additive on the CP 
depends on how it affects the intermicellar interactions [155]. Many theories 
are reported in the literature to explain the presence of cloud point, but this 
problem still remains to be understood. Further the effect of different types of 
salts on the same system (polymer) was not discussed earlier. 
In pharmaceuticals, they may serve as either drug-delivery agents or as 
an excipient for enhancing the stability of drugs, while in petrochemicals, they 
are useful in enhanced oil recovery [156, 157]. In personal care formulations, 
they can be used as a viscosity modifier or as gelling agents [158]. When 
dmg/polymer, these two entities are present in systems, they generally provide 
better properties as compared to a single entity. Thus, drugs and polymers in 
aqueous solutions attract attention in a wide field of practical applications as 
well as from a fundamentally academic point of view. Phenomena such as 
aggregation, swelling/deswelling, adsorption, solubilization, and phase 
separation can be controlled, influenced, and employed in specific applications 
[159, 160]. 
Water-soluble polymers having polar groups, for instance, hydroxyl, 
carboxylic acid, or ether groups are capable of taking part in the hydrogen 
bonding stracture of water. As the temperature rises, the hydrogen bonding is 
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diminished, and the polymer solubility becomes less. Eventually, phase 
separation may occur [161]. A characteristic feature of nonionic cellulose 
ether/ water systems is the existence of reversible phase separation including a 
lower critical solubility temperature, LCST, also denoted as cloud point, CP, 
above which the solution becomes "cloudy" [162, 163]. Therefore, CP gives an 
easy and powerful tool for qualitative depiction of the polymer 
thermodynamics in systems with LCST behavior and their interactions with 
amphiphilic molecules. Water-soluble nonionic derivatives of cellulose are 
physiologically harmless and are preferred for the use in foodstuffs and the 
pharmaceutical industry [164-167]. The phase behavior of these cellulose 
ethers can easily be tuned with the help of adding suitable additives. Several 
cellulose derivatives, like hydroxypropylmethyl cellulose (HPMC), considered 
in the present study, are distinguished by mixed hydrophobic and hydrophilic 
stractural units [168-189]. 
Interaction between Surfactants and Polymers in Aqueous Solutions 
The basic surface active components of many detergents, cosmetic and 
pharmaceutical products is usually a blend containing ionic surfactant and 
polymers very often mixed with other additives and a non-ionic surfactant. 
These mixtures form a class of materials which have direct impact on phase 
separation, rheological and interfacial properties [190, 191]. The behavior of 
ionic surfactant/polymer mixtures can be quite different from individual 
polymer or surfactant solution due to an attractive interaction often resulting in 
surfactant micelles binding to polymers below their normal critical micellar 
concentration (CMC). It is often necessary to optimize the formulation of these 
blends so that a product emerges which satisfies stringent criteria for 
processing, appearance and marketing. In the absence of a theory to predict the 
behavior of such mixtures, the formulation of products has traditionally relied 
on trial and error approaches based on trends and rules many of which are 
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deduced on an empirical basis from fundamental studies on model 
polymer/surfactant mixtures. Now a days, largely as a result of health, safety, 
energy conservation and issues involving the environment, more and more 
surfactant/polymer mixtures are being tested as potential products. These 
studies have been carried out using a diverse range of physiochemical 
techniques and have led to new insights on the binding characteristics of many 
different polymer/surfactant mixtures [190-193]. In many of these systems, 
most of the useful infomiation has emerged by complementing data from more 
than one experimental method-this is extremely important in these systems 
since different experiments probe different aspects of these 
macromolecular/aggregating systems [190-193]. In most studies, the choice of 
surfactant has remained more or less the same since the pioneering work-the 
anionic sodium dodecyl sulfate has been used in the majority of publications, 
there is a small body of studies with cationic and finally non-ionic surfactants 
feature in very few experiments. On the other hand, the use of different 
polymers has mushroomed mainly because of the emergence of new 
methodologies in polymer synthesis with particular emphasis on the addition of 
functional groups at the end or along the polymeric backbones. Although the 
field of polymer/surfactant interactions has been well reviewed with two books 
[190, 191] and various review articles, [192, 193] some of the fundamental 
methodologies and new results have yet to be considered in a single treatment. 
Since surfactant micelles feature in most of this study, we shall briefly consider 
this aggregating phenomenon. The onset of micelle formation in surfactants 
usually occurs at a well defined concentration that is denoted as the critical 
micellar concentration. It is now recognized that the dominant controlling force 
for micellization is driven by the gain in entropy. This positive gain can be 
attributed to the tendency of the hydrophobic group of the surfactant to remove 
itself from the solvent environment to aggregate at the interior of the micellar 
hydrophobic core. The large entropy increase can be further elaborated as 
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follows. The first explanation relates to the extensive hydrogen-bonding 
environment in water. As water does not hydrogen bond with the surfactant 
hydrocarbon chains, the water molecules would form a structure surrounding 
the hydrophobic groups, which produces cavities in the water structure. The 
resulting water molecules become more ordered, which caused a noticeable 
decrease in entropy. When there is sufficient surfactant in the aqueous solution, 
micellization begins when the surfactant hydrophobic groups are removed from 
the water and they form a micellar hydrophobic core with their hydrophilic 
parts directed toward the water. The cavities formerly occupied by the 
hydrocarbon chains are returned to the bulk water. That is the highly organized 
water structure, formerly involved in the cavities, returns to the normal 
hydrogen-bonded water causing an increase in entropy that drives the 
micellization process. The thermodynamic analysis of micelle formation 
process has been treated using a mass action model and phase separation model 
[191]. 
The interaction of polymers with surfactants, unlike with other small 
molecules such as salt, is complicated by the micellization of the surfactants 
and sometimes, the self aggregation of certain associating polymers. 
Polymer-surfactant interaction involves a surfactant aggregation process that is 
akin to micellization. As an analogy with free surfactant micellization, the 
onset of surfactant molecules binding on the polymers is denoted as the critical 
aggregation concentration, CAC. By making assumptions that the driving force 
for surfactants aggregating onto polymers is similar to that for a normal free 
surfactant micellization process, the standard free energy of surfactant in terms 
of CAC can be used. 
Free energy is a quantitative measure of the strength of interaction 
between the polymer and the surfactant. It is argued that the ratio CAC/CMC 
should be less than one because if CAC is greater than CMC, the situation 
would suggest that the surfactant molecules would prefer to micellize with 
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themselves instead of forming mixed micelles, which would otherwise indicate 
that no polymer-surfactant interactions exist at all. 
Most studies concerned with the determination of surfactant binding to 
polymers are carried out at low polymer concentration, with surfactant 
concentrations determined by the binding region. Much current research 
focuses on systematic variations of polymer structure, including in particular 
the introduction of hydrophobic modifications in polymers which are normally 
considered hydrophilic. In many such systems concepts traditionally used in 
polymer surfactant studies, such as the critical aggregation concentration, CAC 
(sometimes still referred to as Tj) and the degree of binding are not applicable 
or need modification. Already some of the earliest studies in polymer-
surfactant systems, especially those involving nonionic surfactants, point out 
that considerable change in system properties can be observed even though 
there is no observable change in critical micelle concentration, (CMC) [194]. 
On the other hand, for polyelectrolytes and surfactants of opposite charge, 
surfactant binding is clearly observable and may starts at concentrations two or 
three orders of magnitude below the CMC. 
Another distinction of interest which has been widely discussed 
concerns the difference between anionic and cationic surfactants. In particular, 
the observation that anionic surfactants display a relatively strong and 
cooperative interaction with nonionic hydrophilic polymers such as poly 
(ethyleneoxide) (PEO) and polyvinylpyrrolidone (PVP), while cationic 
surfactants do not exhibit interaction, remains relevant. This may be another 
example where one has to be careful in applying apparently simple concepts 
such as polymer charge or induced charge or dipolar effects. A better 
understanding of the microscopic structure of the aggregates and the role of 
hydrophobic interactions may be needed, as exemplified by the difference in 
micellar surface structure of anionic and cationic surfactants, evident from 
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NMR and SANS studies on alkylsulfate micelles [195, 196] and on 
alkylammonium surfactants [197]. 
The precise structure of a polymer-surfactant complex will of course 
depend on the structures of the molecules involved, in particular the 
hydrophobicity and molecular weight of the polymer, and the charge and shape 
of the surfactant. For linear polymers, a general model has emerged, often 
referred to as the "necklace" or "based on the string" model, in which one or 
more small surfactant micelles reside within the random coil of the polymer 
[198]. There are proven exceptions to this structure, particularly for surfactants 
which form rod-shaped micelles or vesicles [199], and with hydrophobically 
modified polymers, however, the model has become accepted as the typical 
, structure of a polymer-surfactant complex [21, 193, 200-207]. It is interesting 
to note that interactions of surfactants with protein have been known since the 
1930s [208, 209], well before the first studies for synthetic polymers were 
published. Anionic surfactants such as sodium dodecyl sulfate (SDS) were 
found to bind to positive charge sites on proteins in stoichiometric proportions, 
in some cases opening up the protein conformations, and at higher surfactant 
concentrations with much higher ratios of surfactant molecules per protein 
molecule. The possibility this excess binding to proteins was micelle-like was 
discussed nearly twenty years before the "necklace" model was proposed for 
binding of surfactants to synthetic polymers [198, 210]. Isemura and 
co-workers observed that poly (vinyl formal), poly (vinyl butyral), poly (vinyl 
acetate) (PVAc) and poly(vinyl alcohal) (PVA), which have poor solubility 
both in organic solvents and in water, could be dissolved in an SDS solution 
[211,212]. 
Interaction between Drugs and Polymers in Aqueous Solutions 
The interaction of drugs with macromolecules had been interesting 
topic, because of their biological importance. The system becomes more 
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interesting when the drug is amphiphihc [213]. Thus, a knowledge of the 
aggregation behavior of amphiphilic drugs in aqueous medium (especially, in 
the presence of other foreign materials) is vital for understanding how these 
molecules participate as components in practical applications. There is both a 
technological interest in optimizing the manipulation and control of these 
mixtures and a scientific interest in understanding the physicol98chemical 
reasons that determine high performance of some polymer-amphiphilic drug 
combinations. The physico-chemical aspect of this problem can be addressed 
through the study of interaction mechanism in aqueous medium. Further, in 
order to achieve the goal of reducing the side effects of diugs, supplementary 
components are used, which improve the solubility of drugs or restrict the area 
of contact between drug and mucous membrane. Various polymers are among 
these supplementary components. 
Drug delivery has matured in the last few decades and is now 
recognized as an integral part of drug discovery and development [214-216], 
with current emphasis in designing/selecting favorable physicochemical 
properties of new carriers. The key aspect of any successful solution 
formulations are solubility and stability. Since many dmgs are amphiphilic or 
hydrophobic, several problems arise with respect to their formulation, 
solubilization in body fluids, and interaction with banier membranes in the 
organism, to reach their final targets. The effects of micellar solubilization on 
the solubility and absorption of non-polar solutes are quite well documented. It 
is well documented that polymer-amphiphile interactions depend on both the 
concentration and molecular structure of the two components. Successful drug 
delivery necessitates concern of various factors and simultaneously the 
effectiveness and safety of therapy are of foremost important [217-219]. Since 
many drugs are amphiphilic in nature such as phenothiazines, tranquillizers, 
analgesics, peptides, antibiotics, tricyclic antidepressants, etc., they may 
interact with polymers in surfactant-like manner and plays an important role in 
40 
Chapter I Introduction 
the drug delivery formulations [220-224]. Many of these drugs contain one or 
more (condensed or not) aromatic rings, while others are of peptide nature. 
Amphiphilic compounds bear an ionic or nonionic polar head group and a 
hydrophobic portion, which may undergo different kinds of associations such 
as micelles, bilayers, monolayers, etc. [225-231]. The spatial separation 
between the polar and nonpolar moieties, as well as the shape and hydrophilic-
hydrophobic balance, determines their tendency to form different structures 
which are pH-, temperature-, ionic strength-, and concentration-dependent. 
Relevance of the Research Problem 
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The behavior of many excipients and active drug substances in water are 
known but much is still unknown about the mixture of excipients of different 
types or each excipient-drug mixtures. The physicochemical behavior of these 
mixtures is important to understand both in the formulation, e.g., for stability 
reasons, and as the formulation enters and dissolves m the body fluids. 
Polymers in different forms are used in pharmaceuticals in various 
ways, such as gelling and viscosity increasing agents, filling materials, 
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suspending agents, tablet disintegrations, tablet binders, film formers, and 
extended release materials [232]. The amalgamation of polymer and 
pharmaceutical sciences led to the introduction of polymer in the design and 
development of drug delivery systems. Polymeric delivery systems are mainly 
intended to achieve controlled or sustained drug delivery. Polysaccharides 
fabricated into hydrophilic matrices remain popular biomaterials for 
controlled-release dosage forms and the most abundant naturally occurring 
biopolymer is cellulose; so hydroxypropylmethyl cellulose, hydroxypropyl 
cellulose, microcrystalline cellulose and hydroxyethyl cellulose can be used for 
production of time controlled delivery systems. Additionally microcrystalline 
cellulose, sodium carboxymethyl cellulose, hydroxypropylmethyl cellulose, 
hydroxyethyl cellulose as well as hydroxypropyl cellulose are used to coat 
tablets. One approach for altering a drug's pharmacokinetics and duration of 
action involves covalently bonding the drug to a water-soluble polymer such as 
poly (ethylene glycol). For specific tissue targeting, water-soluble 
biocompatible polymers that will either degrade or be eliminated by the body, 
are chemically bonded to the required drug. Ideally, the polymer-dnig bond 
will be cleaved once the combination reaches its target. For example, this 
approach has been used in cancer chemotherapy [233]. The concept is that low 
molecular weight anticancer diugs when given intravenously will penetrate 
most tissues because they pass rapidly through cell membranes, even those 
with no tumor selectivity. However, if the polymer-drug bonds are designed so 
that they are stable in blood, the polymer-drug conjugate circulates for a longer 
time than just the drug itself Because most normal tissues have intact nonleaky 
microvasculature, the polymer-drug accumulates more rapidly in the tumor, 
which has a leaky vascular bed. 
One of the newer polymeric controlled release systems utilizes 
hydrogels. Basically, hydrogels are cross-linked hydrophilic polymer networks 
that swell in an aqueous phase without dissolution. If the hydrogel contains 
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ions, swelling or deswelling may depend on the degree of ionization in the 
network. More highly swollen networks facilitate more rapid drug diffusion 
than less swollen networks. The pH of the fluid, and many other factors also 
control swelling. For example, hydrogel based systems exist for protecting 
acid-sensitive medications from the hostile environment of the stomach by 
shrinking when exposed to low pH conditions, but expand in the more alkaline 
environment of the intestines [233, 234]. While getting the drug into the 
hydrogel is an important problem in its own right, the more important part of 
the polymer-drug diffusion problem relates to diffusion of the drug out of the 
polymer gel and into the body. 
Complexes between nonionic polymers and ionic amphiphiles have long 
been a subject of intensive research [205, 209, 235, 236]. However, they still 
continue to attract interest due to the need to better understand the mechanisms 
of interaction and the nature of the structures formed, evidenced by the steady 
stream of publications dealing with this topic [237-239]. This has been driven 
by the important role of such systems in applications in the pharmaceuticals, 
cosmetics, agricultural, and industrial sectors and the need to be able to tailor, 
control, and manipulate them. Although the pharmacological activity of the 
amphiphilic drugs appears at low concentration where aggregation is negligible 
[123], the accumulation of drug can occur at certain sites of organism after long 
period of administration, giving rise to formation of aggregates that are unable 
to pass through membranes, decreasing transport rate and consequently leading 
to adverse effect on health. Thus, the study of physicochemical properties of 
amphiphilic drugs is important irom physical, chemical, biological and 
pharmaceutical point of view for their implication. As most of the drugs form 
micelles at concentrations which they do not attain in vivo, it is most likely that 
it is their surface-active characteristics which are most important biologically, 
although the propensity of the molecules to form associations by hydrophobic 
bonding will manifest itself The study of the properties of surface active drugs 
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in solution provides an opportunity to investigate the influence of the structure 
of the hydrophobe on the mode of association of amphiphiles. 
The amphiphilic drugs (such as IBF, IMP, PMT, PMZ etc.) suffer from 
several drawbacks such as nausea, gastrointestinal ulceration, cardiovascular 
anticholinergic, antiarrhythmic, parkinsonism, abnormal liver function etc., 
side effects. These undesirable side effects may be reduced if the drug is 
properly targeted to the organism. In this endeavor, use of surfactants and 
polymers as drug carriers presents advantages in comparison to other 
alternatives. They can solubilize poorly soluble drugs in their hydrophobic 
core, thus increasing their bioavailability. Also, protect drugs from destructive 
factors upon parenteral administration; modify their biodistribution [234, 240]. 
Keeping this in view, we have studied physicochemical properties of 
some drug-excipient mixtures. Excipients fonn an integral part of all 
pharmaceutical dosage forms. Drugs exhibit poor solubility and stability, and 
the role of excipients is to provide physical and chemical stability and retain 
bioavailability. A major consideration in the choice of biomaterials for drug 
delivery is drug-polymer interaction, drug transformation, and its degradation 
[241]. 
At times excipients also promote the degradation of drugs. Functional 
groups or residues in excipients are prone to interaction with certain drugs. 
These interactions often modify the physicochemical characteristics of the drug 
[242]. The interactions are either reversible or irreversible in nature and alter in 
most cases dissolution, bioavailability, safety, and efficacy and in extreme 
cases even the stability of the drug [243-245]. A wide range of excipients has 
been used for temporal and spatial release of drugs by the oral route. In 
addition, to release the dmgs at the desired site, excipients are used to help 
deliver drugs to patients in fonns that facilitate administration. Pediatric and 
geriatric patients often experience difficulty in swallowing tablets and capsules. 
Drugs are therefore administered to such patients as solutions, suspensions, and 
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emulsions. This often leads to the perception of bitterness [246, 247] and 
patient noncompliance. [247, 248]. The choice of the taste-masking technique 
to overcome this problem is governed by the physicochemical and 
pharmacokinetic parameters of the drug and the type of dosage form. 
Keeping the above in view, amphiphilic substances, are potentially 
important encapsulating/solubilizing agents, we have performed 
conductometric, tensiometric, fluorescence, and, 'H N M R measurements on 
some amphiphilic dnig-polymer systems. 
The solution properties of amphiphiles are sensitive to the presence of 
polymers. The values of CAC and CMC are found to depend on the type and 
nature of polymers. To optimize the applications of amphiphile mixtures, it is, 
therefore, important to understand the interplay of forces that govern the 
micellization behavior in the presence of polymers. It was shown by Mouritsen 
and Jorgensen [249] and Tieleman et al [250] that amphiphilic drugs insert 
into membranes as interstitial components and they affect the organization of 
lipids. As the electrolyte concentration in the membranes may vary, their 
presence and concentration may affect the micellization tendency of the drug. 
Therefore, it is important to have knowledge of drug's association behavior 
with temperature and also when present with electrolytes. 
The amphiphilic drugs, because of their surfactant-like nature, exhibit 
concentration, temperature and pH dependent phase separation. It was observed 
that cloud point (CP) of HPMC can vary with additives. When using these 
drugs it should be kept in mind that nornial body temperature is typically 12 
degrees above ambient. Even if the CP of pure HPMC is above this 
temperature, it may decrease in presence of additives therefore, it is important 
to have knowledge of clouding behavior of the polymers in designing more 
effective drug-carrier combinations. With this idea in mind CP behavior of 
HPMC with amphiphilic drugs and electrolytes has been examined. 
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Layout of the Thesis 
This thesis consists of the following four chapters: 
Chapter-I General Introduction 
Chapter-II Experimental 
Chapter-Ill Studies on the Drug-Polymer Systems 
Part A-Conductometric, Tensiometric, and CD Studies of IMP/Gelatin 
Systems 
Part B-Conductometric and Tensiometric Studies of IBF, IMP, and 
PMT/Polymer Systems 
Part C-Fluorescence and 'H NMR Studies of IBF/Polymer Systems 
Chapter-IV Effect of Inorganic Salts on the Cloud Point of HPMC in Presence 
of Amphiphilic Drugs (IMP, PMZ, IBF) 
46 
Chapter 11 Introduction 
References 
1. J.A. Brydson, B. Heinemann, "Plastics Materials", 6* ed., Oxford, England, 
1995. 
2. A. Ridell, "Characterization of Aqueous Solutions, Liquid Crystals, Solid 
State of Nonionic Polymers in Association With Amphiphiles and Drugs", 
Ph. D. Thesis, Acta Universitatis Upsalinesis, Uppsala, 2003. 
3. P. Atkins, "The Elements of Physical Chemistry", 3"* ed., Oxford 
University Press, New York, 2001. 
4. C.V. Uglea, "Oligomer Teclinology and Applications", Dekker, New York, 
1998. 
5. R. Faust, A. Fehervari, J.P. Kennedy, "Reactive Oligomers", F.W. Harris, 
H. J. Spinelli (Eds.), American Chemical Society, Washington, DC, 1985. 
6. C.V. Uglea, I.I. Negulescu, "Synthesis and Characterization of Oligomers", 
CRC Press, Boca Raton, FL, 1991. 
7. "Principle of Polymer Science and Technology in Cosmetics and Personal 
care", E.D. Goddard, J.V. Gruber (Eds.), Union Carbide Corporation 
Tarrytown, New York, Amerchol Corporation Edison, New Jersey, 1999. 
8. S.A. Baemie, J. Mathematical ChemisUy, 46, 2009, 363. 
9. D. Gennes, P. Gilles, "Scaling Concepts in Polymer Physics", Comell 
University Press, Ithaca, NY, 1979. 
10. R. Michael, H.R. Colby, "Polymer Physics", Oxford, New York, Oxford 
University Press, 2003. 
11. N.G. McCrum, C.P. Buckley, C.B. Bucknall, "Principles of Polymer 
Engineering", Oxford University Press, New York, 1997. 
12. C.P. Paul, M.C. Michael, "Fundamentals of Polymer Science", : An 
Introductory Text, Lancaster, Pa, Technomic Pub, 1997. 
13. C. Holmberg, S. Nilsson, S.K. Singh, L.O. Sundelof, J. Phys. Chem., 96, 
1992,871. 
14. C. Holmberg, L.O. Sunddof, Langmuir, 12,1996, 883. 
47 
Chapter I j Introduction 
15. S. ^ilsson, Macromolecules, 28,1995, 7837. 
16. S. Nilsson, C. Holmberg, L.O. Sundelof, Colloid Polym. ScL, 272, 1994, 
338. 
17. S. Nilsson, C. Holmberg, L.O. Sundelof, Colloid Polym. Sci., 273,1995, 83. 
18. H. Evertsson, S. Nilsson, C. Holmberg, L.O. Sundelof, Langmuir, 12,1996, 
5781. 
19. H. Evertsson, S. Nilsson, Macromolecules, 30,1997,2377. 
20. D. Bai, C.C. Chin, S.B. Chen, C-C Tsai, B-H Chen, J. Phys. Chem. B, 109 
2005,4909 
21. J.C. Brackman, J.B.F.N. Engberts, Chem. Sac. Rev., 22,1993, 85. 
22. J. Kevelam, J.F.L. van Breemen, W. Blokzijl, J.B.F.N. Engberts, Langmuir, 
12,1996, Aim. 
23. M.J. Blandamer, P.M. Cullis, J.B.F.N. Engberts, J. Chem. Soc, Faraday 
Trans., 94,1998,2261. 
24. J. Skerjanc, K. Kogej, G. Vesuaver, J. Phys. Chem., 92,1988, 6382. 
25. J.C. Brachnan, N.M. van Os, J.B.F.N. Engberts, Langmuir, 4, 1988, 1266. 
26. D.M. Bloor, J.F. Flolzwarth, E. Wyn-Jones, Langmuir, 11,1995, 2312. 
27. D.M. Bloor, W.M.Z. Wan-Yunus, W.A. Li, Y. Wan-Badhi, J.F. Holzwarth, 
E. Wyn-Jones, Langmuir, 11,1995, 3395. 
28. G. Wang, G. Olofsson, /. Phys. Chem., 99,1995, 5588. 
29. Y. Wang, B. Han, H. Yan, J.C.T. Kwak, Langmuir, 13,1997, 3119. 
30. M.J. Blandamer, B. Briggs, P.M. Culhs, K.D. Irlam, J.B.F.N. Engberts, J. 
Kevelam, J. Chem. Soc, Faraday Trans., 94,1998, 259. 
31. S.K. Singh, N. Caram-Lelham, /. Colloid Interface Sci., 203,1998, 430. 
32. Y. Inoue, T. Wada, Adv. Supramol. Chem., 4,1997, 55. 
33. H.J. Gdihivi^, Pharm. Res., 15,1998, 23. 
34. G.J.T. Tiddy, A. Khan, Curr. Opin. Colloid Interface Sci., 4,1999, 379. 
35. S. Lang, Curr. Opin. Colloid Interface Sci, 7, 2002, 12. 
48 
Chapter I Introduction 
36. A. Cheema, P. Taboada, S. Barbosa, M. Siddiq, V. Mosquera, Molecular 
Phys., 104,2006,3203. 
37. P. Mukerjee, J. Pharm. ScL, 63,1974,972. 
38. P. Mukerjee, "Physical Chemistry: Enriching Topics from Colloid and 
Surface Science", H. van Olphen, K.J Mysels (Eds.), Theorex, La JoUa, CA, 
1975. 
39. D. Attwood, V. Mosquera, M. Garcia, M.J. Suarez, F. Sarmiento, 
J. Colloid Interface Sci, 175,1995,201. 
40. W. Caetano, M. Tabak,./. Colloid Interface Sci., 225, 2000, 69. 
41. W. Caetano, L.R.S. Barbosa, R. Itri, M. Tabak, J. Colloid Interface Sci., 
260, 2003, 414. 
42. D. Attwood, A.T. Florence, "Surfactant Systems", Chapman & Hall, 
London, 1984. 
43. D. Marcel, "Cationic Surfactants", E. Jungermann (Ed.), New York, 1970. 
44. J.N. Israelachvili, D.J. Mitchell, B.W. Ninham, J. Cheni. Soc, Faraday 
Trans.2, 72,1976, 1525. 
45. "Solution Chemistry of Surfactants", K.L. Mittal (Ed.), Plenum, New York 
1979. 
46. B. Lindman, H. Wennerstrom, Top. Curr. Chem., 87,1980, 1. 
47. L.S.C. Wan, F.S. Lee, J. Pharm. Sci, 63,1974, 136. 
48. S.P. Moulik, S. Ghosh, /. MoL Liq., 72,1997, 145. 
49. C.W. Brown, D. Cooper, LC.S. Moore, /. Colloid Interface Sci., 32, 1970, 
584. 
50. N. Kamenka, G. Haouche, B. Faucompre, B. Brun, B. Lindman, /. Colloid 
Interface Sci., 108,1985,451. 
51. P. Li, M. Jansson, P. Bahadur, P. Stilbs, / Phys. Chem., 93,1989, 6458. 
52. Z. Gao, R.E. Wasyhshen, J.C.T. Kwak,/. Colloid Interface Sci., 137,1990, 
137. 
49 
Chapter I Introduction 
53. S.M. Hajji, B. Azize, A. Cao, R. Coudert, E. Hantz, R.R. Durand, 
E. Taillandier, /. Phys. Chem., 94,1990, 7220. 
54. K. Kogej, J. Skerj&nc, Langmuir, 15,1999, 4251. 
55. S.E. Burke, S.L. Andrecyk, R. Palepu, ColloidPolym. Set, 279, 2001, 131. 
56. T.M. Herrington, CM. Taylor, /. Chem. Soc, Faraday Trans. 1, 78, 1982, 
3409. 
57. H.N. Singh, S. Singh, D.S. Mahalwar, J. Colloid Interface Sci., 59, 1977, 
386. 
58. D. Attwood, D. Doughty, V. Mosquera, V. P. Villar, J. Colloid Interface 
Sci, 141,1991,316. 
59. J.H. Clint, "Surfactant Aggregation", Blackie, Chapman and Hall, New 
York 1992. 
60. E. Rodenas, M. Valiente, M.S. Villafruela, J. Phys. Chem. B, 103, 1999, 
4549. 
61. ?.M. Holland, D.N. Rubingh, J. Phys. Chem., 871,1983, 984. 
62. B. Gu, M.J. Rosen, J Colloid Interface Sci., 129,1989, 537. 
63. K. Motomura, M. Yamanaka, M. Aratono, Colloid Polym. Sci., 262, 1984, 
948. 
64. C. Sarmoria, S, Puvvada, D. Blankschtein, Langmuir, 8, 1992, 2690. 
65. S. Puvvada, D. Blankschtein, J. Phys. Chem., 96,1992, 5567. 
66. S. Puvvada, D. Blankschtein, /. Phys. Chem., 96,1992, 5579. 
67. A. Shiloach, D. Blankschtein, Langmuir, 14,1998,4105. 
68. A. Shiloach, D. Blankschtein, Langmuir, 14,1998,7166. 
69. C. Tanford, J. Phys. Chem., 16,1972, 3020. 
70. D.J. Mc Clements, "Food Emulsion: Principles, Practice, and Techniques", 
New York, CRC Press, 1999. 
71. E. Dickinson, "Introduction to Food Colloids", Oxford University Press, 
1992. 
50 
Chapter I Introduction 
72. D.J. McClements, "Food Emulsion: Principles, Practice, and Techniques", 
2""^  ed., CRC Press, FL, Boca Raton, 2005. 
73. P.C. Hiemenz, "Principles of Colloids and Surface Chemistry", 2""^  ed., 
Marcel Dekker, New York, 1986. 
74. P.C. Hiemenz, R. Rajagopalan, "Principles of Colloid and Surface 
Chemistry", Marcel Dekker, New York, 1997. 
75. R.J. Hunter, "Introduction to Modem Colloid Science", Oxford University 
Press, Oxford, New York, 1993. 
76. R.C. Srivastava, A.N. Nagappa, "Surface Activity in Drug Action", 
Elsevier, The Netherlands, 2005. 
77. G. Zografi, "Remington's Pharmaceutical Science", A. Osol, J.E. Hoove 
(Eds.), Mack Publishing Company, Easton, PA, 1975. 
78. A.T. Florence, Adv. Colloid Interface Sci., 2,1968, 115. 
79. P.S. Guth, M.A. Spirtes, Int. Rev. Neurobiol. 1,1964, 231. 
80. A. Felmierster, J. Pharm. Sci., 61,1972, 151. 
81. D. Attwood, J. Gibson, /. Pharm. Pharmacol., 30,1978, 176. 
82. D. Attwood, J. Pharm. Pharmacol, 24,1972, 751. 
83. D. Attwood, J. Pharm. Pharmacol, 28,1976, 407. 
84. P.M. Seeman, H.S. Bialy, Biochem. Pharmacol., 12,1963, 1181. 
85. J. M. Ritchie, P. Greengard, Ann. Rev. Pharmacol., 6,1966, 405. 
86. F.A. Vilallonga, E.W. Phillips, J. Pharm. Sci., 69,1980, 102. 
87. N.T. Pryanishnikova, Farma^o/. Toxicol. (Moscow), 36,1973,195. 
88. D. Hellenbrechet, B. Lemmer, G. Weithold, H. Grobecker, Naunyn-
Schmiedeberg's Arch. Pharmacol., Ill, 1973, 211. 
89. J.M.A. Sitsen, J.A. Fresen, Pharm. Weekbl, 108,1973, 1053. 
90. K. Thoma, K. Albert, Pharm. Acta Helv., 54,1979, 324. 
91. A. Gesher, A. Li wan Po, J. Pharm. Pharmacol, 30,1978, 353. 
92. S. Schreier, S.V.P. Malheiros, E. de Paula, Biochim. Biophys. Acta, 1508, 
2000,210. 
51 
Chapter I Introduction 
93. D. Attwood, A.T. Florence, J.N.M. Gillian, J. Pharm. Set, 63,1974, 988. 
94. D. Attwood, R. Natarajan, J. Pharm. Pharmacol, 33,1981,136. 
95. A.D. Atherton, B.W. Barry, J. Colloid Interface ScL, 106,1985, 479. 
96. E. Wajnberg, M. Tabak, P.A. Nussenzveig, CM. Lopes, S.R. Louro, 
Biochim. Biophys. Acta, 944,1988,185. 
97. D. Attwood, V. Mosquera, C. Rey, M. Garcia, J. Colloid Interface Sci., 147, 
1991,316. 
98. D. Attwood, V. Mosquera, J.L. Lopez-Fonton, M. Garcia, F. Sarmiento, 
J. Colloid Interface Sci., 184,1996, 658. 
99. M. Perez-Rodrigues, G. Prieto, C. Rega, L.M. Varela, F. Sarmiento, V. 
Mosquera, Langmuir, 14,1998,4422. 
100. D. Attwood, R. Blundell, V. Mosquera, M. Garcia, J. Colloid Interface Sci., 
161,1993, 19. 
101. P. Seaman, Pharmacol Rev., 24,1972, 583. 
102. M. Huang, J.W. Daly, J. Med Chem., 15,1972,458. 
103. L.N. Domelsmith, L.L. Munchausen, K.N. Houk, J. Am. Chem. Sac, 99, 
1977, 6506. 
104. D. Attwood, J.A. Tolley, / . Pharm. Pharmacol, 32,1980, 761. 
105. P. Taboada, D. Attwood, J.M. Ruse, M. Garcia, F. Sarmiento, V. Mosquera, 
J. Colloid Interface Sci., 216,1999,270. 
106. L.M. Varela, C. Rega, M.J. Suarez-Filloy, J.M. Ruso, G. Prieto, D. 
Attwood, F. Sarmiento, V. Mosquera, Langmuir, 15,1999, 6285. 
107. K.L. Rundlett, D.W. Armstrong, ^ «fl/. Chem., 67,1995, 2088. 
108. S.D. Rychnovsky, B.N. Rogers, T.I. Richardson, Ace. Chem. Res., 31, 1998, 
9. 
109. A.D. Atherton, B.W. Barry, J. Pharm. Pharmacol, 37,1985, 854. 
110. D. Attwood, V. Mosquera, M. Garcia, M.J. Suarez, F. Sarmeinto, J. Colloid 
Interface Sci., 175,1995,201. 
52 
Chapter I Introduction 
111. F. Sarmiento, J.L. Lopez-Fontan, G. Prieto, D. Attwood, V. MosqueraT 
Colloid Polym. Sci., 275,1997,1144. 
112. D. Causon, J. Gettins, J. Gormally, R. Greenwood, N. Natarajan, 
E. Wyn-Jones, J. Chem. Sac, Faraday Trans.2,11,1981, 143. 
113. S. Yokoyama, Y. Fujino, Y. Kawamoto, A. Kaneko, Chem. Pharm. Bull, 
42,1994, 1351. 
114. J.M. Ruso, D. Attwood, C. Rey, P. Taboada, V. Mosquera, F. Sarmiento, J. 
Phys. Chem. B, 103,1999, 7092. 
115. W.A. Frezzatti Jr, W.R. Toselli, S. Schreier, Biochim. Biophys. Acta, 860, 
1986,531. 
116. D. Attwood, P. Fletcher, J. Pharm. Pharmacol, 38, 1986, 494. 
117. M. Wakita, Y. Kuroda, Y. Fujiwara, T. Nakagawa, Chem. Phys. Lipids, 62, 
1992, 45. 
118. H. Matsuki, S. Hashimoto, S. Kaneshina, M. Yamanaka, Langmuir, 10, 
1994, 1882. 
119. T. Rades, C.C. Muller-Goymann, Int. J. Pharm., 159,1997, 215. 
120. S.Y. King, A.M. Basista, G. Torosian, J. Pharm. Sci., 78,1989, 95. 
121. D. Attwood, A.T. Florence, "Surfactant Systems, Their Chemistry, 
Pharmacy and Biology", Chapman and Flail, New York, 1983. 
122. K. Thoma, K. Albert, Pharmazie, 38,1983, 807. 
123. D. Attwood, Adv. Colloid Interface Sci., 55,1995, 271. 
124. A.J. Clark, "The Mode of Action of Drugs on Cells", E. Arnold Co, 
London, 1933. 
125. A.J. Clark, "General Pharmacology in Handbuch der Experimentellen 
Pharmacologie", A. Heffter, (Ed.), Springer-Verlag, Berlin, 1937. 
126. W.D.M. Paton, Proc. Roy. Sac. B, 21,1961,154. 
127. W.D.M. Paton, H.P. Rang, Adv., Drug Res., 3,1966, 57. 
128. W.D.M. Paton, Proc. Roy. Soc. Med, 53,1960, 815. 
129. B. Katz, S. Thesleff, J. Physiol., London, 63,1957, 138. 
53 
Chapter I Introduction 
130. T.P. Kenakinn, "Pharmacologic Analysis of Drug-Receptor Interaction", 3'^ '' 
ed., Lippincott, Williams and Wilkins, Philadelphia, PA, 1997. 
131. N.M. van Os, J.R. Haak, L.A.M. Rupert, "Physico-Chemical Properties of 
Selected Anionic, Cationic and Nonionic Surfactants", Elsevier, 
Amsterdam, 1993. 
132. D. Blankschtein, G.M. Thurston, G.B. Benedek, /. Chem. Phys., 85, 1986, 
7268. 
133. C.L. Liu, Y.J. Nikas, D. Blankschtein, Biotechnol. Bioeng., 52,1996, 185. 
134. F. Krafft, Ber. Deutch Chem. Gesell, 32,1899, 1596. 
135. Y. Moroi, R. Matuura, Bull. Chem. Soc. Jpn., 61,1988, 333. 
136. C. La Mesa, L. Coppola, Collloids Surf., 35,1989, 325. 
137. H. Matsuki, R. Ichikawa, S. Kaneshina, H. Kamaya, I. Udeda, J. Colloid 
Interface Sci.. 181,1996, 362. 
138. R.L Robson, E.A. Dennis, J. Phys. Chem., 81,1977, 1075. 
139. M. Corti, C. Minero, V. Degiorgio, J. Phys. Chem., 88,1984, 309. 
140. K.H. Raney, H.L. Benson, J. Am. Oil Chem. Soc., 61,1990, 722. 
141. J.E. Glass, "Polymers in Aqueous Media Performance Through 
Association". Advances in Chemistry Series 223, American Chemical 
Society, Washington, DC, 1989. 
142. S.W. Shalaby, C.L. McCormic, G.B. Butler, "Water Sohible Polymers, 
Synthesis, Solution Properties and Applications", ACS Symposium Series 
467, American Chemical Society, Washington, DC, 1991. 
143. M. Prasad, S.P. Moulik, A. Al. Wardian, S. Moore, A. van Bommel, R. 
Palepu, J. ColloidPolymn. Sci., 283, 2005, 887. 
144. M. Prasad, S.P. Moulik, D. Chisholm, R. Palepu, /. Oleo Sci., 52, 2003, 
523. 
145. H. Scott, J. Colloid Interface Sci, 192,1997, 458. 
146. H. Scott, J. Colloid Interface Sci., 205,1998,496. 
147. S. Ghosh, S.P. Moulik, Indian! Chem., 38A, 1999, 10. 
54 
Introduction -^^4/'Chapter I 
'^), 
II—•Ji>u»,umjjr|()ij^ij j r^yjjjm^^tLl^iii 
148. S. Ghosh, S.P. Moulik, Ind. Chem., 38A, 1999, 201. 
149. G. Karlstrom, A. Carlsson, B. Lindman, J. Phys. Chem., 94,1990, 5005. 
150. D. Varade, R. Sharma, V.K. Aswal, P.S. Goyal, P. Bahadur, Eur. Polym. J., 
40, 2004, 2457. 
151. S. Saito, J. Colloid Interface Set, 24,1967, 227. 
152. Z.-J. Yu, G. Xu, /. Phys. Chem.. 93,1989, 7441. 
153. B.L. Bales, R. Zana, Langmuir, 20, 2004,1579. 
154. R. Zana, M. Benrraou, B.L. Bales, /. Phys. Chem. B, 108, 2004, 18195. 
155. D. Mitra, I. Chakarborty, S.C. Bhattacharya, S.P. MouUk, Langmuir, 23, 
2007, 3049. 
156. Z.-J. Yu, G. Xu, J. Phys. Chem., 93,1989, 7446. 
157. R.L. Revia, G.A. Malharadze, Talanta, 48,1999, 409. 
158. J.-L. Chai, J.-H. Mu, Colloid J., 64, 2002, 550. 
159. V. Ranade, M.A. Hollinger, "Drug Delivery Systems", T^ ed., CRC Press, 
Boca Raton, 2003. 
160. G.A. Stahl, D.N. Schulz, "Water-Soluble Polymers for Petroleum 
Recovery", Plenum Press, New York, 1986. 
161. E.D. Goddard, J.V. Gluber, "Principles of Polymer Science and Technology 
in Cosmetics and Personal Care", Marcel Dekker, New York, 1999. 
162. P. Chandar, P. Somasundaran, N.J. Turro, Macromolecules, 21,1988, 950. 
163. P. Hansson, B. Lindman, Curr. Opin. Colloid Interface Sol, 1, 1996, 604. 
164. E.D. Goddard, K.P. Ananthapadamanabhan, "Interactions of Surfactants 
with Polymers and Proteins", CRC Press, Boca Raton, 1993. 
165. J.C.T. Kwak, "Polymer-Surfactant Systems", Surfactant Science Series, 
Marcel Dekker, New York, 1998. 
166. G. Karlstorm, J. Phy. Chem., 89,1985, 4962. 
167. M.L. Zhang, Carhohydr. Polym., 45, 2001,1. 
168. I. Racz, "Drug Formulation", Wiley, New York, 1989. 
55 
Chapter I Introduction 
169. J.H. Guo, G.W. Kinner, W.W. Harcum, P.E. Bamum, Pharm. Sci. Tech. 
Today, 1,1998, 254. 
170. L.A. Doshier, J. Hepp, K. Benedek, Am. Lab, 34,2002, 18. 
171. K. Kamide, Macromolecules, 28,1995,7837. 
172. B. Persson, S. Nilsson, R. Bergman, J. Colloid Interface Sci., 218, 1999, 
433. 
173. A. Riddel, H. Evertsson, S. Nilsson, L.O. Sundelof, J. Pharm. Sci., 88, 
1999, 1175. 
174. D. Ostrouskii, A.L. Kjoniksen, B. Nysthon, L.M. Torell, Macromolecules, 
32,1999, 1534. 
175. A. Avsanas, P. Ilion, J. ColloidMerface Sci. 258, 2003, 102. 
176. V. Sovily, L. Petrovic, Colloids Surf. A, 298, 2007, 94. 
177. R.M. de Martins, CM. Becker, D. Samios, C.I.D Bica, Macromol Symp., 
24-246, 2006, 287. 
178. A. Carlsson, G. Karlstrom, B. Lindman, Langmuir, 2,1986, 536. 
179. J.C. Drummond, S. Albers, D.N. Furlong, Colloids Surf, 62,1992, 75. 
180. K.W. Zhang, G. Karlstrom, B. Lindman, Colloids Surf, 61,1992, 147. 
181. S. Suto, I. Iwasawa, J. Polym. Sci., A. Polym. Chem., 31,1993, 1599. 
182. K. Thuresson, B. Nystrom, G. Wang, B. Lindman, Langmuir, 11, 1995, 
3730. 
183. C. Holmberg, Colloid Polym. Sci. H 11 A, 1996, 836. 
184. C. Holmberg, S. Nilsson, L.O. Sundelof, Langmur, 13,1997, 1392. 
185. H. Evertsson, C. Holmberg, Colloid Polym. Sci., 275,1997, 830. 
186. H. Bu, A.L. Kjoniksen, B. Nystrom, Biomacromolecules, 5, 2004, 610. 
187. M. Olsson, G. Bostrom, L. Karlson, L. Picullel, Langmuir, 21, 2005, 743. 
188. G. Zhao, S.B. Chen, Langmuir, 22, 2006, 9129. 
189. M.A. Mir, A.A. Dar, A. Amin, G.M.L Rather, Mol Liq., 150, 2009, 86. 
190. E.D. Goddard, K.P. Ananthapadmanaban, "Interactions of Surfactants with 
Polymer and Proteins", CRC Press, Boca Raton, FL, 1993. 
56 
Chapter 11 Introduction 
191. P. Somasundran, S. Chakraborty, J. Cosmet. Sci., 55, 2004, SI. 
192. P.C. Griffiths, A.Y.F. Cheung, Mater. Sci. Technol, 18, 2002, 591. 
193. S. Saito, "Nonionic Surfactants", Physical Chemistry, M.J. Schick (Ed.), 
Marcel Dekker, New York, 1987. 
194. K.A. Dill, D.E. Koppel, R.S. Canter, J.D. Bendedouch, S.H. Chen, Nature, 
309,1984,42. 
195. P.M. Menger, D.W. T>o\\,J.Am. Chem. Soc, 106,1984, 1109. 
196. J. Tabony, Mol. Phys. 51,1984, 975. 
197. K. Shirahama, K. Tsujii, T. Takagi, J. Biochem., 75,1974, 309. 
198. Y.Q. Zhang, T. Tanaka, M. Shibayama, Nature, 360,1992, 142. 
199. M.M. Breuer, I.D. Robb, Chem. Ind., 530 1972. 
200. I.D. Robb, "Anionic Surfactants: Physical Chemistry of Surfactants 
Action", E.H. Lucassen Reynders (Ed.), Marcel Dekker, New York, 1981. 
201. E.D. Goddard, Colloids Surf. 19,1986, 255. 
202. E.D. Goddard, Colloids Surf. 19,1986, 301. 
203. K. Hayakawa, J.C.T Kwak, "Cationic Surfactants", Physical Chemistry, D. 
N. Rubingh, P.M. Holland (Eds.), Marcel Dekker, New York, 1991. 
204. K.P. Ananthapadmanabhan, "Interactions of Surfactants with Polymers and 
Proteins", E.D. Goddard, K.P. Ananthapadmanabhan (Eds.), CRC Press, 
Boca Raton, 1993. 
205. E.D. Goddard, "Interactions of Surfactants with Polymers and Proteins" E. 
D. Goddard, K.P. Ananthapadmanabhan (Eds.), CRC Press, Boca Raton, 
1993. 
206. Y.C. Wei, S.M. Hudson, J. Macromol. Sci. Rev. Macromol. Chem. Phys. C, 
35,1995,15. 
207. H.B. Bull, H. Neuarth, J. Biol Chem., 118,1937, 163. 
208. M.L. Anson, Science, 90,1939, 256. 
209. R.M. Hill, D.R. Briggs, J. Am. Chem. Soc, 78,1956, 1590. 
210. T. Isemura, Y. Kimura, J. Polym. Sci., 16,1955, 92. 
57 
Chapter I f Introduction 
211. T. Isemura, A. Imanishi, J. Polym. Sci., 33,1958, 337. 
212. Kabir-ud-Din, M.D.A. Al-Ahmadi, A.Z. Naqvi, M. Akram, Colloids Surf. 
B. 64, 2008, 65. 
213. W.C. Bowman, M.J. Rand, "Textbook of Pharmacology, Blackwell 
Science" Publishers, Cambridge, 1990. 
214. M.S. Ali, G. Ghosh, Kabir-ud-Din, Colloids Surf. B, 75, 2010, 590. 
215. R.T. Borchardt, R.M. Freidinger, T.K. Sawyer, P.L. Smith, "Integregation 
of Pharmaceutical Discovery and Development Case Histories", Plenum 
Press, New York, 1998. 
216. S. Venkatesh, R.A. Lipper, J. Pharm. Sci., 89,2000, 145. 
217. E.F. Gene Fiese, J. Pharm. Sci., 92,2003, 1331. 
218. B. Wang, T. Siahaan, R. Soltero, "Drug Delivery, Principles and 
Applications", John Wiley and Sons, New York, 2005. 
219. K.K. Jain, "Drug Delivery Systems", Springer, Berlin, 2008. 
220. M.J. "Groves, Pharmaceutical Biotechnology", 2"^ ed., Taylor and Francis, 
Boca Raton, 2005. 
221. S. Puttipipatkhachom, J. Nunthanid, K. Yamamoto, G.E. Peck, Drug Dev. 
Ind. Pharm., 27, 2001, 143. 
222. H. Schott, J. Macromol. Sci. Phys. 5, 31,1992, 1. 
223. R. T)Vincm, Anti-Cancer Drugs, 3,1992, 175. 
224. L. Yang, P. Alexandridis, Curr. Opin. Colloid Interface Sci., 5, 2000, 132. 
225. A. Rosier, G.W.M. Vandermeulen, H.A. Klok, Adv. Drug Deliveiy Rev., 
53,2001,95. 
226. D. Attwood, S.P. Agarwal, J. Chem. Soc. Faraday Trans., 176,1980, 570. 
227. D. Attwood, P. Fletcher, E. Boitard, J.P. Dubes, H. Tachoire, J. Phys. 
Chem., 91,1987, 2970. 
228. Kabir-ud-Din, A.B. Khan, A.Z. Naqvi, Colloids Surf. B, 80, 2010, 206. 
229. Kabir-ud-Din, M.A. Rub, A.Z. Naqvi, Colloids Surf. B, 82, 2011, 87. 
58 
Chapter 11 Introduction 
230. A.J. Muller, Y. Garces, M. Torres, B. Scharifker, A.E. Saez, Prog. Colloid 
Polym.Sci,. 122,2003,73. 
231. M.S. Bakshi, R. Kaur, I. Kaur, R.K. Mahajan, P. Sehgal, H. Doe, Colloid 
Polym.Sci., 2%\,2m^,l\6. 
Til. M.S. Ali, M. Suhail, G. Ghosh, M. Kamil, Kabir-ud-Din, Colloids Surf. A, 
350,2009,51. 
233. M. Jones, J. Leroux, Eur. J. Pharm. Biopharm., 48,1999, 101. 
234. R. Langer, N.A. Peppas, AIChEJ., 49, 2003, 2990. 
235. Y. Osada, S.B. Ross-Murphy, Sci. Am.. 268,1993, 82. 
236. B. Lindman, K. Thalberg, "Interactions of Surfactant with Polymers and 
with Proteins", E.D. Goddard, KA. Ananthapadmanabhan (Eds.), CRC 
Press, Boca Raton, FL, 1993. 
237. G.J. Fox, D.M. Bloor, J.F. Holzwarth, E. Wyn-Jones, Lajjgmuir, 14, 1998, 
1026. 
238. Y. Wang, B. Han, H. Yan, D.J. Cooke, J. Lu, R.K. Thomas, Langmuir, 14, 
1998, 6054. 
239. K. Lindell, B. Cabane, Langmuir, 14,1998, 6361. 
240. T. Oida, N. Nakashima, S. Nagadome, J.S. Ko, S.W Oh, G. Sugihara, J. 
Oleo Sci.. 52, 2003, 509. 
241. R. Langer, E.G. Cima, J.A. Tamad, E. Wintermant, Biomaterials. 11, 1990, 
738. 
242. A.M. Serajuddin, A.B. Thakur, R.N. Ghoshal, M.G. Fakes, S.A. Ranadive, 
K.R. Morris, S.A. Varia, J. Pharm. Sci., 88,1999, 696. 
243. P. Mura, G.P. Bettinetti, M.T. Faucci, A. Manderioli, P.L. Parrini, 
Thermochim. Acta. 321,1998, 59. 
244. G.A.G. Novoa, J.H. Ki, S. Mirza, 0. Antikainen, A.I. Colarte, A.S. Paz, J. 
Ylivmsi, Eur. J. Pharm. Biopharm., 59, 2005, 343. 
245. R.K. Verma, S. Garg, J. Pharm. Biomed Anal, 38, 2005, 633. 
246. G. Mukherji, S. Goel, V.K.U.S. Arora, Patent 6, 565, 877, 2003. 
59 
Chapter I Introduction 
247. D. Friend, J. Microencapsulation, 9,1992, 469. 
248. B. Albertini, C. Cavallari, N. Passerini, D. Voinovich, M.L. Gonzalez-
Rodriguez, L. Magarotto, L. Rodriguez, Eur. J. Pharm. Sci., 21, 2004, 295. 
249. O.G. Mouritsen, K. Jorgensen, Chem. Phys. Lipids, 73,1994, 3. 
250. D.P. Tieleman, S.J. Marrink, H.J.C. Berendesen, Biochim. Biophys. Acta, 
1331,1997,235. 
60 

Chapter III Experimental 
Materials 
The materials used throughout the study are given in Table 2.1, which 
also includes their abbreviation, chemical formula, make and purity. 
Preparation of Solutions 
Hygroscopic chemicals (drugs: PMT, IMP, PMZ, IBF) were stored in 
desiccators. PMT, PMZ and IMP are not only hygroscopic but also 
photosensitive, so they were stored in desiccator at a dark place 
(wrapped in aluminium foil). 
The water used to prepare solutions was distilled twice over alkaline 
KMn04 in all-glass (Pyrex) distillation set-up. The specific conductivity of the 
water was in the range 1-2 x 10"* S cm''. 
Special care was taken for cleaning the glasswares, which were properly 
washed with freshly prepared chromic acid and distilled water, then rinsed with 
acetone and kept in oven for drying before use. 
Instrumentation 
Surface Tension Measurements 
The surface tension (y) measurements were performed by the ring 
detachment method using an S. D. Hardson tensiometer (Kolkata, India). All 
the experiments were performed at 30 °C. The accuracy in the measurement of 
surface tension with the tensiometer is ± 0.15 mN m\ The CMC values were 
obtained from the break point of surface tension versus log C isotherms. Two 
linear fits were used for each of the isotherms. The first line was fitted to the 
interval of concentration characterized by linear decrease of the surface tension 
and second one to the region of concentration with nearly constant surface 
tension. 
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Conductivity Measurements 
The conductivity measurements were performed on an ELICO 
(type CM 82 T, India) bridge equipped with platinized electrodes 
(cell constant = 1.02 cm '). The conductivity runs were carried out by adding 
progressively concentrated drug stock solution into the thermostated solvent 
(water) or solvent containing polymer at 30 °C. The critical micelle 
concentration (CMC) values were taken from the intersection of the two 
straight lines drawn before and after the intersection point in the specific 
conductance versus [drug] plots. As in case of the polymer-diaig mixtures the 
plots showed two breaks, the CAC was determined by the intersection of the 
first and second linear parts and the CMC by the intersection point of the 
second and third linear parts of mixtures. 
Cloud Point Measurements 
Cloud Points (CP) were obtained by placing Pyrex glass tubes 
(containing the drug solutions) into a temperature-controlled bath, the 
temperature of which was ramped at the rate of 0.1 °C/min near the CP. The 
temperature at the onset of turbidity in the solution (on heating) was noted 
[1-3]. The heating was continued well above the temperature and then 
discontinued until the solution became clear - this temperature was also noted. 
The values of the two steps agreed within 0.5 K. The temperature was cycled 
twice in this way and the quoted CP values are the average of two such 
determinations. The uncertainty in the measured CP was ± 0.5 °C. Similarly, 
CP measurements were made by using different [salts] at fixed [polymer] 
(1 % w/v) with [IMP] = 200 mM, [PMZ] = 200 mM, and [IBF] = 500 mM. 
This was done by diluting the sample to smaller concentrations and repeating 
the same procedure. 
Circular Dichroism Measurements 
Circular dichroism (CD) instrument measures the difference in 
absorbance between the L and R circularly polarized components 
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(AA =^  A L - AR), but generally report this in terms of ellipticity (0) in degrees. It 
should be noted that 0 = tan'' (b/a), where b and a are the minor and major axes 
of the resulting eclipse. There is a simple numerical relationship between AA 
and ellipticity (in degrees), namely 0 = 32.98 AA. The CD spectrum is obtained 
when the dichroism is measured as a function of wavelength. In most of the 
biological studies the observed CD signals are very small, i.e., ellipticities are 
typically in the range of millidegrees (mdeg). It is, therefore, especially 
important in CD work to pay attention to the experimental conditions in order 
to ensure that meaningful data are obtained. 
CD signals only arise where absorption of radiation occurs, and thus 
spectral bands are easily assigned to distinct structural features of a molecule. 
CD measurements were carried out with a Jasco spectropolarimeter, 
model J-815, equipped with a microcomputer. The instrument was calibrated 
with D-10-camphorsulfonic acid. All the CD measurements were carried out 
at 25 °C with a thermostatically controlled cell holder attached to a Neslab 
RTE-110 water-bath with an accuracy of ±0.1 °C. Spectra were collected with 
a scan speed of 0.2 nm/min and response time of Is. Each spectrum was the 
average of four scans. 
Fluorescence Measurements 
For analysis of the bulk properties of polymer films in-situ, various 
optical techniques can be employed including vibrational, fluorescence, and 
UV-visible absorption spectroscopy of solvatochromic probes (UVASSP) 
[4, 5]. Fluorescence methods are inherently more sensitive than absorption 
methods and there is a wide scale use of fluorescence probes for monitoring the 
local environment of materials and biological systems [6]. The general use of 
fluorescent methods to study biological systems, for which micelles and 
bilayers have often been considered models, has also promoted this type of 
investigation [7, 8]. Study on the lifetime of the excited probe, excitation and 
emission spectra, vibronic intensity ratios, anisotropics, quantum yields, etc., 
may be helpful to have mformation regarding the structure of the micelles 
63 
Chapter III Experimental 
[7, 9—11]. Quenching studies provide information regarding micellar size as 
well as the dynamic properties of both the micelle and of species solubilized 
therein [12-14]. 
Pyrene, used as fluorescent probe, was recrystallized from hexane prior 
to use. Stock solution of pyrene in ethanol was prepared and the desired 
concentration 3 (J.M for single micelles and mixed micelles, was made by 
dilution with the respective solution after evaporating the solvent. 
Hexadecylpyridinium chloride (CPC) was used as quencher and its 
concentration was varied, confirming full solubilization of probe in the 
micelles and the Poisson distribution [15-17] for quencher. It was ensured that 
the fluorescence lifetime of pyrene was longer than the residence time of 
quencher in the micelle. 
Fluorescence measurements were taken on a Hitachi F-4500 
Fluorescence spectrometer at an excitation wavelength of 334nm. Excitation 
and emission slit widths were fixed at 5 nm and 2.5 nm, respectively. Emission 
spectra of pyrene were recorded in the range 350-450 nm (350-420 nm for 
mixed micelles). Five vibronic peaks had been obtained in all the spectra. The 
fluorescence intensities of the peaks decreased with increase in the quencher 
concentration without appearance of any new peak. 
' H N M R Measurements 
' H NMR spectra of the amphiphilic drug were recorded on 400MHz 
Bruker Avance NMR spectrometer (Central Drug Research Institute, Lucknow) 
in D2O with 'H chemical shifts relative to internal standard IMS. 
For drug-polymer interaction studies the stock solutions of drug and 
polymers were prepared in D2O. About 1 ml of each solution was transferred 
to a 5mm NMR tube and the chemical shifts were recorded on the § (ppm) 
scale (reproducibility within 0.01 ppm). 
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Chapter III Part A 
Introduction 
Macromolecules at interfaces are vital because of both their useful 
applications and fundamental properties. For example, the adsorption of 
polymers onto colloid surfaces plays a critical task in the stabilization of 
emulsions in various industries [1]. Furthermore, biopolymers frequently have 
disordered hydrophobic and hydrophilic sequences that make them' quite 
interesting [2]. Gelatin is a polypeptide that is obtained from collagen by 
breaking the triple-helix structure of collagen and comprising all 20 amino acid 
residues such as glycine, proline, glutamic acid, aspartic acid, lysine, arginine, 
etc., in different proportions [3]. The lysine and arginine groups comprise about 
7.5 % of the residues and are positively charged. Glutamic and aspartic acids, 
constituting about 12.5 % of the residues, gives the negative nature to the 
chain. Another 6 % of the residues are strongly hydrophobic in nature leaving 
58 % of the chain to be neutral. Several pharmaceutical applications of gelatin 
have already been reported (either alone or in support of any other polymer) in 
the form of hydrogels in drug delivery technology [4-6]. Interactions of ionic 
surfactants with gelatin have been widely studied and are very much important 
for photographic and food industries and in drug delivery too [7-14]. Gelatin is 
a denatured protein and does not interact with surfactants as the folded proteins 
do [10]. Rather it interacts in a simple polymer-like manner, i.e., the existence 
of critical aggregation concentration (CAC) and critical micelle concentration 
(CMC) or polymer saturation point (PSP). CAC, the onset of aggregation, is 
either near or well below the CMC of pure surfactant while the PSP is assigned 
to the saturation of polymer domains by the monomers and/or micelle-like 
aggregates [15]. Above the PSP, formation of normal micelles takes place. 
Both hydrophobic and electrostatic forces play an important role in the 
interaction of polymers and surfactants when both the entities are ionic in 
nature. 
Like surfactants, a variety of drugs exhibit amphiphilic character and 
comprise a propensity to form aggregates above a critical concentration [16]. 
The drugs belonging to tricyclic antidepressant (TCA) category, such as 
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imipramine hydrochloride (IMP), display such a behavior. Studies show that 
overdose of TCAs may be harmful; therefore, their controlled release is 
necessary [17]. A large number of polymers are being used in controlled 
release for-mulations and studies on the interaction between polymers and 
drugs are necessary to understand the behavior of such systems. The system 
becomes more interesting when the drug is amphiphilic [18]. Therefore, we 
have initiated the study on the interaction of gelatin with a model TCA drug 
IMP using surface tensiometric and conductometric. It was found that this drug 
interacts with gelatin in a distinctive surfactant-like mode. Circular dichroism 
(CD) study was also performed to see the effect of IMP on the secondary 
structure of the gelatin. 
Results and Discussion 
(a)Conductometric Studies 
Figure 3A.1 shows a specific conductivity profile as a function of 
concentration of IMP and Figure 3A.2 shows surface tension plots as a function 
of concentration of IMP. The intersection point of the two straight lines 
represents the usual critical micellar concentration (CMC) of IMP and was 
found to be 0.046 mol dm , which is in agreement with the reported value 
[19]. The conductivity and surface tension plots of IMP with varying %age of 
gelatin are shown in Figure 3A.3a and 3A.3b. Clearly, the plots show two 
breaks in presence of gelatin in comparison to a single break observed in 
absence of the protein [15]. The two breaks in presence of gelatin are ascribed 
to the occurrence of two kinds of aggregation phenomena. The first break is 
called as critical aggregation concentration (CAC) where the interaction of 
macromolecule chain with the amphiphile (dmg) starts. The second break 
point, PSP, is attributed to the saturation of polymer or protein with drug 
monomers and/or micelle-like aggregates, followed by formation of protein-
free aggregates on adding more amount of the drug. It is remarkable to note 
that in presence of gelatin the first break point, CAC, is less than to the break 
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point observed in absence of macromolecule, i.e., CMC of IMP in pure 
aqueous solution (Figure 3A.2). The appearance of first break shifted to lower 
concentrations of the drug as the concentration of gelatin increases, i.e., the 
CAC decreases on increasing the gelatin concentration. The second break 
point, on the other hand, is higher than the first one and also more than the 
CMC of the drug in gelatin free (pure aqueous IMP) solution. Thus, contrary to 
the decrease in CAC, PSP increases on increasing the gelatin concentration. A 
decrease in the CAC value, mainly credited to the interactions between the 
macromolecule and amphiphilic drug, is the characteristic of polyelectrolytes 
and amphiphiles of opposite charges. In the present case, the decrease may be 
due to the electrostatic interaction between negatively charged amino acids 
(aspartic and glutamic acids; 12.5 %) and the cationic head group of IMP, 
supported by the nonpolar interactions between the hydrophobic segments of 
gelatin (58 %) and the drug. Due to the presence of both hydrophobic and 
hydrophilic interactions the onset of interaction decreases on increasing the 
gelatin concentration. 
The values of PSP increase as the concentration of gelatin increases, this 
may be due to the fact that, as the amount of macromolecule increases, there is 
increase in the binding sites accessible to the drug monomers (or dmg 
aggregates), and therefore, more amount of the dioig is required to bind to the 
macromolecule. After the total binding sites are occupied, the drug monomers 
become free to form micelles [15]. 
The degree of micelle ionization (a) was calculated by taking the ratio 
between the slopes of the linear portions above and below the break point in the 
conductivity profiles [15]. Hence, two values, i.e., aj and ai, were obtained in 
our systems (Table 3A.1). The larger value of a for the complex micelles is 
indication of an increased degree of ionic dissociation as a result of the 
interaction of amphiphile with macromolecule. 
The free energy of aggregation, AG°aga, and the free energy of 
micellization, AG°,nic, (or free energy of polymer saturation, AG°PSP, in presence 
of polymer) can be calculated using the following Equations [20] 
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AG*^ agg = RT (2-ai) In CAC (3 A. 1) 
AG^njc = RT (2-a2) In CMC or AG%ST = RT (2-a2) In PSP (3 A.2) 
The free energy of transfer, AG°t, associated with the binding interaction 
between the drug and macromolecule, is then given by 
AG V AG°agg-AG°psp (3A.3) 
The free energy of micellization, obtained with the help of Eq. (3A.1), 
was found to be —11560 Jmol . In presence of gelatin (0.02%, w/v), AG a^gg 
was found to be more negative as compared to AG^ i^c of pure IMP 
(Table 3A.1) due to the interaction between the dnig and macromolecule 
leading to the aggregation more favorable. A further increase in gelatin 
concentration further decreases the free energy of aggregation and thus again 
makes the interaction more feasible. Therefore, on the basis of these 
observations we can safely conclude that IMP interacts with gelatin and the 
interaction is due to the dominating negative sites under the present conditions 
of study. Furthermore, an increase (less negative) in AG p^sp on increasing the 
gelatin concentration may be ascribed to the delayed micellization of IMP 
when more amount of macromolecule is present. Finally, AG t, which is mainly 
associated to the transfer of amphiphile from the micellar to the 
macromolecule-amphiphile complex, was found to decrease on increasing the 
gelatin concentration. This is also a strong evidence in favor of our findings. 
(b)Tensiometric Studies 
Surface tension measurement is an easy and efficient technique of 
studying the interactions between macromolecules and surface active agents 
[21, 22]. The curves, shown in Figure 3A.3b, exhibit several of the normally 
observed uniqueness of interacting macromolecule-amphiphile systems. The 
CMC of pure drug from surface tension data was found to be 0.047 mol dm , 
which is in good justification with reported by our conductometric 
measurements. Gelatin shows meager surface activity under the experimental 
conditions, divulged by a lower surface tension (70 mN m , with 0.2 %, w/v 
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gelatin) as compared to the pure water (72 mN m~'). The surface tension 
decreases further on increasing the concentration of the gelatin. These 
observations indicate that gelatin affects surface tension of water by means of 
interfacial adsorption. Furthermore, a synergistic lowering of surface tension at 
very low drug concentration implies the formation of highly surface active 
complex [21, 22]. It is clear from Figure 3A.3b that gelatin and drug mixtures 
show lowering of surface tension. Addition of drug decreases the surface 
tension because of the adsorption of the cationic monomers onto the negatively 
charged sites present in gelatin. The less vertical slope of gelatin-drug system 
as compared to the drug only in water was due to the partial removal of the 
protein from the air-water interface. In addition, the slope becomes less steep 
on increasing the gelatin concentration. From the surface tension isotherms of 
IMP it is clear that the first break point (CAC) is not very clear in presence of 
low amount of gelatin while CAC becomes more clear as the concentration of 
gelatin increases. This may be attributed to the relatively weaker interaction of 
macromolecule with the drug at low concentration of gelatin which becomes 
significant as the concentration of gelatin increases. The CAC and PSP 
obtained with both conductivity and surface tension measurements, given in 
Table 3A.1 and plotted in Figure 3A.4, are in good corroboration with each 
other. 
(c)rar-UV CD 
CD spectroscopy measures the variation in absorption of left and 
right-circularly polarized light as it passes through a chiral or optically active 
substance. Spectra in the far-ultraviolet wavelength range (usually from 
~200 nm to 250 nm) give information on the polypeptide backbone 
conformations (secondary structure) of proteins. Changes in CD spectra can 
provide information on ligand-protein interactions. For example, a-helices 
display large CD bands with negative ellipticity at 222 and 208 nm, and 
positive ellipticity at 193 nm, p-sheets exhibit a broad negative band near 218 
nm and a large positive band near 195 nm, while disordered extended chains 
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(random coil) have a weak broad positive CD band near 217 nm and a large 
negative band near 200 nm [23]. To gain information on the secondary 
structure present in gelatin in the system, CD measurements were performed at 
various concentrations of IMP (Figure 3A.5). The positive peak at 220 nm, 
characteristic of the triple-helix, disappears completely and the CD spectra of 
gelatin only exhibit the negative peak at 200 nm after complete denaturation of 
collagen. Addition of low amount of IMP (4 jiM) to gelatin solution does not 
alter the CD spectra significantly, but the content of the randorn coil increases 
on addition of more amount of drug leading to a more random structure. The 
ellipticity was at a maximum for the highest concentration of the drug and 
negative peaks with lower intensity were observed in comparison to gelatin 
alone. 
Figure 3A.6 illustrates the schematic representation of the interaction of 
gelatin (preferably with dominating negative sites) with IMP, which has 
cationic charged head groups. The interaction is mainly electrostatic supported 
by the hydrophobic forces due to the non-polar residues present both in the 
drug and macro molecule. 
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Figure 3A.1: Plots of specific conductivity (K) VS. drag concentration at 25 °C. 
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Figure 3A.2: Variation of surface tension vs. log [IMP]. 
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Figure 3A.4: Characteristic concentration breaks, critical aggregation 
concentration (CAC) (filled symbols) and polymer saturation concentration 
(PSP) (open symbols) on conductometric (squares) and surface tension (circles) 
titration curves as a function of gelatin concentration. 
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Figure 3A.6: Schematic representation of the IMP-gelatin complex indicating 
various amino acids: GL, glycine; VA, valine; LY, lysine; GA, glutamic acid; 
HP, hydroxyproline; AS, aspartic acid; LI, isoleucine; LU, leucine; PR, proline. 
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Introduction 
The release of bioactive substances from polymeric materials has 
fascinated the significant interest of investigators among the scientific 
community. Successful drug delivery necessitates concern of various factors 
and, therefore, different approaches have been developed which depend upon 
the route of administration, the indication at hand, the properties of the drug, 
and so on. Amongst these the effectiveness and safety of therapy are of 
foremost importance [1-3]. Essentially, the concentration of drug should be 
high enough at the targeted site to facilitate the therapeutic effect, but 
simultaneously it should not be too high, because this may result in 
unfavourable side effects. Keeping these effects in mind, the drug delivery 
systems should, therefore, be designed with proper knowledge of the properties 
of drug-carrier conjugates. The interaction of drugs with polymers (the most 
often used carrier) is also a very important aspect among these properties and 
plays an important role in the drug delivery formulations [4-8]. These 
interactions become more interesting when the drag is amphiphilic and have a 
tendency to form micelle-like aggregates [9]. A variety of drag molecules, 
such as antihistamines, antidepressants, tranquilizers, local anesthetics, and 
nonsteroidal anti-inflammatory drags (NSAIDs) are known to be amphiphilic 
in character that form ordinary micelles or micelle-like associations above a 
critical concentration (the so-called critical micelle concentration) [10-14]. 
These drags may interact with polymers in surfactant-like manner, i.e., there 
may exist critical aggregation concentration (CAC) and critical micelle 
concentration (CMC) or polymer saturation point (PSP) [9]. The CAC, the 
onset of aggregation, is either near or well below the CMC of pure amphiphile 
while the CMC is assigned to the saturation of polymer domains by the 
monomers and/or micelle-like aggregates [15-19]. Above the CMC, formation 
of normal micelles takes place. Both hydrophobic and electrostatic forces play 
an important role in the interaction of polymers and amphiphiles when either 
both or one of the entities are ionic in nature. The knowledge of CAC may be 
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of importance as the interaction of amphiphilic drug with polymer starts at this 
concentration. 
As a large number of polymers are being used in controlled release 
formulations, studies on the interaction between polymers and drugs are 
necessary to understand the behavior of such systems. In continuation with our 
keen interest on drug-polymer [20-24] and analogous surfactant-polymer 
interactions [19, 25-31], we have taken one anionic and two cationic 
amphiphilic drugs, namely, sodium salt of ibuprofen (IBF), imipramine 
hydrochloride (IMP) and promethazine hydrochloride (PMT) and studied their 
interactions with different polymers (cationic, anionic, and neutral). The 
following biocompatible polymers were used: neutral-polyvinylpyrrolidone 
(PVP), polyethylene glycol (PEG), hydroxypropylmethyl cellulose (HPMC), 
hydroxyethyl cellulose (HEC); anionic-sodium carboxymethyl cellulose 
(NaCMC), dextran sulfate (DxS); cationic-hydroxyethyl cellulose ethoxylate 
(PIECEQ). 
The purpose of this study is to investigate the general problem of the 
aqueous association of surface active drugs and polymers by understanding the 
interactions among them through conductometric and tensiometric studies. 
Results and Discussion 
Addition of amphiphilic molecules in aqueous solution allows their 
preferential adsorption at the air/water interface (in order to minimize the 
hydrophobic interaction) which results in the reduction of the cohesive 
interaction between the solvent molecules at the interface. Consequently, the 
surface tension of water is lowered progressively up to the complete saturation 
of the interface. After the saturation, the amphiphilic molecules start 
self-aggregating and settle in the bulk solution without affecting the interface. 
Due to occurrence of many stabilizing effects, the molecular interactions 
between drugs and polymers are associated with a significant change of 
thermodynamic parameters. As the values of CAC, CMC and degree of 
counterion dissociation (a) are used to calculate various energetic parameters, 
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it is important to get consistent values for these parameters. Conductometric 
and tensiometric measurements were, therefore, performed to obtain the above 
mentioned values. 
For the sake of convenience this part has been divided into the following two 
sections: 
(a) Conductometric Studies 
Critical aggregation concentration (CAC) and critical micellization 
concentration (CMC) 
The conductivity plots of pure drugs are shown in Figures 3B.la and 
3.B.lb which have only single breaks, producing the CMC values. The 
intersection points of the two straight lines represent the usual critical micellar 
concentration (CMC) [32] which were found to be 0.090 mol dm" , 0.046 mol 
dm"^ and 0.037 mol dm"\ respectively, for IBF, LMP, and PMT. In 
Figures 3B.2-3B.4, the effect of increasing concentration of polymers on 
specific conductivity profiles of IBF, IMP, and PMT are shown. 
The CAC corresponds to the onset of cooperative binding of the drugs 
with polymer segments. The binding concentration of the daigs with the 
studied polymers decreases with increase in polymer percentage. On the 
contrary, the CMC increases because micellization of drug monomers happens 
when all binding sites of polymers are occupied by dioig monomer, therefore, at 
higher polymer contents, more amount of the drug is required to bind the 
polymer. After the total binding sites are occupied, the amphiphile (i.e., the 
drug) becomes free to self-aggregate and forms micelles. A decrease in CAC 
values, mainly credited to the interactions between the polymer and 
amphiphile, is the characteristic of both the polyelectrolyte and amphiphile. 
Effect of charged and neutral polymers 
As in this study we have taken the polymers of various natures, it can be 
concluded on the basis of results (given in Tables 3B.1-3B.3 and 
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Figures 3B.2-3B.4) that cationic polymer HECEQ has more affinity towards 
the anionic drug IBF as implied by the lowest values of CAC in this case. The 
larger decrement in the values of CAC is obvious for HECEQ as the two 
entities present in the solution have opposite charges. Further, the neutral 
polymers were found to be of showing the intermediate extent of interaction, 
followed by the anionic polymers. Among the neutral polymers, cellulose 
HPMC and HEC derivatives interact strongly as compared to PEG and PVP. 
Furthermore, the extent of interaction of PVP was slightly greater than PEG. 
This seems to be an usual phenomenon as PVP is more hydrophobic as 
compared to PEG which is responsible for the stronger interaction of former as 
compared to latter [33]. For the anioninc polymers, i.e., NaCMC and DxS, 
despite a possibility of electrostatic repulsion between the constituents in these 
cases, hydrophobicity is supposed to play an important role behind the 
interaction between the polymers and the drug. Seemingly, the hydrophobic 
forces dominate over the electrostatic forces leading to the appearance of CAC 
as a result of interaction between the drug and polymers of same charges. 
Although the values of CAC are large as compared to die cationic and nonionic 
polymers, a decrease in CAC is a clear indication of the dnig-polymer 
interaction (Figures 3B.5-3B.7). Further, the decrease in CAC for anionic 
polymers being not so sharp as compared to the cationic and nonionic ones 
supports the argument of weaker interaction. It seems from our results that the 
chain saturates first for anionic polymers, followed by the nonionic polymers, 
and the amount of drug needed to saturate the cationic polymers is maximum. 
All these observations favour our discussion on the relative extent of 
interaction between various polymers and IBF. 
Similarly, the CAC values in presence of NaCMC (anionic polymer) are 
the lowest which indicates strong interaction between IMP/PMT. Neutral 
polymers also interact with the IMP/PMT, but to a lesser extent as compared to 
the anionic, and the least interaction shown by the cationic polymer. 
Anionic polymer NaCMC has more affinity towards the cationic drugs 
IMP and PMT as implied by the lowest values of CAC in this case. A general 
Chapter III j Part B 
schematic representation of the drug-polymer interaction is shown in 
Scheme 3B.1. Further, the neutral polymers were found to be of showing the 
intermediate extent of interaction, followed by the anionic polymers. 
Effect of counterion binding on micellization of drug-polymer systems 
The formation of micelles in aqueous solutions of amphiphilic compounds 
has been the object of considerable investigation, both theoretical and 
experimental. One of the factors which stabilizes the micelle formation by 
screening the hydrophilic repulsions to stabilize the self-aggregated systems by 
way of surface charge neutralization and hence lowering in intermicellar 
repulsion potential which results in sharp breaks in the specific conductivity 
versus [drug] isotherms corresponding to onset of micellization is 
dissociation/binding of counterions. Therefore, fraction of counterions 
bound/dissociated is considered to be important parameter in the process of 
micellization. The electrostatic contribution to the energy of a micelle is 
generally evaluated in the Debye-Huckel approximation, assuming the micelle 
to be fully dissociated. In considering the binding of ions to some substrate, 
such as a macromolecule or an aggregate of smaller molecules, one is 
immediately confronted by a question of definition. Some ions may be 
attached to specific sites on the surface. Obviously, these are to be considered 
bound. However, even counterions not so attached are not completely free. On 
the contrary, the closer these counterions are to the substrate the more their 
electrostatic attraction for the substrate restricts them to moving parallel to the 
surface. These ions are therefore also bound to the extent that they move with 
the substrate and are thus not osmotically active. A number of experimental 
techniques are available for investigating the interaction between ions and 
substrates, e.g., NMR spectroscopy or transport property and osmotic pressure 
determinations. These enable some conclusions to be drawn concerning the 
nature of ion binding. In some cases results can be explained adequately on the 
basis of the diffuse double layer only. 
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The degree of micelle ionization (a) was calculated by taking the ratio 
between the slopes of the linear portions above and below the break point in the 
conductivity profiles [34]. Hence, two values, i.e., aj and aj, were obtained in 
our systems (Tables 3B.1-3B.3). The larger value of a for the complex 
micelles is indication of an increased degree of ionic dissociation as a result of 
the interaction of amphiphile with macromolecule. 
The free energy of aggregation, AG°agg, the free energy of micellization, 
AG mic, and the free energy of transfer, AG t, associated with the binding 
interaction between the drug and macromolecule were also calculated 
(seeEqs. 3A.1-3A.3). 
Though a complete account of the free energies associated vv'ith 
aggregation, micellization and transfer is not possible as various factors like, 
charges, polarity, hydrophobicity, etc., are associated with them and, due to 
these factors the uncertainties in values are very large. However, we have 
discussed about these energies by considering the average values wherever 
required. In case of cationic polymer HECEQ, the value of AG°a„g varies from 
about -11.2 to -12.8 kJ mof', -15.0 to -17.2 kJ mof', -14.5 to -16.8 kJ 
mol' , while for nonionic polymers the variation is from about -9.7 to -13.7 
-14.4 to -19.1 kJ mof', -6.6 to -20.4 kJ mof', for IBF, IMP and PMT, 
respectively. Anionic polymers with IBF have the least negative values of 
energy of aggregation -9.2 to -11.0 kJ mof', while AG^ agg of IMP/PMT with 
anionic polymer varies from -15.6 to -18.0 kJ mol", -15.8 to -17.9 kJ mol", 
respectively. The aggregation is most favorable in case of cationic and nonionic 
polymers with IBF, while with IMP/PMT aggregation is most favorable in case 
of anionic and nonionic polymers and causes the appearance of CAC at very 
low concentrations. It is apparent from Tables 3B.1-3B.3 that the feasibility of 
the aggregation was maximum in case of HEC. This might be due to the 
expected high hydrophobicity of the nonionic polymer and the possible 
Coulombic repulsion among counterions (of dmg) and the cationic/nonionic 
polymers. The most important among these, i.e., AG°,, also follows the trend of 
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AG agg and for all polymers it was found that it increases with the increase in 
the polymer concentration which is a strong indication of the interaction 
between the polymer and amphiphile. 
The AG agg, AG mic, and AG, values, which are given in 
Tables 3B.1-3B.3, confirm the spontaneity of aggregation, micellization and 
transfer processes. Both the energies of aggregation and micellization decrease 
with increase in polymer %age which is well supported by the trend of CMC 
and CAC. Negative values of AG°t confirm the feasibility of interaction 
between the amphiphile and polymers. 
(b)Tensiometric Studies 
Energetics of adsorption and micelliztion 
The surface tension plots of pure drugs are shown in Figure SB.lb 
which have only single breaks, producing the CMC values 0.090 mol dm'^ , 
0.047 mol dm'^ and 0.037 mol dm"^  for IBF, IMP and PMT, respectively. 
Intcrfacial behavior of drug-polymer molecules 
The interfacial properties of the IBF/IMP/PMT+polymer systems have 
also been studied by surface tension method. As can be seen from 
Figures 3B.8-3B.10, the reduction in surface tension of water, when pure 
IBF/IMP/PMT or that in the presence of studied polymers are added, is due to 
the adsorption of amphiphilic molecules at air-water interface as a result of 
hydrophobic effect. The inherent property of amphiphilic molecules is to orient 
at air/water interface and hence change the surface properties of the water. The 
amount of IBF/IMP/PMT adsorbed per unit of surface area, in the presence and 
absence of studied polymers, can be calculated from the Gibbs adsorption 
equation. The maximum concentration adsorbed at the air-water interface 
(Fmax, known as Gibbs surface excess) is normally expressed in mol m" and is 
estimated from the slope of tensiometric isotherms as per Eq. (3B.1) 
r,„3x= (-l/2.303nRT) (dy/dlog C)T (3B.1) 
91 
Chapter III | Part B 
where R is gas constant, (dy/dlog C)T is the maximum slope and n is the 
number of chemical species per amphiphilic molecule in solution. For pure 
cationic and anionic drugs n value is 2 while for cationic/anionic drugs with 
nonionic/anionic and cationic polymers the n values are 3 and 4, respectively. 
Surface excess is a measure of effectiveness of the amphiphilic adsorption and 
has number of applications as coherently packed interfacial films have different 
properties from that of the non coherently (loosely) packed ones. 
Assuming complete monolayer formation at the CMC, the area of 
exclusion per drug monomer, A„ii„(A^), was calculated from Eq. (3B.2) 
A™„= 102°/NAr,„ (3B.2) 
The values of T„^^^ and A,nin along with the values of surface pressure at 
critical micelle concentration (HCMC) for the pure IBF/IMP/PMT and also for 
their mixtures with polymers at selected concentrations are given in 
Tables 3B.4—3B.6. As can seen from Tables 3B.4-3B.6, these parameters do 
not show a regular trend in their values with respect to the concentration of the 
studied polymers in most of the cases. However, when mixed with polymers 
the Tniax and IICMC values become much lower than that of the pure drugs 
IBF/IMP/PMT whereas the minimum area per molecule is higher in the mixed 
systems (except in few cases) and increase with increase in percentage of die 
polymer (Tables 3B.4~3B.6). The higher Aj^ n values suggest less tendency of 
the polymers to intervene between the IBF/IMP/PMT headgroups. The 
variation in their values with respect to concentration of the different polymers 
suggests that the strength of interaction depends upon both the nature of 
polymers and their concentrations when mixed with the amphiphilic drugs. 
As proposed by Sugihara et al. [35], a thermodynamic quantity, the free 
energy of a surface at equilibrium (Gmin), is another parameter which measures 
thermodynamic stability of surfaces. The lower the value of G,nin, greater is the 
stability, or more surface activity is attained. It is defined as energy needed to 
make a surface area per mole or free energy change accompanied by transition 
from the bulk phase to the surface phase of solution. The obtained values of 
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Gmin does not show any regular behaviour but it can be inferred from the data 
that surfaces formed are not much stable, and, can be represented as 
Gmin=A,ri„YCMcNA ( 3 B . 3 ) 
The free energy of adsorption (AG ads) was calculated from free energy 
of micellization (AG nuc) and through surface tension data (surface pressure at 
CMC and Gibbs surface excess) using Eq. (3B.4) 
A G ads = A G mic~(ncMc/rniax) /'3Q 4-) 
where IICMC is the surface pressure at the CMC and r,^x is Gibbs surface 
excess. For amphiphilic systems in water, the Gibbs surface excess is related to 
the surface pressure (n=yo-yg) by the relation d7r = ErjRTdlnaj(ri is the 
surface excess and a^  is activity of the i"' component at temperature T). 
The last term ricMc/rmax in Eq. (3B.4) expresses the work involved in 
transferring the amphiphile molecule from a monolayer at a zero surface 
pressure to the micelle. Here, for all the binary mixtures, last term of the 
Eq. 3B.4 is very small as compared to the AG°n^ c, which suggests that work 
involved in transferring the surfactant molecule from a monolayer at zero 
surface pressure to the micelle is negligible. AG^ n^^ ic and AG°ads values are 
negative and reveal the latter to be more spontaneous, implying" that the 
adsorption of amphiphiles and their mixtures at air/solution interface is more 
favorable than that of micelle formation. The values of CAC, CMC, AG°ads and 
other thermodynamics parameters are listed in Tables 3B.4-3B.6. With all the 
polymers, the AG°ads values are found to be more in the case of PMT and with 
respect to composition of the polymers the values slightly increase. 
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Figure 3B.1: Conductance (a) and surface tension (b) plots vs. [drug]. The 
scale shown in (b) is for plot denoted as (•). Also, the second and third plots 
have been shifted upwards by 10 and 20 scale units (niN m"'), respectively. 
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Figure 3B.2: Plots of specific conductivity (K) VS. IBF concentration at 
different concentrations of HPMC, HEC, PVP, PEG, HECEQ, NaCMC and 
DxS. The scale shown is for plot denoted as (•). Other plots have been shifted 
upwards by 1.0, 2.0, 3.0, 4.0, 5.0 and 6.0 scale units (1x10"^ Scm"'), 
respectively. 
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Figure 3B.3: Plots of specific conductivity (K) VS. IMP concentration at 
different concentrations of HPMC, HEC, PVP, PEG, HECEQ and NaCMC. 
Tlie scale shown is for plot denoted as (•). Other plots have been shifted 
upwards by 1.0, 2.0, 3.0, 4.0, 5.0 and 6.Q scale units (1x10"^ Scm"'), 
respectively. 
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Figure 3B.4: Plots of specific conductivity (K) VS. PMT concentration at 
different concentrations of HPMC, HEC, PVP, PEG, HECEQ and NaCiMC. 
Tlie scale shown is for plot denoted as (•).Other plots have been shifted 
upwards by 1.0, 2.0, 3.0, 4.0, 5.0 and 6.0 scale units (IxlO"' Scm~ )^, 
respectively. 
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Figure 3B.5: Plots of (a) critical aggregation concentration (CAC) and (b) 
polymer saturation point (PSP) of IBF as a function of polymer concentration. 
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Figure 3B.6: Plots of (a) critical aggregation concentration (CAC) and (b) 
polymer saturation point (PSP) of IMP as a function of polymer concentration. 
104 
Chapter III Part B 
0.014-
0.012 
•g 0.010 
"o 
-5- 0.008 
o 
< o 
0.006 
0.004 
0.0 0.2 0.4 0.6 O.i 
% Polymer (wVvol) 
1.0 
0.048 
0.046 
0.044 
"5 
W Q. 
0.042 
0.040 
0.038 
0.0 0.2 0.4 0.5 0.£ 
% Polymer (wt/vol) 
— I — 
1.0 
(a) (b) 
Figure 3B.7: Plots of (a) critical aggregation concentration (CAC) and (b) 
polymer saturation point (PSP) of PMT as a function of polymer concentration. 
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Figure 3B.9: Variation of surface tension vs. log [IMP] in presence of PIPMC, 
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Polymer chain 
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Scheme 3B.1: Schematic representation of the stages in amphiphile^olymer 
complexation. 
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Table 3B,1: The physico-chemical parameters of IBF in presence of studied 
polymers at 25 "C (evaluated on the basis of conductometry). 
% Polymer 
(w/v) 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
CAC 
(mol dm') 
0.040 
0.039 . 
0.035 
0.033 
0.030 
0.028 
0.025 
0.038 
0.032 
0.026 
0.023 
0.020 
0.036 
0.035 
0.033 
0.032 
0.030 
0.029 
0.027 
0.040 
0.039 
0.038 
0.035 
0.033 
0.030 
0.029 
0.037 
0.029 
0.026 
0.024 
0.020 
0.015 
CMC 
(mol dm") 
0.125 
0.127 
0.130 
0.133 
0.137 
0.148 
0.161 
0,124 
0.129 
0.132 
0.133 
0.145 
0.138 
0.147 
0.153 
0.160 
0.161 
0.161 
0.162 
0.102 
0.107 
0.112 
0.114 
0.120 
0.127 
0.134 
0.134 
0.138 
0.148 
0.155 
0.164 
0.164 
a. 0.2 
HPMC 
0.790 
0.709 
0.621 
0.615 
0.558 
0.589 
0.542 
0.531 
0.527 
0.594 
0.634 
0.550 
0.691 
0.589 
HEC 
0.616 
0.588 
0.571 
0.617 
0.582 
PVP 
0.753 
0.609 
0.696 
0.577 
0.563 
0.603 
0.628 
PEG 
0.654 
0.567 
0.532 
0.591 
0.557 
0.592 
0.629 
0.635 
0.668 
0.616 
0.597 • 
0.576 
1 
0.604 
0.558 
0.592 
0.546 
0.556 
0.608 
0.592 
0.585 
0.589 
0.614 
0.572 
0.540 
0.631 
0.641 
HECEQ 
0.608 
0.714 
0.682 
0.729 
0.843 
0.870 
0.636 
0.578 
0.625 
0.590 
0.636 
0.633 
AGagg 
(kJmol"') 
-9.7 
-10.4 
-11.5 
-11.7 
-12.5 
-12.5 
-13.3 
-11.2 
-12.0 
-12.9 
-12.9 
-13.7 
-10.3 
-11.6 
-11.2 
-12.1 
-12.5 
-12.3 
-12.3 
-10.7 
-11.4 
-11.9 
-11.7 
-12.2 
-12.2 
-12.0 
-11.4 
-11.3 
-11.9 
-11.7 
-11.2 
-11.8 
AG mic 
(kJ mol"') 
-7.6 
-7.5 
-7.1 
-6.8 
-7.1 
-6.2 
-6.4 
-7.1 
-6.8 
-6.9 
-7.0 
-6.8 
-6.9 
-6.9 
-6.6 
-6.6 
-6.5 
-6.3 
-6.4 
-8.0 
-7.8 
-7.5 
-7.7 
-7.7 
-7.0 
-6.8 
-6.8 
-7.0 
-6.5 
-6.5 
-6.1 
-6.1 
AG". 
(kJmol"') 
-2.1 
-2.8 
-4.3 
-4.9 
-5.4 
-6.3 
-6.9 
-4.2 
-5.3 
-6.0 
-5.9 
-6.9 
-3.4 
-4.7 
-4.5 
-5.5 
-6.0 
-6.0 
-5.9 
-2.7 
-3.6 
-4.4 
-4.0 
-4.5 
-5.2 
-5.3 
-4.6 
-4.3 
-5.4 
-5.2 
-5.1 
-5.6 
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1.00 
0.002 
0.003 
0.005 
0.008 
0.010 
0.015 
0.020 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.013 
0.055 
0.050 
0.046 
0.041 
0.038 
0.037 
0.036 
0.050 
0.044 
0.039 
0.038 
0.036 
0.034 
0.033 
.171 
0.099 
0.123 
0.125 
0.129 
0.130 
0.132 
0.135 
0.102 
0.118 
0.127 
0.132 
0.137 
0.143 
0.147 
0.809 0.680 
NaCMC 
0.658 
0.750 
0.779 
0.836 
0.859 
0.685 
0.796 
DxS 
0.609 
0.634 
0.633 
0.668 
0.745 
0.775 
0.770 
0.610 
0.623 
0.600 
0.637 
0.618 
0.686 
0.646 
0.619 
0.607 
0.611 
0.608 
0.649 
0.606 
0.648 
Chapter 
-12.8 
-9.6 
-9.3 
-9.3 
-9.2 
-9.2 
-10.7 
-9.9 
-10.3 
-10.6 
-11.0 
-10.8 
-10.3 
-10.3 
-10.4 
III 
-5.8 
-8.0 
-7.1 
-7.2 
-6.9 
-7.0 
-6.6 
-6.7 
-7.8 
-7.4 
-7.1 
-7.0 
-6.7 
-6.7 
-6.4 
Part B 
-7.0 
-1.7 
-2.1 
-2.1 
-2.3 
-2.3 
-4.2 
-3.2 
-2.5 
-3.2 
-3.9 
-3.8 
-3.7 
-3.5 
-4.0 
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Table 3B.2: The physico-chemical parameters of IMP in presence of studied 
polymers at 30 "C (evaluated on the basis of conductometry). 
% Polymer 
(w/v) 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
CAC 
(mol dm" )^ 
0.011 
0.010 
0.009 
0.008 
0.007 
0.006 
0.005 
0.009 
0.008 
0.007 
0.006 
0.005 
0.010 
0.009 
0.008 
0.007 
0.006 
0.005 
0.004 
0.010 
0.009 
0.008 
0.007 
0.006 
0.005 
0.004 
0.013 
0.011 
0.010 
0.009 
0.008 
0.007 
CMC 
(mol dm"^) 
0.045 
0.046 
0.047 
0.048 
0.049 
0.050 
0.051 
0.047 
0.048 
0.051 
0.053 
0.055 
0.044 
0.045 
0.046 
0.047 
0.048 
0.049 
0.050 
0.044 
0.045 
0.046 
0.047 
0.048 
0.049 
0.051 
0.048 
0.049 
0.051 
0.052 
0.053 
0.054 
a. eta 
HPMC 
0.66 
0.64 
0.63 
0.63 
0.66 
0.65 
0.66 
0.59 
0.61 
0.59 
0.67 
0.65 
0.60 
0.56 
HEC 
0.65 
0.65 
0.60 
0.63 
0.57 
0.58 
0.61 
0.65 
0.57 
0.58 
PVP 
0.69 
0.67 
0.63 
0.67 
0.67 
0.63 
0.67 
0.61 
0.66 
0.61 
0.61 
0.62 
0.63 
0.68 
PEG 
0.76 
0.69 
0.65 
0.65 
0.66 
0.65 
0.70 
0.64 
0.61 
0.66 
0.65 
0.67 
0.69 
0.68 
HECEQ 
0.62 
0.66 
0.68 
0.74 
0.70 
0.65 
0.60 
0.57 
0.60 
0.57 
0.70 
0.66 
AGagg 
(kJ mor') 
-15.2 
-15.8 
-16.3 
-16.7 
-16.7 
-17.5 
-18.6 
-16.0 
-16.5 
-17.5 
-17.6 
-19.1 
-15.1 
-15.8 
-16.7 
-16.7 
-17.1 
-18.3 
-18.5 
-14.4 
-15.5 
-16.4 
-16.9 
-17.2 
-18.0 
-18.1 
-15.1 
-15.3 
-15.3 
-15.0 
-15.8 
-16.9 
AG mic 
(kJmol"') 
-11.0 
-10.8 
-10.9 
-10.2 
-10.3 
-10.5 
-10.8 
-10.9 
-10.7 
-10.1 
-10.6 
-10.4 
-11.0 
-10.4 
-10.7 
-10.7 
-10.6 
-10.4 
-10.0 
-10.7 
-10.8 
-10.4 
-10.4 
-10.1 
-9.9 
-9.9 
-10.7 
-10.9 
-10.5 
-10.6 
-9.6 
-9.9 
AG\ 
(kJ mol"') 
-4.2 
-5.0 
-5.4 
-6.6 
-6.5 
-6.9 
-7.8 
-5.1 
-5.8 
-7.4 
-7.0 
-8.7 
-4.2 
-5.4 
-5.9 
-5.9 
-6.5 
-7.9 
-8.6 
-3.7 
-4.7 
-6.1 
-6.4 
-7.1 
-8.1 
-8.3 
-4.3 
-4.4 
-4.8 
-4.3 
-6.2 
-7.0 
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1.00 
0.002 
0.003 
0.005 
0.008 
0.010 
0.015 
0.020 
0.006 
0.010 
0.009 
0.008 
0.007 
0.006 
0.005 
0.004 
0.055 
0.049 
0.051 
0.052 
0.053 
0.054 
0.055 
0.056 
0.67 0.58 
NaCMC 
0.65 
0.64 
0.65 
0.56 
0.62 
0.65 
0.70 
0.64 
0.69 
0.73 
0.74 
0.56 
0.65 
0.64 
-17.2 
-15.6 
-16.2 
-16.4 
-18.0 
-17.7 
-18.0 
-18.0 
Chapter III 
-10.4 
-10.3 
-9.8 
-9.4 
-9.3 
-10.6 
-9.8 
-9.9 
Part B 
-6.8 
-5.3 
-6.3 
-6.9 
-8.7 
-7.1 
-8.1 
-8.1 
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Table 3B.3: The physico-chemical parameters of PMT in presence of studied 
polymers at 30 °C (evaluated on the basis of conductometry). 
% Polymer 
(w/v) 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.05 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.050 
0.10 
0.20 
0.30 
0.50 
0.80 
1.00 
0.002 
CAC 
(mol dm') 
0.012 
0.010 
0.008 
0.007 
0.006 
0.005 
0.004 
0.009 
0.008 
0.007 
0.006 
0.005 
0.012 
0.010 
0.009 
0.008 
0.007 
0.006 
0.005 
0.012 
0.01 
0.009 
0.008 
0.007 
0.006 
0.005 
0.014 
0.013 
0.012 
0.011 
0.010 
0.009 
0.008 
0.011 
CMC 
(mol dm") 
0.039 
0.041 
0.042 
0.043 
0.044 
0.045 
0.047 
0.038 
0.039 
0.040 
0.041 
0.042 
0.039 
0.040 
0.041 
0.043 
0.044 
0.045 
0.046 
0.038 
0.039 
0.040 
0.041 
0.042 
0.043 
0.044 
0.038 
0.039 
0.041 
0.042 
0.043 
0.044 
0.045 
0.038 
ai 02 
HPMC 
0.59 ,0.66 
0.57 0.73 
0.55 0.74 
0.55 0.66 
0.58 0.68 
0.56 0.60 
0.50 0.71 
HEC 
0.58 0.52 
0.53 0.59 
0.48 0.69 
0.42 0.85 
0.47 0.57 
PVP 
0.53 0.72 
0.48 0.73 
0.51 0.63 
0.55 0.63 
0.58 0.56 
0.64 0.60 
0.61 0.60 
PEG 
0.57 0.71 
0.52 0.73 
0.55 0.64 
0.56 0.70 
0.53 0.70 
0.55 0.64 
0.53 0.65 
HECEQ 
0.51 0.72 
0.54 0.74 
0.49 0.74 
0.67 0.64 
0.67 0.65 
0.78 0.67 
0.72 0.70 
NaCMC 
0.61 0.47 
AG agg 
(kJ mol"') 
-6.6 
-6.6 
-6.7 
-6.8 
-7.5 
-7.5 
-7.0 
-16.9 
-17.9 
-19.0 
-20.4 
-20.4 
-16.4 
-17.6 
-17.7 
-17.6 
-17.7 
-17.6 
-18.6 
-15.9 
-17.1 
-17.2 
-17.5 
-18.4 
-18.7 
-19.6 
-16.0 
-15.9 
-16.8 
-15.1 
-15.5 
-14.5 
-15.5 
-15.8 
AG mic 
(kJ mol"') 
-10.9 
-10.2 
-10.1 
-10.7 
-10.4 
-10.9 
-9.9 
-12.2 
-11.5 
-10.6 
-9.3 
-11.4 
-10.5 
-10.3 
-11.0 
-10.8 
-11.3 
-11.0 
-10.9 
-10.6 
-10.4 
-11.1 
-10.5 
-10.4 
-10.8 
-10.6 
-10.5 
-10.3 
-10.1 
-10.8 
-10.7 
-10.5 
-10.2 
-12.6 
AG°. 
(kJ mol"') 
-4.8 
-6.3 
-7.5 
-7.5 
-7.9 
-8.2 
-10.9 
-4.7 
-6.3 
-8.3 
-11.1 
-8.9 
-5.9 
-7.3 
-6.7 
-6.8 
-6.4 
-6.6 
-7.7 
-5.3 
-6.7 
-6.2 
-7.0 
-8.0 
-7.9 
-9.0 
-5.5 
-5.6 
-6.7 
-4.3 
-4.7 
-4.0 
-5.4 
-3.2 
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0.003 
0.005 
0.008 
0.009 
0.008 
0.007 
0.040 
0.041 
0.042 
0.56 
0.58 
0.57 
0.68 
0.47 
0.54 
-17.0 
-17.2 
-17.9 
-10.7 
-12.3 
-11.7 
-6.3 
-5.0 
-6.2 
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Chapter III Part C 
Introduction 
As drugs (especially, the amphiphilic ones) are almost invariably used in 
presence of a variety of additives (excipients), notwithstanding the knowledge 
of interaction and/or effect of drug molecules with the carrier, that of other 
foreign materials and their role toward drugs' therapeutic activity are required. 
Such a knowledge is essential in order to control/influence/employ (under 
specific conditions) the phenomenon of aggregation, swelling/deswelling, 
adsorption, solubilization, phase separation, etc. 
Among drug carriers, cellulose derivatives and other water soluble 
polymers partake significant role. As such, the interaction of various dioigs with 
carrying agents/vectors (like polymers) had been studied where almost the 
normally accepted polymer-surfactant interaction model was found to be 
operative [1-5]. In the present work, we have studied the interaction of the 
sodium salt of ibuprofen (IBF) with several polymers viz. hydroxyethyl 
cellulose (HEC), hydroxypropyl methyl cellulose (HPMC), polyethylene glycol 
(PEG), polyvinyl pyrrolidone (PVP), sodium carboxymethyl cellulose 
(NaCMC), dextran sulphate (DxS) employing different experimental 
teclmiques. H NMR studies have been used for detailed understanding of the 
interaction and fluorescence quenching was performed to evaluate the average 
aggregation number (Nggg). 
The chosen model drug, IBF, contains a carboxylic acid group. It is a 
non-steroidal anti-inflamraatory drug that is commonly used for relief of 
symptoms of arthritis, fever, primary dysmenon-heal (menstrual pains), and as 
an analgesic. Ibuprofen also has an antiplatelet effect (protects from blood 
clots) [6]. In a recent report on its interaction with some biocompatible 
polymers it was shown that the anionic IBF interacted more strongly with 
cationic polymers as compared to the nonionic ones whereas the anionic 
polymers showed the least interaction. 
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Results and Discussion 
Determination of average aggregation number (Nagg) 
The aggregation number of the ibuprofen has been measured by 
fluorescence quenching method involving the use of a hydrophobic 
fluorescence dye which exhibits different fluorescence characteristics 
depending upon the properties of solubilizing medium. In the presence of 
micelles, the pyrene solubilizes preferentially in the interior hydrophobic 
region of the aggregates modifying its fluorescence spectrum. In particular, 
when pyrene passes from the aqueous bulk to the micellar medium a decrease 
in the ratio of the p^xene fluorescence spectrum is observed. The linear plots 
that resulted between ln(lo/lQ) vs. [CPC] for IBF micellar solutions in the 
presence of different compositions of polymers are shown in Figure 3C.1. The 
average aggregation number (Ngsg) was calculated using Eq. (3C.1) [7]. 
m(VIo) = (N,„[Qj)/([S] - CMC) (3C. 1) 
where IQ, IQ, [Q], [S] are, respectively, fluorescence intensity in the absence of 
quencher, fluorescence intensity in the presence of the quencher, concentration 
of the quencher and concentration of the IBF. The values of Nagg are given in 
Table 3C.1. It can be seen that the inclusion of polymers tends to lower the 
aggregation number of the micelles in comparison with that in pure water. This 
reduction becomes more evident with increasing the polymer content, i.e., 
aggregation number depends strongly on polymers percentage. Thus, at low 
polymers percentage the amphiphile aggregates are large and few, while at 
higher polymers percentage the amphiphile aggregates are smaller and more 
numerous. 
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Monitoring of H^ NMR chemical shifts (6) 
H^ NMR spectroscopy is the most convenient method for simultaneous 
monitoring of changes in aggregate morphology. Therefore, 'H NMR 
measurements have been performed on the drug/polymer systems in order to 
explore the influence of these polymers in the micelles and of their possible impact 
on the overall micellar structural changes. The 'H NMR spectroscopy was used in 
the present investigation to probe the molecular investigation between ibuprofen 
and the cellulose ether polymers like HPMC, HEC, NaCMC and with synthetic 
polymers like PEG, PVP, DxS. The signals of pure ibuprofen are well visible in 
D2O. In particular, the signals of pure ibuprofen at 0.861 (6H, 2CH3), 1.384 (3H, 
CH3), 1.819 (IH, CH), 2.457 (2H, CH2), 3.606 (IH, CH), and 7.223 ppm (4H, 
aromatic) were observed (Figure 3C.2). 
Evidence of complex formation for the drug-polymer was obtained by 
NMR spectroscopy. It was observed (see the sprctra presented in 
Figures 3C.3-3C.8) that addition of polymers in pure drug caused significant 
displacement in chemical shift values, which clearly indicate molecular interaction 
between ibuprofen and the polymers. Tables 3C.2 and 3C.3 enlist the chemical 
shift values of the proton signals CH3(12, 13), 013(8), CH(ll), CH2(10), CFI(7), 
H3,H5 and H2,FI6 in pure and in the mixtures of ibuprofen with HPMC, HEC, 
PVP, PEG, DxS and NaCMC. Ibuprofen has a hydrophobic surface defined by 
aromatic ring and carbon chains. In its interaction with cellulose ethers, the 
complementary hydrophobic sites are provided by alkyl groups on the 
anhydroglucose carbon ring system of the cellulose ether polymers. Luner et al. [8] 
have reported that cellulose ether polymers possess both apolar and acid-base 
characteristics necessary for hydrophobic and hydrogen bonding interaction. 
Seemingly cellulose ether polymers serve as a template for interaction with the 
drug by hydrogen bonding as well, which may occur among polar sites 
(carboxylate moiety of IBF and pendant hydroxyl groups and ether bonds of the 
cellulose ether polymer) [9]. 
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We have used the technique to study the system containing IBF and 
polymers at their two concentrations. Changes in the chemical shifts of H NMR 
spectrum due to alteration in the chemical environment of amphiphile molecule 
provide direct and strong evidence of aggregation [10, 11] and micellar growth 
[12, 13]. In addition, to see the effect of concentration of IBF, the studies were 
conducted at concentrations below and above the CMC. A representative H NMR 
spectrum obtained for 200 mM IBF (in the absence of polymer) is given in Figure 
3C.2. Similar type of spectra were obtained (consisting of 6 peaks, as marked in 
the Figure 3C.2) in presence of polymers also. The chemical shift (5, ppm) values 
associated with these peaks in presence of different compositions (see Figures 
3C.3-3C.8, 0.10 and 0.50 %, except for NaCMC for which compositions of 0.02 
and 0.002% were used) of the polymers and at different concentrations of IBF (50 
niM and 100 mM) are given in Tables 3C.2 and 3C.3, respectively. 
From Table 3C.2, it is clear that, upon addition of polymer, the 5 values of 
pure ibuprofen increase or shift downfield. This depicts that, on addition of 
polymier to the amphiphilic solution, micellar aggregate gets deshielded. This is 
attributed to decrease in electron charge density in the close proximity of head 
group regions. This, in turn, creates local magnetic effects in alignment with 
applied once and enhances deshielding. A closer observation to Table 3C.2 reveals 
that anionic polymers are more effective in shifting the signal (peak) than non-
ionic ones; the reason being the charge dispersal. Among the non-ionic polymers, 
PEG shows effective signal shifting than PVP, HPMC, and HEC. Structural and 
electronegative effects may be attributive. Among anionic polymers, NaCMC is 
more efficient than DxS. From Table 3C.3 it can be seen that, an increase in the 
concentration of IBF decreases the 5 values for all the studied systems. Here the 
concentrations of IBF used are 50 mM and 100 mM which are the concentrations 
below and above the CMC (i.e., 90 mM), respectively. The results indicate that 
when there is an association of monomers, there is a decrease in 5 values. We have 
seen earlier that the addition of polymers decreases the average aggregation 
number (Nagg) of the micelles which causes decrease in micellar size and hence, 
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one can expect an increase in 5 values. Hydrogen bonding as well as hydrophobic 
interaction between the drug IBF and polymer network would be causing for the 
changes in the chemical shift values of all the protons of the drug. In order to 
provide stronger supporting evidence for the above explanation of the drug-
polymer interaction, results were compared with that of fluorescence 
measurements, which' also show aggregation number of IBF decreasing as the 
polymer %age increases. 
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Figure 3C.1: Plots of In (IQ/IQ) VS. [CPC] for the micellar solution of IBF in 
presence of various compositions of the polymers at 25 °C. 
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Figure 3C.2: 400 MHz ' H N M R spectrum of 200 mM sodium salt of 
ibuprofen in D2O at 25 °C. 
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Figure 3C.3: ^H NMR of ibuprofen in absence (bottom) and presence of 
HPMC (top): The spectra of the two solutions are ahgned and the spectral 
changes are indicative of hydrophobic interaction as resonances proximal to 
polar group in ibuprofen. 
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Figure 3C.4: 'H N M R of ibuprofen in absence (bottom) and presence of HEC 
(top): The spectra of the two solutions are aligned and the spectral changes are 
indicative of hydrophobic interaction as resonances proximal to polar group in 
ibuprofen. 
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Figure 3C.5: ' H N M R of ibuprofen in absence (bottom) and presence of PVP 
(top): The spectra of the two solutions are aligned and the spectral changes are 
indicative of hydrophobic interaction as resonances proximal to polar group in 
ibuprofen. 
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Figure 3C.6: 'H NMR of ibuprofen in absence (bottom) and presence of PEG 
(top): The spectra of the two solutions are aligned and the spectral changes are 
indicative of hydrophobic interaction as resonances proximal to polar group in 
ibuprofen. 
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Figure 3C.7: 'H NMR of ibuprofen in absence (bottom) and presence of DxS 
(top): The spectra of the two solutions are ahgned and the spectral changes are 
indicative of hydrophobic interaction as resonances proximal to polar group in 
ibuprofen. 
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Figure 3C.8: 'H N M R of ibuprofen in absence (bottom) and presence of 
NaCMC (top): The spectra of the two solutions are aligned and the spectral 
changes are indicative of hydrophobic interaction as resonances proximal to 
polar group in ibuprofen. 
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Table 3C.1: Average aggregation number (Nggg) for sodium salt of 
ibuprofen/polymer mixed systems at 25 "C, evaluated on the basis of steady 
state fluorescence quenching measurements. 
Polymers 
HEC 
HPMC 
PEG 
PVP 
NaCMC 
DxS 
% polymer (w/v) 
0.1 
0.1 
1.0 
0.1 
1.0 
1.0 
0.002 
0.02 
0.1 
1.0 
N 
34.5 
27.5 
24.0 
30.0 
23.5 
18.5 
41.0 
29.5 
30.0 
20.5 
139 
Chapter III Parte 
Table 3C.2:'H N M R chemical shifts (5, ppm) of sodium salt of ibuprofen 
(IBF, 200 mM) with various percentages of polymers at 25 "C. 
System 
No Polymer (% w/v) 
Non ionic (% w/v) 
0.10 PEG 
0.50 PEG 
O.IOPVP 
0.50 PVP 
0.10 HPMC 
0.50 HPMC 
0.10 HEC 
0.50 HEC 
Anionic (%w/v) 
0.100 DxS 
0.500 DxS 
0.002 NaCMC 
0.020 NaCMC 
CH3 
(12,13) 
0.861 
0.894 
0.902 
0.895 
0.898 
0.853 
0.856 
0.866 
0.861 
0.905 
0.894 
0.905 
0.902 
CH3 
(8) 
1.384 
1.431 
1.433 
1.431 
1.431 
1.387 
1.389 
1.387 
1.387 
1.433 
1.431 
1.434 
1.433 
Chemical shift (5, ppm^ 
CH 
(11) 
1.819 
1.852 
1.859 
1.853 
1.855 
1.809 
1.813 
1.824 
1.819 
1.836 
1.851 
1.863 
1.860 
CH2 
(10) 
2.457 
2.486 
2.493 
2.487 
2.489 
2.444 
2.449 
2.463 
2.456 
2.499 
2.486 
2.499 
2.496 
1 
CH 
(7) 
3.606 
3.662 
3.665 
3.651 
3.650 
3.607 
3.610 
3.600 
3.641 
3.654 
3.652 
3.655 
3.653 
H3,H5 
H2,H6 
7.223 
7.258 
. 7.263 
7.258 
7.260 
7.213 
7.219 
7.228 
7.223 
7.267 
7.258 
7.268 
7.265 
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Table 3C.3:'H NMR chemical shifts (8, ppm) of sodium salt of ibuprofen 
(IBF) at its different concentrations with various polymers at 25 "C. 
System 
Non ionic C0.50 % w/v) 
50 mM IBF/PEG 
lOOmMIBF/PEG 
50 mM IBF/PVP 
lOOmMIBF/PVP 
50 mM IBF/HPMC 
lOOmMIBF/FIPMC 
50 mM IBF/HEC 
lOOmMIBF/HEC 
Anionic (0.50 % w/v) 
50 niM/DxS 
lOOmM/DxS 
50 mM/NaCMC 
lOOmM/NaCMC 
CH3 
(12,13) 
0.922 
0.921 
0.921 
0.920 
0.878 
0.878 
0.873 
0.873 
0.922 
0.921 
0.921 
0.920 
Chemical shift (5, ppm) 
CH3 
(8) 
1.436 
1.436 
1.434 
1.434 
1.391 
1.394 
1.386 
1.388 
1.435 
1.436 
1.434 
1.435 
CH 
(11) 
1.884 
1.882 
1.862 
1.859 
1.839 
1.838 
1.834 
1.834 
1.885 
1.882 
1.884 
1.881 
CH2 
(10) 
2.523 
2.520 
2.522 
2.519 
2.479 
2.479 
2.475 
2.474 
2.525 
2.522 
2.523 
2.520 
CH 
(7) 
3.675 
3.674 
3.656 
3.656 
3.622 
3.616 
3.645 
3.646 
3.659 
3.658 
3.657 
3.658 
H3,H5 
H2,H6 
7.286 
7.284 
7.285 
7.282 
7.242 
7.241 
7.237 
7.237 
7.288 
7.285 
7.286 
7.283 
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Introduction 
Hydroxypropyl methyl cellulose (HPMC), which contains both 
hydrophobic and hydrophilic structural units [1], is a pharmaceutically 
important polymer. In formulations, it either serves as a part of regulating 
system, as a neutral substance to provide adequate flow properties, or as an 
adsorbent for the drug. It is also used as thickener, stabilizer, emulsifier, water 
retention agent, film-forming agent in petrochemicals, building materials, 
agrochemicals, ink, printing, textile dyeing, paper making, cosmetics, etc. 
Interactions involving polymers and amphiphiles in aqueous solution have 
generated considerable interest among researchers because their 
physicochemical properties are important at least for the aforementioned 
applications [2-6]. 
Amphiphilic drugs, e.g., analgesics, antibiotics, anaesthetics, 
phenothiazines and antidepressants, self-associate into micelles (of course, 
unlike surfactants, with a fewer number of monomers in the resulting 
aggregate). Phenothiazines and tricyclic antidepressants possess an almost 
planar tricyclic ring system with a short hydrocarbon chain carrying a terminal, 
charged nitrogen atom. The presence of the alkylamine side chain confers on 
them a "surfactant-like" behavior, which is manifested by self-association of 
these drugs [7]. However, though they (the drugs) are amphiphilic in nature, 
they are not hydrophilic enough to be used without a earner. Among various 
compounds used as carrier, HPMC is advantageous as a number of different 
substituent and viscosity grade pharmaceutically approved HPMC are 
commercially available [8]. 
Aqueous solutions of HPMC, like other cellulose ethers, show 
characteristic feature of phase-separation at certain temperature, which is 
generally termed as cloud point (CP) [9]. Above the CP, solutions 
spontaneously and reversibly separate into two distinct phases; one phase is 
polymer-rich and the other polymer-lean. Presence of electrolytes in the body 
fluid is an important parameter and their excess/deficiency is the cause of 
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concern under a given situation (say, illness). Giving a HPMC-vectored drug 
to the patient will be influenced by the electrolyte level and, as indicated above, 
the system's CP may change. Though there have been a number of studies on 
the CP of cellulose ethers with various types of surfactants (cationic, anionic, 
nonionic, gemini, etc.,) [1, 10-18], the case in the presence of amphiphilic 
drugs is not so and, therefore, studies concerning their effects on cellulose 
ethers in presence and absence of different types of additives is expected to be 
useful for the advancement of the field in addition to their practical 
applications. 
With this view point we have studied the variation in the cloud point 
(CP) of hydroxypropylmethyl cellulose (HPiMC) solution in presence of three 
amphiphilic drugs, viz., imipramine hydrochloride (IMP), promazine 
hydrochloride (PMZ) and sodium salt of ibuprofen (IBF). Effect of certain 
salts, such as NaF, NaCl, NaBr, NaNOa, Na2S04, Na3P04, KCl, KBr, on the CP 
of HPMC were also examined. The concentrations of drugs as well as the salts 
were varied in the study and the various thermodynamic parameters at CP were 
computed and discussed. 
Results and Discussion 
For the sake of convenience this part has been divided into three parts: 
(a)Effect of drugs on the cloud point of HPMC 
It is known that, in aqueous medium, the HPMC molecules are 
surrounded by a network of water molecules (in a thermodynamically stable 
state) and hence form a clear solution with respect to other conditions such as 
temperature, concentration, etc. [10]. In this study, 1 % (w/v) aqueous solution 
of HPMC was used for which a cloud point of 60 "C was obtained. The 
clouding behavior of HPMC at about 60 °C is due to the destruction of water 
network which becomes a reason for the weak van der Waal's attraction 
between the HPMC molecules leading to a phase separation state. 
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Figure 4.1 shows the effect of adding the amphiphilic drugs, viz., IMP, 
PMZ and IBF on the CP of the aqueous solutions of HPMC. All the three drugs 
show increase in CP as the concentrations of the added drugs are increased. 
However, the increase was found to be minimum (less distinct) in the presence 
of anionic amphiphilic drug IBF, compared to the other two. This is in contrast 
to the effect of surfactants on cellulose ethers as it has been reported that, for a 
studied polymer, the anionic surfactants display much stronger affinity as 
compared to the cationic ones [11-13]. In our previous study [14], we had seen 
the effect of charge (on the head group of the surfactants) on the clouding 
behavior of HPMC. A minimum in the CP curve was observed at a low 
concentration of the anionic surfactants (below the CMC), following a steep 
increase. This type of behavior, however, is not obtained when an anionic drug 
is employed (Figure 4.1). The distinct rise in CP with increase in the drugs 
concentrations is a usual sign of polymer's strong binding with them. From the 
experimental observations, the effectiveness of the drugs to raise the CP value 
is found to be in the order: PMZ > IMP > IBF, which shows stronger 
interaction of the cationic drugs with the polymer as compared to the anionic 
IBF. 
(b)Effect of salts on the cloud point of HPMC+IMP/PMZ/IBF systems 
To extract further information about the influence of salts on the CP of 
HPMC, the measurements were extended with cationic drugs IMP, PMZ and 
anionic IBF in the absence and presence of fixed concentrations of the drugs 
(75 mM and 105 mM). The critical micelle concentration (CMC) of IMP is 
46 mM, PMZ is 36 mM, whereas that of IBF is 90 mM and the chosen 
concentrations were higher than the CMC. Various electrolytes of different 
valences such as NaF, NaCl, NaBr, NaN03, KCl, KBr, Na2S04 and Na3P04 
were added at different concentrations to see their effect on the clouding of 
HPMC. Figures 4.2-4.4, respectively, depict the effect of these salts on the CP 
of 1 % (w/v) aqueous solutions of HPMC in presence and absence of IMP, 
PMZ and IBF. It is clear from the plots that, at fixed concentrations of the 
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drugs the CP decreases regularly with increase in salt concentration. Change in 
the CP of the polymer solution on addition of amphiphiles/electrolytes is 
governed by a subtle balance between electrostatic effect and hydrophobic 
interaction [15]. The increase in CP with respect to the drug concentrations 
indicates increased solubility of the HPMC, which could be attributed to the 
binding of IMP/PMZ/IBF to the HPMC, thereby imposing repulsive interaction 
between polymer chains [7, 12, 15, 16]. In the absence of IMP/PMZ/IBF, the 
decrease in CP is small. However, the system containing IMP/PMZ/IBF causes 
decrease in CP when the salt concentrations are varied. The divalent (S04^~) 
and trivalent (PO4 ~) anions show better efficiency than the monovalents at 
much lower molar concentration. As their salts are highly hydrated [17, 18, 
19], they would be assisting for efficient clouding of HPMC at lower 
concentration than the weakly hydrated salts [17] like NaF, NaCl, NaBr, 
NaN03, KCl and KBr. It is known that the kosmotropic anions cause a salting-
out effect by destabilizing the H-bonds between water and the polar groups of 
the polymer and by increasing the degree of hydration, resulting in a linear 
decrease in CP with increasing salt concentration [20]. In addition, chaotropic 
anions can also cause a slight salting-out effect by increasing the hydrophobic 
hydration. 
On addition of salts, decrease in the CP values of HPMC is observed. It 
can be seen from Figures 4.2-4.4, that, in pure HPMC (i.e., in the absence of 
IMP/PMZ/IBF), the effect of salts on the CP is not strong which implies that 
the interactions between HPMC and salts (caused by the addition of salts) do 
not become prominent when they are present individually in the solution. 
However, the effect becomes pronounced in the presence of drugs 
IMP/PMZ/IBF. As the studied concentrations of the drugs are well above their 
CMC values, the electrostatic interactions between the cationic/anionic drug 
micelles and the added salts are to be taken into consideration. Counterions are 
bound primarily by the electric field created by the head groups and also by 
specific interaction that depends upon head group and counterion type [21]. 
A-two site model has been successfully applied to the distribution of ions, i.e., 
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they are assumed to be either 'bound' to the micelles or 'free' in the aqueous 
phase [22]. Increasing the amount of salts would cause the micellar size to 
increase progressively, which should decrease the CP. At low salt 
concentrations, it does happen. However, as the salt concentration increases, 
the CP starts increasing. Br" ion, although less hydrated than F" ion, can 
approach micellar head group more closely as compared to F ion and hence 
increase the CP more [23, 24]. Figure 4.5 depicts the effect of anions on the CP 
of HPMC in the whole concentration regions of the amphiphilic drugs 
IMP/PMZ/IBF. A minimum in the CP values were observed with the increase 
in the IMP/PMZ drug concentrations and this minimum was found to be near to 
their CMC regions; thereafter the CP values increase sharply. In the case of 
IBF no minimum were obsei-ved except with NaBr. The efficiency to increase 
the CP was found to be in the order: Br" > Cf > F" > NO3", CI" > Br~ > F~ > 
NO3 and CI > Br" > NO3" F" > respectively, for the systems containing IMP/ 
PMZ/IBF and HPMC. 
(c) The cloud point of HPMC with varying salt and drug concentrations 
Effect of sahs, viz., NaCl, NaF, NaBr, KCl, KBr, NaNOj, Na2S04, and 
Na3P04 at their different concentrations on the cloud point of FIPMC can be 
seen from Figure 4.6. Though the effectiveness of various ions is different, 
addition of salts used herein decrease the CP of HPMC. 
To know the phenomenon in detail, the CP of HPMC, in presence and 
absence of fixed salt concentrations, was measured by varying the 
IMP/PMZ/IBF concentration well above critical micelle concentration (CMC) 
values (46 niM), (36 mM), (90 mM) and the plots are given in Figures 4.7-4.9. 
In the absence of salt, the CP of HPMC rises by 18 °C, 22 °C, and 
10 °C, by the addition of 123, 128, and 138 mM IMP/PMZ/IBF, respectively, 
but the increase is gradual [18-20, 22]. The variation in CP with respect to the 
concentration of the IMP/PMZ/IBF in presence of various fixed concentrations 
of NaCl, NaBr, NaF, KCl, KBr, NaNOj, Na2S04, and Na3P04 is found to be 
dependent on the nature and concentration of the salts. For example, in 
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presence of 10, 50, and 100 mM of NaCl, the CP of HPMC initially decreases 
and then increases and, at high NaCl concentrations (200 mM and 500 mM), 
the CP decreases and becomes almost constant with IMP/PMZ. With IBF at 
10 mM and 50 mM of NaCl, the CP of HPMC initially decreases and then 
increases and, at high NaCl concentrations (100, 200, and 500 mM), the CP 
decreases over the entire concentration of IBF. But similar concentrations of 
NaNOa didn't show the same behavior and a higher concentration was required 
to observe the same trend. In presence of Na2S04, flattened 'U' type curves 
resulted with the increase in concentration of PMZ/IBF. Similar 'U' type 
curves were observed in presence of Na3P04 with increase in concentration of 
IMP/IBF. With m/[P/Na2S04 and PMZ/Na3P04, no 'U' type curves were 
observed. The effect of salts on the CP of polymer is controlled by ionic 
hydratibility, ionic size, position in the Hofmeister series 
(chaotropic/kosmotropic nature), etc. 
Energetics at the cloud points 
As is evident, the formation of the separate phases of the components 
present in the solution is recognized as the cloud point. The free energy of 
phase separation or clouding (AG c) is then 
AG°, = RTcplnXe "^^ -^ ^ 
where X^  is the mole fraction solubility at CP, and R is the gas constant 
(8.314 J K~'mor'). The slopes of the linear (least-squares) plots between 
(AGVTCP) versus (1/Tcp), as per Eq. (4.2), were then used to obtain the AH°o 
values 
AH°,= d(AGVTcp)/d(l/Tcp) ^^'^^ 
To calculate the entropy changes, the Gibbs-Helmholtz equation, given below, 
was used 
AS°,= (AH«e-AG°e)/TcP ^^'^^ 
The above rationale has been apphed on the clouding behavior of 
HPMC 1 % (w/v) with the fixed salt concentrations and varying concentration 
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of IMP/PMZ/IBF for the evaluation of the thermodynamics of the process. 
Illustrations of AG°(./Tcp vs. 1/Tcp plots are depicted in Figure 4.10-4.12. 
The values of AG°c, AH c^, and TAS^ c for the studied systems in the 
absence and presence of fixed concentration of various salts (NaCl, NaF, NaBr, 
KCl, KBr, NaNOa, Na2S04 and Na3P04) are given in Tables 4.1-4.4. Both in 
the absence and presence of salts, the AG°c values become less negative as the 
concentration of drug increases in the system which indicates that the clouding 
becomes energetically less favorable. However, the variation in AG°c value 
becomes clear from Figures 4.13-4.15 in which plots of AG°c against the 
[IMP]/[PMZ]/[IBF] are shown. That is, the decrease in magnitude of AG°(. is as 
follows: Initially, there is a steep decrease in magnitude of AG'^ ^ till 
[IMP]/[PMZ]/[IBF] reaches around the critical aggregation concentration 
(CAC) value; after which the steepness decreases till [IMP]/[PMZ]/[IBF] 
reaches around critical micelle concentration (CMC) value; after this, it again 
decreases. In all the cases, the clouding of FIPMC becomes energetically less 
favorable when IMP/PMZ/IBF is present or when its concentration increases in 
the system. It may be mentioned here that the aggregation/assemblance of drug 
monomers decreases the clouding tendency of polymers as indicated by the 
AG c values. 
In the absence of salts, the API ^  and TAS^ c values are negative in all the 
cases and the system becomes slightly more ordered on increasing the 
concentration of IMP/PMZ/IBF as indicated by a decrease in the entropy. 
However, in the presence of salts, AH°c and TAS";. values are negative or 
positive, depending upon the type, nature and concentration of the salt. The 
TAS°c values are found to be negative in most of the systems, except at lower 
concentrations of the IMP/PMZ/IBF in the presence of some salts. This 
behavior may not be expected, as the increase in concentration of drugs can 
cause for the micelle formation and thereby disrupting the water stmcture. 
However, energetic parameters reveal that the disruption of water stmcture 
becomes significantly prominent at lower concentrations of the drugs in the 
presence of fixed concentration of the salts. A decrease in the TAS ^ with the 
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increase in the concentration of drugs suggests that the ordering of drug 
molecules in the presence of HPMC is either not disturbing the water structure 
much or the total entropy of the system is decreased (compared to the 
disordered structure, which is expected at lower concentrations of the 
amphiphilic drugs). 
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Figure 4.1: Effect of various amphiphilic drugs on the CP of 1 % (w/v) 
aqueous solution of HPMC. 
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HPMC. 
154 
Chapter IV 1 Phase Separation Study 
50 100 150 
[Salt](mM) 
200 250 
80 
7 0 -
p 
b" 60-
I 50H 
O 
4 0 -
30 
NaCI NoPMZ 
75 mM PMZ 
PMZ 
200 300 400 500 
[Salt] (mM) 
80-
50-
30-
NaBr 
— I — 
50 
NoPMZ 
75mMPMZ 
105 mM PMZ 
100 150 200 
[Salt] (mM) 
80 
75 
70-
65 
p 
° ^ 6 0 -
"c 
'o 
Q. 5 5 -
2 5 0 -
O 
45 
40 
35 
50 
NoPMZ 
75 mM PMZ 
105 mM PMZ 
200 
[Salt] (mM) 
155 
Chapter IV i Phase Separation Study 
80 
75 
70 
^ 65-
°:r 60-
l 55-
T3 
o 50 -
O 
4 5 -
4 0 -
3 5 -
KBr 
— I — 
50 
- • - No PMZ 
- • - 75 mM PMZ 
-*-105mMPIVIZ 
— I — 
100 
— I — 
150 
[Salt] (mM) 
200 
80 
70 
O 60 
50 
O 
40 
3 0 -
NaNO, No PMZ 
75 mWI PMZ 
lOSmMPMZ 
50 100 150 
[Salt] (mM) 
200 
^ 65 -
O 
6 0 -
55 
O 5 0 -
4 5 -
4 0 -
A Na,SO - NoPMZ 
- 75 mM PMZ 
•105mMPMZ 
50 100 
[Salt] (m\ 
150 200 
35 
0,00 
No PMZ 
105 mM PMZ 
0.05 0.10 
[Salt] (m^ 
0.15 0.20 
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Figure 4.8: Effect of increase in molar concentrations of salt (NaCl, NaF, 
NaBr, KCl, KBr, NaNOa, Na2S04 and Na3P04) on the CP of 1 % (w/v) 
aqueous solution of HPMC with the amphiphilic drug, promazinehydrochloride 
(PMZ). 
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Figure 4.10: Plots of AG°/TCP VS. 1/TCP of 1 % (w/v) aqueous solution of 
HPMC with and without fixed concentration of salt (NaCl, NaF, NaBr, KCl, 
KBr, NaNOs, Na2S04 and Na3P04) with the amphiphilic drug, imipramine 
hydrochloride (IMP). 
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Figure 4.11: Plots of AG^/TCP VS. 1/TCP of 1 % (w/v) aqueous solution of 
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Figure 4.12: Plots of AG°/TCP VS. 1/TCP of 1 % (w/v) aqueous solution of 
HPMC with and without fixed concentration of salt (NaCl, NaF, NaBr, KCl, 
KBr, NaNOa, Na2S04 and Na3P04) with the amphiphilic drug, sodium salt of 
ibuprofen (IBF). 
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Figure 4.13: Plots of AG°of 1 % (w/v) aqueous solution of HPMC vs. [IMP] 
with and without fixed concentration of salt (NaCl, NaF, NaBr, KCl, KBr, 
NaNOs, Na2S04 and Na3P04). 
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Figure 4.14: Plots of AG°of 1 % (w/v) aqueous solution of HPMC vs. [PMZ] 
with and without fixed concentration of salt (NaCl, NaF, NaBr, KCl, KBr, 
NaN03, Na2S04 and Na3P04). 
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Figure 4.15: Plots of AG°of 1 % (w/v) aqueous solution of HPMC vs. [IBF] 
with and without fixed concentration of salt (NaCl, NaF, NaBr, KCl, KBr, 
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Table 4.2: Energetic parameters for clouding of 1 % (w/v) aqueous solution of 
HPMC in the presence of amphiphilic drug, imipramine hydrochloride (IMP) 
and different salts (NaCl, NaBr, NaF, KCl, KBr, NaNOj, Na2S04, Na3P04) at 
their various concentrations. 
[MP] 
(mM) 
6.5 
12.5 
23.5 
33.3 
42.1 
53.7 
63.6 
72.3 
80.0 
86.8 
92.9 
98.3 
103.2 
107.7 
111.8 
115.5 
118.9 
122.1 
125.0 
6.5 
12.5 
23.5 
33.3 
42.1 
50.0 
60.5 
69.6 
77.6 
84.6 
90.9 
96.6 
101.6 
106.3 
110.4 
114.3 
AG"e 
(kJ moF') 
AH'^ c 
(kJ moF') 
NaCl (10 mM) 
-25.0 
-^ 23.2 
•'21.5 
-20.6 
-20.0 
-19.5 
-19.0 
-18.7 
-18.5 
-18.3 
-18.2 
-18.2 
-18.1 
-18.0 
-18.0 
-17.9 
-18.0 
-17.9 
-18.1 
-155.5 
-32.0 
NaCl (100 mM) 
-24.8 
-22.9 
-21.1 
-20.0 
-19.4 
-19.0 
-18.5 
-18.2 
-17.9 
-17.8 
-17.7 
-17.7 
-17.5 
-17.5 
-17.5 
-17.5 
279.8 
-27,0 
TAS"e 
(kJmoF') 
-130.5 
-132.3 
-134.0 
-134.9 
-135.5 
-136.0 
-136.5 
-136.8 
-137.0 
-13.6 
-13.7 
-13.8 
-13.9 
-13.9 
-14.0 
-14.0 
-14.0 
-14.0 
-13.9 
304.6 
302.7 
300.9 
299.8 
299.2 
-110.1 
-no.6 
-110.9 
-111.2 
-9.3 
-9.4 
-9.5 
-9.6 
-9.5 
-9.5 
-9.6 
[MP] 
(mM) 
6.5 
12.5 
18.2 
23.5 
28.6 
37.8 
50.0 
60.5 
69.6 
77.6 
84.6 
90.9 
96.6 
101.6 
106.3 
110.4 
114.3 
117.8 
6.5 
12.5 
18.2 
23.5 
28.6 
37.8 
46.2 
53.7 
60.5 
69.6 
80.0 
100.0 
114.3 
125.0 
AG^e 
(kJmor') 
Affe 
(kJ moF') 
NaCl (50 mM) 
-24.9 
-23.0 
-22.0 
-21.4 
-20.8 
-20.0 
-19.3 
-18.8 
-18.5 
-18.3 
-18.1 
-17.9 
-17.8 
-17.8 
-17.7 
-17.7 
-17.6 
-17.6 
-113.0 
-34.6 
NaCI (200 mM) 
-24.6 
-22.6 
-21.4 
-20.6 
-20.0 
-19.2 
-18.7 
-18.4 
-18.1 
-17.7 
-17.3 
-16.8 
-16.5 
-16.3 
140.5 
-143.6 
TAS"c 
(kJ moF') 
-88.1 
-90.0 
-91.0 
-91.6 
-92.2 
-93.0 
-93.7 
-94.2 
-94.5 
-94.7 
-94.9 
-16.7 
-16.8 
-16.8 
-16.9 
-17.0 
-17.0 
-17.0 
165.1 
163.1 
161.9 
161.1 
160.5 
159.7 
159.2 
158.9 
-125.5 
-125.9 
-126.3 
-126.8 
-127.1 
-127.3 
contd.... 
180 
117.8 
121.1 
124.1 
6.5 
12.5 
18.2 
23.5 
33.3 
46.2 
57.1 
72.3 
94.7 
110.4 
122.1 
131.0 
6.5 
18.2 
42.1 
60.5 
75.0 
86.8 
96.6 
104.8 
117.8 
127.7 
6.5 
18.2 
42.1 
60.5 
75.0 
86.8 
96.6 
104.8 
117.8 
127.7 
135.5 
6.5 
18.2 
42.1 
60.5 
75.0 
86.8 
-17.4 
-17.3 
-17.3 
NaCl (500 mM) 
-24.0 140.9 
-21.9 
-20.7 
-20.0 
-19.0 
-18.2 
-17.7 
-17.0 
-16.4 
-16.0 
-15.8 
-15.6 
-67.8 
NaF (10 niM) 
-222.4 -197.5 
-57.3 
-200.4 
-202.6 
-203.4 
-38.8 
-39.1 
-39.3 
-39.4 
-39.6 
-39.8 
NaF (100 mlVl) 
-24.5 531.4 
-21.6 
-19.3 
-18.3 
-17.9 
-17.6 
-17.4 
-17.2 
-17.0 
-17.0 
-17.0 
-70.3 
NaF (230 mM) 
-24.0 310.2 
-21.0 
-18.7 
-17.7 
-17.3 
-16.9 
-87.0 
-9.6 
-9.7 
-9.7 
164.9 
162.8 
161.6 
160.9 
159.9 
159.1 
158.6 
157.9 
157.3 
-51.8 
-52.0 
-52.1 
-32.4 
-35.3 
-37.4 
-38.3 
-38.8 
-39.1 
-39.3 
-39.4 
-39.6 
-39.8 
555.9 
553.0 
550.7 
-52.0 
-52.4 
-52.7 
-52.9 
-53.1 
-53.3 
-53.5 
-53.6 
334.2 
331.2 
328.9 
327.9 
-69.8 
-70.1 
Chapter 
6.5 
18.2 
42.1 
60.5 
75.0 
86.8 
96.6 
104.8 
117.8 
127.7 
6.5 
18.2 
42.1 
60.5 
75.0 
86.8 
96.6 
104.8 
117.8 
127.7 
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NaF (50 mM) 
-24.6 -329.7 
-21.8 
-19.5 
-18.7 
-18.2 -67.6 
-17.9 
-17.7 
-17.6 
-17.4 
-17.2 
NaF (200 mM) 
-24.1 310.8 
-21.1 
-18.8 
-17.9 -100.7 
-17.4 
-17.1 
-16.9 
-16.7 
-16.5 
-16.3 
1 Study 
-305.1 
-307.9 
-310.2 
-311.0 
-49.4 
-49.6 
-49.8 
-50.0 
-50.2 
-50.3 
334.9 
331.9 
329.6 
-82.8 
-83.3 
-83.6 
-83.8 
-84.0 
-84.2 
-84.4 
contd.... 
181 
96.6 
104.8 
117.8 
127.7 
12.5 
23.5 
46.2 
63.6 
77.6 
88.9 
106.3 
118.9 
128.6 
12.5 
23.5 
46.2 
63.6 
77.6 
88.9 
106.3 
118.9 
128.6 
12.5 
37.8 
57.1 
72.3 
84.6 
94.7 
103.2 
110.4 
122.1 
131.0 
18.2 
33.3 
53.7 
69.6 
82.4 
-16.7 
-16.6 
-16.3 
-16.1 
NaBr (10 mM) 
-23.0 
-21.3 
-19.5 
-18.8 
-18.4-
-18.2 
-17.8 
-17.5 
-17.4 
-175.5 
-70.9 
NaBr (100 ni^ I) 
-22.7 
-20.7 
-18.7 
-18.0 
-17.6 
-17.3 
-16.8 
-16.6 
-16.4 
KCl (10 
-23.1 
-20.1 
-19.1 
-18.6 
-18.2 
-18.0 
-17.9 
-17.8 
-17.6 
-17.4 
KCl (100 
-21.6 
-19.8 
-18.6 
-18.0 
-17.6 
139.9 
-106.5 
mM) 
-120.3 
-61.8 
mM) 
0.9 
-57.0 
-70.3 
-70.5 
-70.7 
-70.9 
-152.5 
-154.2 
-156.0 
-156.7 
-52.5 
-52.8 
-53.1 
-53.4 
-53.6 
162.6 
160.7 
158.6 
-88.5 
-88.9 
-89.2 
-89.6 
-89.9 
-90.0 
-97.2 
-100.2 
-101.2 
-101.7 
-43.5 
-43.7 
-43.9 
-44.0 
-44.2 
-44.3 
22.5 
20.8 
19.5 
-39.0 
-39.4 
Chapter 
12.5 
23.5 
33.3 
53.7 
69.6 
82.4 
92.9 
101.6 
109.1 
115.5 
125.9 
134.1 
12.5 
23.5 
33.3 
42.1 
60.5 
12.5 
37.8 
57.1 
72.3 
84.6 
94.7 
110.4 
122.1 
131.0 
12.5 
37.8 
57.1 
72.3 
84.6 
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NaBr (50 mM) 
-22.8 
-20.9 
-20.0 
-18.7 
-18.1 
-17.8 
-17.6 
-17.4 
-17.3 
-17.2 
-17.0 
-16.9 
-64.6 
-52.4 
NaBr (200 mM) 
-22.5 
-20.3 • 
-19.3 
-18.7 
-17.8 
KCl (50 
-22.8 
-19.8 
-18,8 
-18.3 
-18.0 
-17.8 
-17.4 
-17.3 
-17.2 
KCl (200 
-22.6 
-19.2 
-18.2 
-17.6 
-17.2 
0.9 
-242.5 
mM) 
-112.8 
-61.0 
mM) 
0.9 
-65.9 
I Study 
-41.7 
-43.6 
-44.6 
-45.8 
-46.4 
-46.8 
-47.0 
-35.0 
-35.0 
-35.2 
-35.3 
-35.5 
23.4 
21.2 
-223.2 
-223.8 
-224.7 
-90.0 
-93.0 
-94.0 
-94.5 
-42.9 
-43.2 
-43.5 
-43.7 
-43.8 
23.5 
20.1 
-47.7 
-48.3 
-48.6 
contd.... 
182 
92.9 
101.6 
115.5 
125.9 
134.1 
6.5 
33.3 
53.7 
75.0 
90.9 
103.2 
113.0 
124.1 
132.6 
12.5 
23.5 
46.2 
63.6 
77.6 
88.9 
98.3 
106.3 
113.0 
124.1 
132.6 
6.5 
18.2 
28.6 
50.0 
66.7 
80.0 
90.9 
100.0 
107.7 
114.3 
120.0 
129.4 
-17.4 
-17.2 
-17.0 
-16.8 
-16.8 
KBr(10 
-24.8 
-20.5 
-19.2 
-18.4 
-18.0 
-17.9 
-17.7 
-17.5 
-17.4 
imM) 
-387.7 
-58.3 
KBr (100 mM) 
-22.7 
-20.7 
-18.7 
-18.0 
-17.5 
-17.2 
-17.0 
-16.8 
-16.7 
-16.5 
-16.4 
139.9 
-68.5 
NaNOa (10 niM) 
-24.9 
-22.1 
-20.9 
-19.4 
-18.7 
-18.3 
-18.1 
-17.9 
-17.8 
-17.7 
-17.6 
-17.5 
-195.4 
-46.1 
-39.6 
-39.8 
-40.0 
-40.2 
-40.2 
-362.9 
-367.2 
-368.5 
-369.3 
-40.3 
-40.4 
-40.6 
-40.8 
-40.9 
162.6 
160.6 
158.6 
157.9 
-51.0 
-51.3 
-51.5 
-51.7 
-51.8 
-52.0 
-52.1 
-170.5 
-173.3 
-174.5 
-176.0 
-176.7 
-27.7 
-28.0 
-28.2 
-28.3 
-28.4 
-28.5 
-28.6 
Chapter 
94.7 
110.4 
122.1 
131.0 
6.5 
33.3 
53.7 
69.6 
82.4 
92.9 
104.8 
114.3 
125.0 
133.3 
12.5 
23.5 
46.2 
63.6 
77.6 
88.9 
106.3 
6.5 
18.2 
28.6 
37.8 
46.2 
63.6 
77.6 
88.9 
98.3 
106.3 
113.0 
118.9 
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-17.0 
-16.7 
-16.6 
-16.5 
KBr (50 niM) 
-24.8 
-20.0 
-18.8 
-18.2 
-17.8 
-17.6 
-17.4 
-17.2 
-17.1 
-17.0 
KBr 
-22.9 
-21.0 
-18.5 
-17.6 
-17.2 
-16.9 
-16.5 
-138.2 
-42.0 
(200 mlSl) 
62.7 
-129.7 
NaN03 (50 niM) 
-24.8 
-21.8 
-20.3 
-19.5 
-19.0 
-18.3 
-17.8 
-17.6 
-17.4 
-17.3 
-17.2 
-17.1 
212.7 
-46.7 
Study 
-48.8 
-49.1 
-49.3 
-49.4 
-113.4 
-118.2 
-119.4 
-120.0 
-120.4 
-24.4 
-24.6 
-24.7 
-24.9 
-25.0 
85.5 
83.7 
81.2 
80.3 
-112.5 
-112.8 
-113.2 
237.5 
234.5 
233.0 
232.2 
231.7 
-28.5 
-28.9 
-29.2 
-29.3 
-29.4 
-29.6 
-29.7 
contd.... 
183 
6.5 
12.5 
18.2 
23.5 
28.6 
37.8 
46.2 
63.6 
77.6 
88.9 
98.3 
106.3 
113.0 
118.9 
124.1 
132.6 
6.5 
18.2 
42.1 
60.5 
75.0 
86.8 
96.6 
104.8 
111.8 
117.8 
127.7 
6.5 
1,2.5 
33.3 
53.7 
69.6 
82.4 
92.9 
101.6 
115.5 
125.9 
134.1 
NaN03 (100 mM) 
-24.8 101.9 
-22.7 
-21.6 
-20.6 
-20.0 
-19.1 
-18.7 
-17.9 
-17.5 
-17.3 
-17.1 
-16.9 
-16.8 
-16.7 
-16.7 
-16.5 
-62.1 
Na2S04 (1 niM) 
-25.2 
-22.3 
-20.1 
-19.2 
-18.8 
-18.5 
-18.3 
-18.1 
-18.0 
-17.9 
-17.7 
-92.0 
-74.3 
Na2S04 (5 mM) 
-25.2 
-23.3 
-20.7 
-19.4 
-18.8 
-18.5 
-18.4 
-18.1 
-17.8 
-17,6 
-17.5 
-375.3 
-94.9 
126.7 
124.6 
123.5 
122.5 
121.9 
121.0 
-43.4 
-44.2 
-44.6 
-44.8 
-45.0 
-45.2 
-45.3 
-45.4 
-45.4 
-45.6 
-66.8 
-69.7 
-71.9 
-72.7 
-73.2 
-55.8 
-56.0 
-56.2 
-56.3 
-56.4 
-56.6 
-350.1 
-352.0 
-354.6 
-355.9 
-356.5 
-76.4 
-76.5 
-76.7 
-77.1 
-77.3 
-77.4 
Chaptei 
124.1 
132.6 
6.5 
12.5 
18.2 
33.3 
53.7 
69.6 
6.5 
18.2 
42.1 
60.5 
75.0 
86.8 
96.6 
104.8 
111.8 
117.8 
127.7 
6.5 
12.5 
23.5 
46.2 
63.6 
77.6 
88.9 
98.3 
106.3 
113.0 
118.9 
124.1 
132.6 
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-17.0 
-16.9 
NaN03 (200 mM) 
-24.6 90.3 
-22.4 
-21.2 
-19.2 
-17.7 
-17.1 
Na2S04 (2 niM) 
-25.2 
-22.4 
-20.1 
-18.7 
-18.4 
-18.2 
-18.1 
-17.9 
-17.8 
-17.6 
-25.2 
-379.6 
-58.3 
Na2S04 (10 mM) 
-24.9 586.1 
-23.1 
-21.3 
-19.6 
-18.9 
-18.5 
-18.3 
-18.1 
-18.0 
-17.9 
-17.8 
-17.7 
-17.6 
-45.3 
-29.7 
-29.9 
114.9 
112.7 
111.5 
109.5 
108.0 
107.4 
-354.4 
-357,2 
-359.5 
-360.4 
-39.6 
-39.9 
-40.1 
-40.3 
-40.4 
-40.5 
-40.7 
611.0 
609.2 
607.4 
605.7 
-26.4 
-26.8 
-27,0 
-27,2 
-27.3 
-27,4 
-27,5 
-27,6 
-27,7 
contd,,,. 
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6.5 
12.5 
37.8 
57.1 
72.3 
84.6 
94.7 
103.2 
110.4 
122.1 
131.0 
6.5 
42.1 
60.5 
75.0 
86.8 
96.6 
104.8 
111.8 
123.1 
77.6 
88.9 
98.3 
106.3 
113.0 
118.9 
Na2S04 (15 mM) 
-25.1 
-23.3 
-20.3 
-19.1 
-18.5 
-18.1 
-18.0 
-17.8 
-17.7 
-17.4 
-17.3 
-152 
-78.8 
Na3P04 (0.1 niM) 
-24.9 
-18.8 
-18.6 
-18.4 
-18.2 
-18.2 
-18.0 
-17.9 
-17.7 
Na3P04 
-17.2 
-17.3 
-17.3 
-17.6 
-17.7 
-17.7 
0.8 
-30.3 
(0.5 mM) 
-11.1 
-1495.9 
-1497.7 
-1500.7 
-1501.9 
-60.3 
-60.7 
-60.9 
-61.0 
-61.2 
-61.4 
-61.6 
25.7 
19.6 
-11.7 
-11.9 
-12.1 
-12.1 
-12.3 
-12.4 
-12.6 
6.1 
6.2 
6.2 
6.4 
6.6 
6.6 
6.5 
18.7 
42.5 
60.8 
75.3 
89.1 
100.2 
109.2 
116.8 
126.9 
134.9 
6.5 
72.3 
84.6 
94.7 
103.2 
110.4 
116.7 
Na2S04 (20 mM) 
-25.0 
-22.1 
-19.8 
-18.9 
-18.5 
-18.0 
-17.8 
-17.7 
-17.5 
-17.4 
-17.2 
-132.4 
-56.2 
Na3P04 (0.2 mM) 
-23.7 
-17.9 
-17.9 
-18.0 
-18.0 
-17.9 
-17.8 
0.74 
-16.1 
-107.4 
-110.3 
-112.6 
-113.5 
-113.9 
-38.2 
-38.4 
-38.6 
-38.7 
-38.9 
-39.0 
24.4 
18.6 
1.8 
1.9 
1.9 
1.8 
1.7 
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Table 4.3: Energetic parameters for clouding of 1 % (w/v) aqueous solution of 
HPMC in the presence of amphiphilic drug, promazine hydrochloride (PMZ) 
and different salts (NaCl, NaBr, NaF, KCl, KBr, NaNOs, Na2S04, Na3P04) at 
their various concentrations. 
[PMZ] 
(mM) 
6.5 
18.2 
33.3 
46.2 
57.1 
66.7 
80.0 
90.9 
100.0 
107.7 
114.3 
120.0 
125.0 
129.4 
133.3 
6.5 
12.5 
23.5 
33.3 
42.1 
50.0 
57.1 
66.7 
80.0 
90.9 
100.0 
107,7 
114,3 
125,0 
6,5 
12.5 
AG", 
(kJ mor') 
AH^ e 
(kJ mor') 
NaCl (10 mM) 
-25.0 292.6 
-22.0 
-20.2 
-19.2 
-17.9 
-17.9 
-18.1 
-18.0 
-18.1 
-18.2 
-18.1 
-18.0 
-17.9 
-17.9 
-17.8 
-17.8 
NaCl (100 niM) 
-24.6 141.8 
-22.6 
-20.7 
-19.5 
-19.1 
-18.7 
-18.4 
-18.0 
-17.6 
-17.4 
-17.3 
-17.1 
-17.0 
-16.8 
NaCI 
-23.7 
-21.5 
-75.1 
(500 mM) 
1.0 
TAS"c 
(kJmor') 
317.6 
314.6 
312.8 
311.8 
35.7 
35.7 
35.8 
35.8 
35.9 
36.0 
35.8 
35.7 
35.7 
35.6 
35.6 
166.4 
164.4 
162.5 
-55.6 
-56.1 
-56.4 
-56.8 
-57.1 
-57.5 
-57.7 
-57.9 
-58.0 
-58.1 
-58.3 
24.7 
22.5 
[PMZ] 
(mM) 
6.5 
12.5 
23.5 
37.8 
50.0 
60.5 
69.6 
82.4 
92.9 
101.6 
109.1 
115.5 
121.1 
125.9 
130.2 
6.5 
12.5 
23.5 
33.3 
46.2 
57.1 
72.3 
94.7 
131.0 
AG'^ e 
(kJ mor') 
AH^ c 
(kJ mor') 
NaCl (50 mM) 
-24.6 99.1 
-22.6 
-20.5 
-18.9 
-18.8 
-18.7 
-18.4 
-18.2 
-17.9 
-17.7 
-17.6 
-17.5 
-17.4 
-17.4 
-17.3 
-43.6 
NaCl (200 mM) 
-24.3 115.6 
-22.3 
-20.2 
-19.3 
-18.5 
-18.0 
-17.4 
-16.7 
-16.0 
-159.6 
TAS'e 
(kJ mor') 
123.7 
121.7 
119.6 
118.0 
-24.8 
-24.8 
-25.2 
-25.4 
-25.6 
-25.9 
-25.9 
-26.1 
-26.1 
-26.2 
-26.2 
139.9 
137.9 
135.8 
134.9 
134.1 
133.6 
-142.2 
-142.9 
-143.6 
contd.... 
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18.2 
28.6 
37.8 
46.2 
57.1 
66.7 
75.0 
6.5 
53.7 
69.5 
82.3 
92.9 
101.6 
6.5 
53.7 
69.6 
82.4 
92.9 
101.6 
115.5 
125.9 
134.1 
6.5 
53.7 
69.6 
82.4 
92.9 
101.6 
115.5 
125.9 
134.1 
66.7 
80.0 
90.9 
100.0 
107.7 
114.3 
120.0 
125.0 
129,4 
-20.5 
-19.3 
-18.5 
-18.0 
-17.5 
-17.1 
-16.9 
NaF (10 
-23.7 
-18.6 
-18.2 
-18.0 
-17.9 
-18.0 
NaF 
-24.3 
-17.9 
-17.7 
-17.6 
-17.5 
-17.4 
-17.2 
-17.1 
-17.1 
NaF 
-23.8 
-18.0 
-17.2 
-16.9 
-16.6 
-16.4 
-16.1 
-16.0 
-15.9 
NaBr 
-17.7 
-17.6 
-17.7 
-17.7 
-17,7 
-17.8 
-17.7 
-17.6 
-17,6 
(IOC 
(230 
(10 
185.4 
-105.8 
mM) 
-17.5 
1 mM) 
0.8 
-29.5 
niM) 
400.7 
-81.2 
mM) 
17.9 
21.5 
204.7 
203.9 
203.4 
-88.3 
-88.7 
-88.9 
6.3 
1.1 
0.8 
0.5 
0.5 
0.5 
25.1 
18.7 
-11.8 
-11.9 
-12.0 
-12.1 
-12.3 
-12.4 
-12.5 
424.5 
418.7 
417.9 
-64.3 
-64.5 
-64.7 
-65.0 
-65.2 
-65.3 
-0.2 
-0.3 
-0.2 
-0.2 
-0.2 
-0.1 
-0.2 
-0.3 
-0.3 
Chapter 
6.5 
53.7 
69.6 
82.4 
92.9 
101.6 
115.5 
125.9 
134.1 
6,5 
53.7 
69.6 
82.4 
92.9 
101.6 
115.5 
125.9 
134.1 
50.0 
66.7 
80.0 
90.9 
100.0 
107.7 
120.0 
129.4 
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NaF (50 
-24.4 
-17.8 
-17.7 
-17.6 
-17.5 
-17.5 
-17,5 
-17,4 
-17,4 
NaF (20C 
-23,8 
-18.0 
-17.5 
-17.1 
-16.8 
-16.1 
-16,0 
-16,1 
-16,0 
NaBr 
-18.9 
-18,3 
-18.0 
-17,7 
-17,6 
-17.5 
-17,2 
-17,1 
(50 
mM) 
0.8 
-21.2 
1 mM) 
0.8 
•111.4 
mM) 
55,6 
Study 
25.2 
18.6 
-3.5 
-3.6 
-3.7 
-3.7 
-3.8 
-3.8 
-3.9 
24.5 
18.8 
-93.9 
-94.3 
-94.6 
-94.8 
-95.1 
-95.3 
-95.4 
-36.7 
-37.2 
-37.5 
-37,8 
-38,0 
-38,1 
-38.3 
-38.5 
contd.... 
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28.6 
50.0 
66.7 
80.0 
100.0 
114.3 
125.0 
133.3 
57.1 
72.3 
84.6 
94.7 
103.2 
110.4 
116.7 
122.1 
131.0 
37.8 
57.1 
72.3 
84.6 
103.2 
116.7 
126.8 
134.8 
6.5 
37.8 
57.1 
72.3 
84.6 
94.7 
104.8 
117.8 
127.7 
135.5 
6.5 
12.5 
NaBr (100 mM) 
-19.8 0.9 
-18.4 
-17.6 
-17.3 
-16.8 
-16.5 
-16.3 
-16.2 
KCl (10 
-17.9 
-17.7 
-17.7 
-17.7 
-17.7 
-17.8 
-17.9 
-17.8 
-17.7 
-73.8 
mM) 
-17.2 
KCl (100 mM) 
-19.2 -112.2 
-18.2 
-17.7 
-17.4 
-17.0 
-16.8 
-16.7 
-16.6 
KBr 
-24.8 
-19.2 
-18.0 
-17.9 
-17.9 
-17.8 
-17.9 
-17.8 
-17.7 
-17.7 
KBr 
-24.4 
-22.2 
(10 
(100 
-39.5 
mM) 
132.1 
-20.1 
mM) 
156.1 
20.7 
19.3 
-56.2 
-56.6 
-57.1 
-57.3 
-57.5 
-57.6 
0.74 
0.57 
0.53 
0.49 
0.57 
0.58 
0.68 
0.60 
0.50 
-93.0 
-94.0 
-94.5 
-94.8 
-22.5 
-22.7 
-22.8 
-22.9 
156.9 
151.3 
150.1 
-2.2 
-2.1 
-2.2 
-2.2 
-2.3 
-2.4 
-2.4 
180.5 
178.3 
80.0 
90.9 
100.0 
107.7 
114.3 
57.1 
72.3 
84.6 
94.7 
110.4 
122.1 
131.0 
37.8 
57.1 
84.6 
6.5 
12.5 
37.8 
57.1 
72.3 
84.6 
94.7 
103.2 
110.4 
122.1 
131.0 
6.5 
12.5 
NaBr (200 mM) 
-16.7 -69.6 
-16.4 
-16.2 
-16.1 
-16.0 
KCl (50 mM) 
-18.3 -23.1 
-18.2 
-18.0 
-17.8 -77.5 
-17.4 
-17.2 
-17.1 
KCl (200 mM) 
-18.9 -327.7 
-17.9 
-17.0 
KBr (50 mM) 
-24.5 145.7 
-22.2 
-19.2 
-18.5 -43.6 
-18.0 
-17.8 
-17.6 
-17.5 
-17.4 
-17.2 
-17.1 
KBr (200 mM) 
-24.2 0.9 
-22.2 
-52.9 
-53.2 
-53.4 
-53.5 
-53.6 
-4.8 
-4.8 
-5.1 
-59.7 
-60.1 
-60.3 
-60.4 
-308.8 
-309.8 
-310.7 
170.2 
167.9 
164.9 
-25.1 
-25.6 
-25.9 
-26.1 
-26.2 
-26.2 
-26.4 
-26.5 
25.1 
23.1 
contd.... 
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37.8 
57.1 
72.3 
84.6 
94.7 
110.4 
122.1 
131.0 
6.5 
33.3 
53.7 
69.6 
82.4 
92.9 
101.6 
109.1 
115.5 
6.5 
12.5 
37.8 
57.1 
72.3 
84.6 
94.7 
103.2 
110.4 
122.1 
131.0 
6.5 
12.5 
23.5 
33.3 
42.1 
50.0 
57.1 
63.6 
69.6 
77.6 
84.6 
94.7 
103.2 
110.4 
116.7 
126.8 
-19.1 
-17.9 
-17.4 
-17.1 
-16.8 
-16.5 
-16.3 
-16.1 
-87.3 
NaNOa (10 mM) 
-24.9 
-20.2 
-18.7 
-18.0 
-18.0 
-17.8 
-17.7 
-17.6 
-17.5 
288.2 
-39.5 
NaN03 (100 niM) 
-24.5 
-22.2 
-18.8 
-17.9 
-17.4 
-17.0 
-16.8 
-16.6 
-16.4 
-16.3 
-16.1 
Na2S04 
-24.9 
-23.0 
-21.1 
-19.3 
-19.0 
-18.9 
-18.8 
-18.8 
-18.7 
-18.5 
-18.4 
-18.2 
-18.0 
-17.9 
-17.8 
-17.7 
105.7 
-92.4 
(10m]\'I) 
291.2 
1.0 
-33.9 
175.2 
174.0 
-69.9 
-70.2 
-70.4 
-70.8 
-71.0 
-71.1 
313.1 
308.4 
306.9 
306.2 
-21.5 
-21.7 
-21.9 
-21.9 
-22.0 
130.1 
127.9 
124.5 
-74.4 
-75.0 
-75.3 
-75.6 
-75.8 
-75.9 
-76.1 
-76.2 
316.1 
314.2 
22.1 
20.3 
-14.9 
-15.0 
-15.1 
-15.1 
-15.2 
-15.3 
-15.5 
-15.7 
-15.9 
-16.0 
-16.1 
-16.2 
Chapter 
18.2 
42.1 
60.5 
75.0 
96.6 
6.5 
33.3 
53.7 
69.6 
82.3 
92.9 
101.6 
109.1 
115.5 
6.5 
12.5 
37.8 
57.1 
72.3 
84.6 
94.7 
103.2 
6.5 
12.5 
23.5 
33.3 
42.1 
53.7 
63.6 
72.3 
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-20.7 
-18.4 
-17.5 
-17.1 
-16.5 
-186.8 
NaNOs (50 mM) 
-24.7 
-19.6 
-18.8 
-18.3 
-18.2 
-17.9 
-17.8 
-17.7 
-17.7 
Nn: 
• -24.3 
-22.1 
-18.8 
-17.6 
-16.9 
-16.4 
-16.1 
-16.0 
Na; 
-24.4 
-22.4 
-20.5 
-19.9 
-19.3 
-18.7 
-18.3 
-18.0 
0.8 
-36.2 
NO3 (200 niM) 
126.7 
-76.3 
.SO4 (50 mM) 
157.1 
-171.3 
Study 
21.6 
19.3 
-169.3 
-169.7 
-170.3 
25.5 
20.4 
-17.4 
-17.9 
-18.1 
-18.3 
-18.4 
-18.5 
-18.5 
151.0 
148.8 
145.5 
144.3 
143.6 
-60.0 
-60.2 
-60.4 
181.5 
179.5 
177.6 
-151.4 
-152.0 
-152.6 
-153.0 
-153.3 
contd.. 
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134.8 
6.5 
18.2 
28.6 
37.8 
50.0 
66.7 
80.0 
90.9 
100.0 
107.7 
114.3 
120.0 
129.4 
101.6 
109.1 
115.5 
121.1 
125.9 
130.2 
134.1 
-17.5 
Na2S04 (100 mM) 
-24.7 74.1 
-21.2 
-19.5 
-19.2 
-18.7 
-18.1 
-17.8 
-17.5 
-17.3 
-17.1 
-17.0 
-16.9 
-16.8 
-70.8 
Na3P04 (0.1 m 
-16.5 -15.1 
-16.5 
-16.5 
-16.6 
-16.6 
-16.6 
-16.6 
M) 
-16.3 
98.8 
95.3 
93.6 
-51.6 
-52.2 
-52.7 
-53.1 
-53.4 
-53.6 
-53.7 
-53.8 
-53.9 
-54.0 
1.4 
1.4 
1.4 
1.5 
1.4 
1.5 
1.5 
Chapter 
6.5 
18.2 
28.6 
37.8 
50.0 
66.7 
80.0 
100.0 
116.7 
131.0 
101.6 
109.1 
115.5 
121.1 
125.9 
130.2 
134.1 
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Na2S04 (200 mM) 
-24.4 139.8 
-21.1 
-19.7 
-19.1 
-18.3 
-17.6 
-17.1 
-16.6 
-16.2 
-16.0 
-135.1 
Na3P04 (0.2 mM) 
-16.4 -34.2 
-16.3 
-16.2 
-16.2 
-16.1 
-16.1 
-16.0 
164.2 
160.9 
159,5 
158.9 
158.1 
-117.5 
-118.0 
-118.5 
-118.9 
-119.1 
-17.9 
-17.9 
-18.0 
-18.1 
-18.1 
-18.2 
-18.2 
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Table 4.4: Energetic parameters for clouding of 1 % (w/v) aqueous solution of 
HPMC in the presence of amphiphilic drug, sodium salt of ibuprofen (IBF) and 
different salts (NaCl, NaBr, NaF, KCl, KBr, NaNOj, Na2S04, Na3P04) at their 
various concentrations. 
[IBF] 
(mM) 
6.5 
12.5 
37.8 
57.1 
72.3 
84.6 
103.2 
12.5 
23.5 
46.2 
63.6 
88.9 
106.3 
118.9 
136.2 
12.5 
23.5 
46.2 
63.6 
77.6 
88.9 
106.3 
118.9 
6.5 
33.3 
53.7 
69.6 
82.4 
92.9 
101.6 
109.1 
121.1 
130.2 
AG\ 
(kJ mof') 
AH"e 
(kJmoF') 
NaCl (10 mM) 
-24.9 
-23.1 
-20.0 
-18.9 
-18.3 
-17.9 
-17.4 
NaCl 
-22.9 
-21.1 
-19.3 
-18.4 
-17.4 
-16.8 
-16.5 
-16.1 
NaCl 
-22.4 
-20.6 
-18.7 
-17.7 
-17.0 
-16.5 
-15.9 
-15.5 
801.4 
-176.3 
(100 niM) 
289.4 
91.2 
(500 mM) 
355.2 
49.1 
NaF (100 mM) 
-24.6 
-20.0 
-18.7 
-18.0 
-17.5 
-17.1 
-16.8 
-16.6 
-16.3 
-16.0 
721.5 
72.5 
TAS"e 
(kJmoF') 
826.3 
824.5 
821.4 
-157.4 
-158.0 
-158.4 
-158.9 
312.3 
310.5 
308.7 
307.8 
108.6 
108.0 
107.7 
107.2 
377.6 
375.8 
373.9 
66.7 
66.1 
65.5 
65.0 
64.6 
746.1 
741.5 
740.2 
739.5 
90.0 
89.7 
89.4 
89.1 
88.8 
88.5 
[IBF] 
(mM) 
6.5 
12.5 
37.8 
57.1 
72.3 
84.6 
103.2 
12.5 
23.5 
46.2 
63.6 
77.6 
98.3 
113.0 
124.1 
6.5 
33.3 
53.7 
69.6 
82.4 
92.9 
101.6 
115.5 
125.9 
134.1 
AG", 
(kJmol 
AH", 
') (kJ moF') 
NaCI (50 mM) 
-24.9 
-23.0 
-19.9 
-18.9 
-18.3 
-17.9 
-17.4 
m 
-22.9 
-21.1 
-19.2 
-18.3 
-17.6 
-16.8 
-16.4 
-16.1 
796,6 
-176.3 
iCl (200 mM) 
489.4 
64.8 
NaF (200 mM) 
-24.1 
-19.6 
-18.3 
-17.5 
-16.9 
-16.5 
-16.2 
-15.8 
-15.5 
-15.3 
444.9 
57.4 
TAS"e 
(kJ mof') 
821.5 
819.6 
816.5 
-157.4 
-158.0 
-158.4 
-158.9 
512.3 
510.5 
508.6 
507.7 
82.4 
81.6 
81.1 
80.8 
469.0 
464.5 
463.2 
74.9 
74.3 
73.9 
73.6 
73.2 
72.9 
72.7 
contd.... 
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137.5 
6,5 
33.3 
53.7 
69.6 
82.4 
92.9 
101.6 
115.5 
125.9 
134.1 
12.5 
37.8 
57.1 
72.3 
84.6 
103.2 
116.7 
134.8 
12.5 
37.8 
57.1 
72.3 
94.7 
110.4 
131.0 
28.6 
50.0 
66.7 
80.0 
90.9 
100.0 
12.5 
37.8 
57.1 
72.3 
84.6 
-15.8 
NaF (230 mM) 
-24.1 442.1 
-19.6 
-18.2 
-17.4 
-16.8 
-16.4 
-16.1 
-15.7 
-15.5 
-15.3 
65.7 
NaBr (10 mM) 
-23.1 -696.9 
-20.1 
-19.1 
-18.5 
-18.1 
-17.6 
-17.3 
-16.9 
-146.8 
NaBr (100 mM) 
-23.1 -293.4 
-20.0 
-18.9 
-18.3 
-17.6 
-17.2 
-16.8 
-149.3 
NaBr (500 mM) 
-20.6 70.4 
-18.8 
-17.8 
-17.2 
-16.7 
-16.4 
KCl 
-22.9 
-19.8 
-18.7 
-18.0 
-17.5 
(100 mM) 
675.5 
100.6 
88.4 
466.2 
461.7 
460.3 
83.1 
82.5 
82.1 
81.8 
81.5 
81.2 
81.0 
-673.8 
-676.8 
-677.8 
-128.3 
-128.7 
-129.2 
-129.5 
-129.9 
-270.3 
-273.4 
-274.5 
-275.1 
-131.7 
-132.1 
-132.5 
91.0 
89.1 
88.2 
87.6 
87.1 
^6.^ 
698.4 
695.3 
694.2 
118.6 
118.1 
12.5 
37.8 
57.1 
72.3 
94.7 
110.4 
131.0 
28.6 
50.0 
66.7 
80.0 
90.9 
100.0 
114.3 
125.0 
133.3 
12.5 
37.8 
57.1 
72.3 
84.6 
NaBr 
-23.1 
-20.0 
-18.9 
-18.4 
-17.7 
-17.3 
-16.9 
(50 mM) 
-295.2 
-150.2 
NaBr (200 mM) 
-20.7 104.2 
-19.0 
-18.1 
-17.5 
-17.0 
-16.7 
-16.5 
-16.3 
-16.3 
-26.0 
KCl (200 mM) 
-22.7 402.9 
-19.7 
-18.4 
-17.6 49.4 
-17.1 
-272.1 
-275.2 
-276.3 
-276.8 
-132.5 
-132.9 
-133.3 
124.9 
123.2 
122.3 
121.7 
121.2 
120.9 
-9.5, 
-9.7 
-9.7 
425.6 
422.6 
421.3 
67.0 
66.5 
contd.... 
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103.2 
116.7 
126.8 
12.5 
37.8 
57.1 
72.3 
84.6 
94.7 
6.5 
33.3 
53.7 
75.0 
90.9 
107.7 
120.0 
6.5 
12.5 
23.5 
46.2 
69.6 
86.8 
104.8 
117.8 
127.7 
135.5 
6.5 
12.5 
23.5 
46.2 
63.6 
77.6 
88.9 
98.3 
106.3 
113.0 
118.9 
'28.6 
-16.9 
-16.3 
-16.0 
KCl 
-22.5 
-19.3 
-17.9 
-17.1 
-16.5 
-16.1 
KBi 
-24.9 
-20.5 
-19.2 
-18.4 
-17.9 
-17.5 
-17.3 
KBr 
-25.0 
-23.1 
-21.3 
-19.4 
-18.2 
-17.6 
-17.1 
-16.7 
-16.4 
-16.2 
KBr 
-24.8 
-22.9 
-21.2 
-19.3 
-18.2 
-17.4 
-16.9 
-16.6 
-16.4 
-16.2 
-16,0 
-15.7 
1 (500 niM) 
0.9 
40.2 
• (10 mM) 
-573.3 
-147.7 
(100 iiiM) 
545.6 
74.9 
(500 niM) 
583.1 
50.6 
Chapter 
117.5 94.7 
116.9 
116.6 
23.3 
20.1 
58.1 
57.3 
56.7 
56.3 
-548,4 
-552.8 
-554.1 
-554.9 
-129.8 
-130.2 
-130.4 
570.6 
568.7 
566.9 
565.0 
563.8 
563.2 
92.0 
91.6 
91.4 
91.2 
607.9 
606.0 
604.3 
602.4 
68.8 
68.0 
67.6 
67.3 
67.0 
66.8 
66,6 
66,3 
110,4 
122,1 
131,0 
6,5 
53,7 
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